MASS SPECTROMETRY METHOD DEVELOPMENT FOR THE DISCOVERY AND CHARACTERIZATION OF SECONDARY METABOLITES by Kelley, Zachary
University of Kentucky 
UKnowledge 
Theses and Dissertations--Chemistry Chemistry 
2021 
MASS SPECTROMETRY METHOD DEVELOPMENT FOR THE 
DISCOVERY AND CHARACTERIZATION OF SECONDARY 
METABOLITES 
Zachary Kelley 
University of Kentucky, zachkelley64@yahoo.com 
Author ORCID Identifier: 
https://orcid.org/0000-0002-7076-5450 
Digital Object Identifier: https://doi.org/10.13023/etd.2021.282 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Recommended Citation 
Kelley, Zachary, "MASS SPECTROMETRY METHOD DEVELOPMENT FOR THE DISCOVERY AND 
CHARACTERIZATION OF SECONDARY METABOLITES" (2021). Theses and Dissertations--Chemistry. 143. 
https://uknowledge.uky.edu/chemistry_etds/143 
This Doctoral Dissertation is brought to you for free and open access by the Chemistry at UKnowledge. It has been 
accepted for inclusion in Theses and Dissertations--Chemistry by an authorized administrator of UKnowledge. For 
more information, please contact UKnowledge@lsv.uky.edu. 
STUDENT AGREEMENT: 
I represent that my thesis or dissertation and abstract are my original work. Proper attribution 
has been given to all outside sources. I understand that I am solely responsible for obtaining 
any needed copyright permissions. I have obtained needed written permission statement(s) 
from the owner(s) of each third-party copyrighted matter to be included in my work, allowing 
electronic distribution (if such use is not permitted by the fair use doctrine) which will be 
submitted to UKnowledge as Additional File. 
I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and 
royalty-free license to archive and make accessible my work in whole or in part in all forms of 
media, now or hereafter known. I agree that the document mentioned above may be made 
available immediately for worldwide access unless an embargo applies. 
I retain all other ownership rights to the copyright of my work. I also retain the right to use in 
future works (such as articles or books) all or part of my work. I understand that I am free to 
register the copyright to my work. 
REVIEW, APPROVAL AND ACCEPTANCE 
The document mentioned above has been reviewed and accepted by the student’s advisor, on 
behalf of the advisory committee, and by the Director of Graduate Studies (DGS), on behalf of 
the program; we verify that this is the final, approved version of the student’s thesis including all 
changes required by the advisory committee. The undersigned agree to abide by the statements 
above. 
Zachary Kelley, Student 
Dr. Bert Lynn, Major Professor 
Dr. Yinan Wei, Director of Graduate Studies 
MASS SPECTROMETRY METHOD DEVELOPMENT FOR THE DISCOVERY AND




A dissertation submitted in partial fulfillment of the 
requirements for the degree of Doctor of Philosophy in the 
College of Arts and Sciences 
at the University of Kentucky 
By 
Zachary David Kelley 
Lexington, Kentucky 
Director: Dr. Bert C. Lynn, Professor of Chemistry 
Lexington, Kentucky 
2021 
Copyright © Zachary David Kelley 2021 
https://orcid.org/0000-0002-7076-5450
     
 




MASS SPECTROMETRY METHOD DEVELOPMENT FOR THE DISCOVERY AND 
CHARACTERIZATION OF SECONDARY METABOLITES 
 
Secondary metabolites are organic compounds produced by an organism for 
reasons other than growth and development. In plants, secondary metabolites generally 
act as defense agents produced to deter predators and inhibit other competitive species. 
For humans, these compounds can often have a beneficial effect and are pursued and 
utilized as natural pharmaceuticals. The development of sensitive, high-throughput 
analytical screening methods for plant derived metabolites is crucial for natural 
pharmaceutical product discovery and plant metabolomic profiling. Here, metabolomic 
profiling methods were developed using a microfluidic capillary zone electrophoresis 
device and evaluated against traditional separation approaches. An alkaloid screening 
assay was constructed to analyze transgenic mutant plant extracts for novel metabolites. 
Putatively identified novel features were detected, elucidated, and then isolated and 
purified for pharmaceutical evaluation. Additionally, methods for the analysis of 
polyphenolic plant-derived secondary metabolites, such as cannabinoids, were also 
developed and evaluated. In this case, the occurrence of cross-instrumental variation was 
addressed, given the tight legal restrictions regarding commercialization the products in 
question. Lastly, the microfluidic CZE-MS methods were further applied for both 
primary and secondary metabolite profiling in a DMPK assay. This assay was developed 
to inclusively monitor metabolic changes as a response to varying concentrations of a 
therapeutic in circulation. The metabolomic methods developed and evaluated in this 
work displayed high sensitivity, efficiency, and accuracy and can be utilized across a 
wide variety of applications.  
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CHAPTER 1.  INTRODUCTION 
Background 
The term “natural products” refers to the class of chemical compounds arising from 
biological sources of production ranging from simple bacteria to complex plants, fungi, 
and animals. These chemical entities arise from both primary and secondary metabolic 
pathways. Natural products have been used medicinally across the world for thousands of 
years, with recorded uses dating back as far as 2600 BC in Mesopotamia.1–3 Though 
diverse in origin, it has been reported that over 50% of natural products commercially 
available for a variety of uses are plant derived secondary metabolites.3–6 These plant-
derived natural products are also the foundation behind a majority of traditional Chinese 
medicines (TCM).2,7 Organic and medicinal chemists have found interest in these novel 
metabolites and extensively investigate their chemical properties and pharmacological 
activities. These investigations of natural products have motivated method development 
for new practical separation techniques, structure elucidation experiments, and synthetic 
methodologies that now constitute the foundations of modern organic, analytical, and 
medicinal chemistry. This interest in natural products has been both academic and driven 
by the potential industrial impact of their complex biosynthesis and application.7 Natural 
products are commonly commercialized as dyes, industrial fibers, adhesives, oils, waxes, 
flavors, fragrances, and, most importantly, pharmaceuticals.2,7 Recognition of the 
potential biological activity associated with a myriad of natural products has fueled the 
current focus of this field, specifically, the search for new pharmaceuticals, antibiotics, 
and pesticides. This field is also a source of many analytical challenges. The complex 
nature of these metabolites paired with the wide variety of compounds with subtly 
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different variations to their structures all found within the same organism greatly 
complicate the analysis and characterization of these compounds. These complexities and 
similarities also complicate downstream purification for pharmacological testing and 
production. The focus of this work is to develop new metabolomics-centered analytical 
methods for the discovery and characterization of several types of secondary plant 
metabolites. 
Secondary Metabolites and Metabolomics 
The metabolic products produced by all living organisms are classified as either 
primary or secondary metabolites. Primary metabolites are fairly conserved across all 
living organisms and consist of groups of small molecules that are crucial for survival 
such as nucleic acids, amino acids, and lipids.7 Secondary metabolites are organic 
molecules that are not necessarily essential to the normal growth or development of an 
organism.7 While primary metabolites have a key role in the survival of the species, the 
absence of secondary metabolites does not result in immediate death, but rather in long-
term impairment of the organism’s survivability, as they often play an important role in 
defense. There is some ambiguity in the classification, however, as many primary and 
secondary metabolites share biosynthetic pathways or similar base structures. Secondary 
metabolites are produced by all types of organisms, but the most commonly discussed 
secondary metabolites are those produced by plants.7–10 Most plant secondary 
metabolites, such as terpenes, phenolic compounds, and alkaloids are classified based on 
their biosynthetic origin or key chemical functional groups. Figure 1.1 displays some 











sulfur-based compounds. Terpenes, the largest class with over 25,000 known compounds, 
consist of varying combinations of isoprene subunits, with subclasses based on the 
number of subunits. Terpenes are highly volatile compounds often associated with the 
scent of a plant (pinene, limonene, myrcene, linalool, etc). Phenolic compounds, though 
less diverse with approximately 8000 identified secondary metabolites, make up a larger 
portion of the total biomass of plants due to lignin falling under the category. This 
subclass also contains more homologous secondary metabolites conserved across 
numerous species such as various stilbenes, flavonoids, anthraquinones, and tannins. 
Lastly are the more exotic nitrogen or, less common, sulfur containing compounds. These 
metabolites are usually derived from amino acids, specifically in the case of true 
alkaloids, and are the most heterologous of secondary metabolites.11 Despite the vast 
diversity of these secondary metabolites, both within and between classes, similarities 
can be observed in their biosynthesis (Figure 1.2). Primary biosynthetic pathways, such 
as the shikimate, phenylpropanoid, and polyketide pathways, are fairly conserved across 
species, with differences not usually occurring until the later enzymatic conversions.12   
 The role of many of these metabolites in plants has been a subject of debate as 
there are multiple plausible explanations for their presence. Several hypotheses have been 
presented: 1) they are the byproducts of mutations and are not harmful or beneficial, 2) 
they are an example of “evolution in progress” in that they are the result of the organism 
attempting to make new functional metabolites, 3) they are waste products, 4) further 
expanding on 2), the enzymes responsible for their production are the result of 
prophylactic measures to ensure primary metabolism is unhindered, 5) they formerly had 











 resulted as evolutionary responses to aid in the survival of the plant by acting as 
attractors or deterrents.13,14 It is also likely that all six hypotheses are true to an extent, 
however the sixth would confer the most evolutionary advantage. As attractors, such as 
pigments or fragrances, these metabolites could function to attract for pollinators or be 
secreted in resins as defense agents to trap predators and insects.14,15 As deterrents, bitter 
taste as well as antibiotic and antimicrobial activities are often associated with many 
secondary metabolites. A defense-centric evolutionary impact can also be inferred in that 
environmental stressors, such as microbial exposure, UV light, temperature, and chemical 
exposure can often affect the relative expression rate of these metabolites.16 
 The activity and application associated with these plant secondary metabolites has 
been of interest to humans for centuries. Traditional Chinese Medicine (TCM) texts, such 
as the The Chinese Materia Medica (1100 B.C.), list various plant-based treatments in the 
form of ointments, tinctures, and extracts.2 Unfortunately, many of the both beneficial 
and determinantal effects discovered before the advent of modern science were the result 
of trial and error driven by the growing necessity of curing new diseases and ailments.17 
Modern controlled in vitro and in vivo assays have since reduced the risk behind testing 
the efficacy of these metabolites and have allowed scientists to uncover the specific 
sources of the activity. These scientific advances have resulted in not only a massive 
academic field, especially in eastern cultures, focusing on understanding how ancient 
remedies, such as those found throughout TCM, function, but also in the development of 
lead compounds with industrial application and as treatments for many diseases and 
conditions. Figure 1.3 shows an example of three out of the thousands of naturally 








pharmaceuticals. Gallic acid, a simple acidic, phenolic secondary metabolite, is widely 
utilized as a dye, an excellent base molecule for organic synthesis, and even as a 
treatment for reducing coronary arterial disease and arterial thrombosis.18 Quinine, a 
more complex quinoline alkaloid approved by the FDA in 2004 for pharmaceutical use, 
had been used for centuries for the treatment of malaria, fever, indigestion, mouth and 
throat diseases and cancer.2,7,19 Increasing in complexity, paclitaxel (Taxol®) isolated 
from the bark of Taxus brevifolia, has been widely utilized as a chemotherapeutic agent 
for the treatment of ovarian, esophageal, breast, lung, cervical, and pancreatic 
cancer.2,4,17,19–24 Despite paclitaxel’s complexity, the application of the metabolite has 
caused the demand to exceed what is practical in terms of natural isolation (~2g per 
treatment requires the bark of six 100-year-old trees versus 50,000 treatments annually), 
therefore synthetic and semi-synthetic methods have been developed.2,19 The demand for 
these naturally-derived products has increased exponentially over the past few decades, 
owing to the success of therapeutics like paclitaxel and the avoidance of complex organic 
synthesis to design lead compounds for initial testing. Additionally, the public desire for 
more “natural” consumer products has further compelled interest in refocusing research 
towards identification and application of these metabolites. 
 Not all aspects of the secondary metabolite natural product field are positive, 
however. Drug abuse has plagued society throughout the history of both modern and 
ancient medicine. Almost all commonly abused drugs (Figure 1.4) are of natural origin. 
The most historically well-known abused natural products would be those derived from 
the alkaloid, morphine, produced by the opium poppy, Papaver somniferum. Morphine is 









narcotic analgesic and highly addictive drug of abuse. It is also the precursor to heroin, 
diacetylmorphine, a schedule I-controlled substance twice as potent as its precursor.16,22 
Cocaine is a tropane alkaloid derived from the leaves of Erythroxylon coca. It is a 
schedule II-controlled topical anesthetic, potent central nervous system stimulant, and 
adrenergic blocking agent.16,22 Cannabinoids, such as ∆9−ΤΗC, are a unique class of 
secondary metabolites derived from the buds of various Cannabis plant species, such as 
Cannabis sativa and Cannabis indica. Various schedules (III-V) are assigned to the 
cannabinoids, however, they are not considered to be of high risk for abuse and have 
been legalized for reactional use in several states. Psilocybin (fungal secondary 
metabolite derived from various members of the genus Psilocybe), lysergic acid 
(precursor to LSD, or “acid”, derived from ergot fungus and found in the seeds of various 
flowering plants), and mescaline (protoalkaloid found in the peyote cactus, Lophophora 
williamsii) all hallucinogenic or psychedelic schedule I-controlled substances.7,22 Despite 
the risk of abuse, the beneficial applications of secondary metabolite natural products 
maintain the necessity for the continued effort and investigations in regards to these 
complex and novel metabolic entities.  
 The discovery and characterization of these complex metabolites presents an 
analytical challenge. When testing for possible activity, inclusive whole plant extracts or 
simple partitions of the extracts are screened in a high-throughput manner. If activity is 
observed, analytical chemists are then tasked with the difficult process of generating 
inclusive metabolite profiles of the whole or fractionated extracts to determine the 
molecular constituents that may be the source of the activity. The generation of these 










 Metabolomics is a branch of the “-omic” sciences defined as the “systematic 
study of the unique chemical fingerprints that specific cellular processes leave behind.”25–
27 When paired with the other “-omic” sciences, such as genomics, transcriptomics, and 
proteomics, metabolomics can provide information in regards to the phenotypic 
expression of different organisms, especially plants. The analytical targets of these 
analyses are largely primary and secondary metabolites with molecular weights less than 
1500 Da.26 Comprehensive metabolomic profiling assays typically focus on dividing the 
metabolome into subsets of metabolites, usually based on compound polarity, common 
functional groups, or structural similarity. From there, specific sample preparation or 
extraction methods and analytical procedures are developed and optimized for each 
subset.25,26 This leads to a patchwork effect when attempting to discuss an organisms 
entire metabolome. Focused efforts have been placed on developing new and efficient 
separation and analytical techniques to aid in the deconvolution of these complex 
datasets. With over 6,500 common known metabolites recorded, these analyses can be 
cumbersome and complicated.25 Metabolomic databases, such as METLIN - developed 
by the Scripps Research Institute, have been developed to aid in the process and, as of 
2021, consist of over 850,000 entries. The primary analytical tools used for metabolomic 
profiling consist of a form of chromatographic or electropherographic separation (gas 
chromatography -GC, liquid chromatography – LC, or capillary electrophoresis – CE) 
coupled to mass spectrometry. As new metabolomics methods are developed and 
technological advancements are made in the field of mass spectrometry, metabolomic 
profiles will become more and more pivotal to our understanding of an organism’s 




The framework for what we now know as modern mass spectrometry was first laid 
by Sir J. J. Thompson with his discovery of the electron in 1897 and description of an 
analytes mass-to-charge ratio, or “m/z”.28,29 Over a decade later in 1912, Thompson 
invented the first mass spectrometer, then known as the “parabola spectrograph”.28 In the 
century since its invention, the field of mass spectrometry has seen numerous 
revolutionary advancements, furthering the technology to a point where it is regularly 
applied across nearly every scientific discipline. To better understand the magnitude of 
these advancements, for example, the improvement of mass resolution can be examined. 
A mass spectrometer’s resolving power is described as the ability of the instrument to 
separate two mass spectral peaks and is calculated by analyzing the ratio of an analytes’ 
mass to the width of the observed mass spectral peak.28 Thompson’s parabola 
spectrograph had a resolving power (RP) of approximately 13, meaning that an ion at m/z 
150 would have a mass spectral peak ranging ~11.5 mass units from approximately m/z 
144 to m/z 156.28 Modern instruments, such as the widely utilized Thermo Q Exactive 
High Resolution Accurate Mass (HRAM) orbitrap mass spectrometer (RP=140,000) or 
the Bruker Scimax (RP= 20,000,000) would detect the same mass peak with widths less 
than 0.001 and 0.000001 respectively. The continued evolution, development, and wide 
application of this analytical tool has further strengthened mass spectrometry as one of 
the most useful and important analytical tools in modern science.  
Though a variety of different types of mass spectrometers have been developed, 
their general working principle is fairly conserved. Samples and analytes are delivered to 
the instrument using an external device such as an LC, GC, or a simple syringe pump.30 
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Upon delivery, the analytes are ionized, using a variety of ionization sources, and 
introduced into the mass spectrometer. Ionization source selection is dependent on the 
nature of the sample matrix and chemical properties of the analytes themselves. Upon 
ionization, the newly formed ions are separated by a mass analyzer. The mass analyzer is 
the section of the instrument responsible for the instruments’ resolving power and they 
are significantly more diverse than the ionization sources. Modern instruments often 
employ more than one of these components, aiding to their higher resolving powers and 
allowing them to be utilized for controlled fragmentation of selected ions, thus providing 
structural information of the analytes as well. Following separation of the ions by the 
analyzers, the ions strike a detection plate inducing an electron cascade, in the case of an 
electron multiplier, and the amplified response is converted into the aforementioned 
mass-to-charge ratio (m/z). In addition to these components, a complex high vacuum 
system is employed throughout the mass spectrometer to maintain a “mean-free path” to 
allow the ions to travel through to the detector uninterrupted. These high vacuum systems 
can reach pressures often as low as 10-10 mbar. A general block diagram of a mass 
spectrometer can be seen in Figure 1.6. The following sections will discuss the finer 
details of some of these mass spectral components to further elucidate the inner workings 










1.1.1 Ionization Sources 
As stated above, analytes must be ionized prior to their separation by the mass 
analyzer. There are a number of ionization techniques employed by modern mass 
spectrometers and the choice is usually dependent on the particular experiment, 
specifically, if a prior form of separation is in place (i.e. LC or GC) and the physical 
nature of the analyte. Ionization sources can be generally grouped by the phase 
requirements of the analytes for proper ionization. Electron ionization (EI) and chemical 
ionization (CI) require analytes to be in the gas phase under vacuum for ionization using 
electrons emitted by a heated filament.28,30,31 These methods are generally employed for 
GC applications and result in fragmentation of the analytes into fragment ions, 
classifying these as “hard ionization methods”. Other, more niche, ionization methods, 
like MALDI (matrix-assisted laser desorption ionization) and SIMS (secondary ion mass 
spectrometry), employ lasers or primary ion beams to ‘desorb’ sample molecules that 
ionize in the subsequent gas phase from a solid surface, such as a MALDI target. These 
sources are better suited for higher mass analytes (>500). The work found in this 
dissertation centers around the use of atmospheric pressure ionization (API) methods, 
specifically, electrospray ionization (ESI). API methods are considered to be “soft” 
ionization methods, in that the analytes are usually detected as intact ions resulting from 
either protonation/deprotonation or cation/anion adduct formation, depending on the 
polarity of the source.32–35  Aside from ESI, atmospheric pressure chemical ionization 
(APCI) and atmospheric pressure photoionization (APPI) are also classified as API 
methods. In APCI, a coronal discharge is used to ionize a reagent gas which then 
interacts with and subsequently ionizes the desolvated analytes through interactions such 
17 
 
as a proton transfer.28,30,33 In APPI, a hydrogen or krypton discharge lamp is used to 
produce 10-10.6 eV photons to ionize analytes that have ionization energy below that of 
the emitted photon.30 Both APPI and APCI are fairly similar and only differ in the usage 
of a photon source rather than the coronal discharge. The method primarily used in this 
work, however, is ESI. John Fenn first developed ESI in 1988 and subsequently was 
awarded a Nobel Prize in 2002 for his contributions.28,30,32 It is arguably the most widely 
utilized ionization source in modern mass spectrometry applications, especially when 
coupling liquid chromatography. In ESI, analytes within a solution are pumped through a 
stainless-steel emitter, or “spray needle”, that is held at a higher potential in regard to the 
inlet of the mass spectrometer. As the solvent solution is pumped through the needle, the 
applied potential causes a “Taylor cone” to form as a combinatorial result of the dipole of 
water in the solvent solution and repulsion of the cations/anions dissolved in solution 
depending on the polarity of the applied potential. In addition to the applied potential, a 
stream of nitrogen gas is also supplied to aid in aerosolization and desolvation of the 
solvated analytes into ions. Droplets are emitted from the tip of the Taylor Cone as a 
result of increasing charge density. The droplets consist of both charged species (protons 
and cations for positive ion mode) and solvated analytes and move toward the inlet of the 
mass spectrometer, driven by both the supplied nitrogen stream and the potential 
difference. The subsequent mechanism of ESI in which the droplets convert to single 
ionized analytes has been explained using two separate models, though it is likely that the 
actual mechanism is a combination of both models. The first model, the Ion Evaporation 
Model (IEM – Figure 1.7) states that, as the droplets evaporate as a function of the 





Figure 1. 7 Electrospray ionization diagram displaying both the ion evaporation model 




Once the charge density has reached a point known as the Rayleigh limit, the repulsion of 
the like-charged ions overcomes the surface tension of the droplet and analyte ions are 
ejected in a similar manner to how the droplets are ejected from the Taylor Cone.28,30,32–35 
For the second model, the Charged Residue Model (CRM – Figure 1.7), when the 
Rayleigh limit has been reached, it is believed that the droplets undergo serial fissions as 
a result of coulombic explosions. These sequential fissions continue until only single 
analyte ions remain and enter the gas phase.1,3,5-8 The electrospray process is widely 
applicable and can be utilized at a variety of flow rates ranging from mL/min to nL/min 
depending on the application and the parameters in place.30  
1.1.2 Mass Analyzers 
Mass spectrometers are usually classified in terms of their mass analyzers. The 
two main classes of analyzers are “beam” analyzers, such as magnetic sector, quadrupole, 
and time-of-flight analyzers, and “trapping” analyzers, such as ion trap, ion cyclotron 
resonance, and orbitrap analyzers. Within each class, however, the difference between 
analyzers is vast and certain metrics must be utilized to make accurate comparisons. 
These metrics are the mass range limit, the analysis speed, the transmission of ions, the 
mass accuracy, and the resolving power (described above).28 Mass range limit and 
analysis speed are fairly self-explanatory, the mass range limit describes the operating 
window in which ions can be measured and the speed is a measure of how long it takes to 
measure the ions in that range. Transmission describes the ratio of ions that enter the 
instrument versus the amount that make it all the way to the detector due to more 
mechanical loss, such as collisions with transfer lenses. This is not to be confused with 
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the “duty cycle” which describes the proportion of time that a system is active within a 
given period. For example, if a wide m/z window is being analyzed but only single m/z’s 
are transmitted at a time, the duty cycle will be low.30 The transmission of an instrument 
is a direct function of the instruments design whereas the duty cycle is a function of the 
applied parameters (full scan vs single ion monitoring- SIM, 100% duty cycle). Mass 
accuracy is directly related to the resolving power of the mass analyzer. An analyzer with 
low resolving power will also have low accuracy. The mass accuracy is derived from the 
difference between m/zobserved and m/zexpected on a ppm or mmu scale. The mass analyzers 
primarily used in this work are quadrupoles and orbitraps. 
Quadrupole mass analyzers are currently among the most popular analyzers 
installed in modern mass spectrometers and are often utilized in tandem with other 
analyzers. Figure 1.8 displays the general setup of a quadrupole mass analyzer. The 
analyzer consists of four parallel metal rods connected pairwise to combination of RF (V)  
and DC voltages (U) with the pairs being 180o out of phase from each other. 30,36–38 At a 
given RF and DC voltage, only ions of a certain m/z are allowed to pass through and 
reach the detector. Ions traveling through the z-axis will experience the electric field and 
be transmitted if their trajectories are stable in the xy plane and do not exceed r0 (Figure 
1.8). For a beam of positively charged ions traveling in the xz plane, as the x electrodes 
cycles between a positive and negative potential, ions will oscillate from being focused 
toward the center axis (positive potential) to moving towards the rods (negative 
potential). The y electrodes operate with an equal potential in magnitude but 180o out of 









Through this, ions are filtered based on their m/z. This motion is better describe using the 
following equations:28,30,36–38 















Where ze is the charge and 𝜕𝜕 represents the applied potentials and are defined as: 
𝜕𝜕0 = +(𝑈𝑈 − 𝑉𝑉 cos𝜔𝜔𝑑𝑑)  𝑎𝑎𝑎𝑎𝑑𝑑  −𝜕𝜕0 = −(𝑈𝑈 − 𝑉𝑉 cos𝜔𝜔𝑑𝑑)  
𝜕𝜕(𝑥𝑥,𝑦𝑦)  =  𝜕𝜕0(𝑥𝑥2  −  𝑦𝑦2)/𝑟𝑟02  =  (𝑥𝑥2  −  𝑦𝑦2)(𝑈𝑈 −  𝑉𝑉 𝑐𝑐𝑐𝑐𝑐𝑐 𝜔𝜔𝑑𝑑)/𝑟𝑟02 
 
 
Further rearrangement and differentiating leads to the Paul equation named after 












(𝑈𝑈 − 𝑉𝑉 cos𝜔𝜔𝑑𝑑)𝑦𝑦 = 0 
While these equations describe the trajectory of an ion at a given m/z, further 
information is required to truly understand the stable trajectory on an ion through the 
quadrupoles. Here, incorporation of the Mathieu equation is employed: 
𝑑𝑑2𝑢𝑢
𝑑𝑑𝑑𝑑2
+ (𝑎𝑎𝑢𝑢 − 2𝑞𝑞𝑢𝑢 cos 2𝑑𝑑)𝑢𝑢 = 0 
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Finally, implementation of the above equations can be used to plot the stable 
combinations of applied RF and DC voltages for an ion at a given m/z to have a stable 
trajectory through the mass analyzer, as depicted in Figure 1.9 where: 
𝑎𝑎𝑢𝑢 =  
8𝑧𝑧𝑧𝑧𝑈𝑈
𝑚𝑚𝜔𝜔2𝑟𝑟02




As depicted in Figure 1.9, the specific combinations of different DC (U) and RF 
(V) voltages are the driving factors behind the stable trajectory. The area under the 
triangular region corresponds to the combinations of U and V in which a specific m/z is 
stable, however, not all m/z’s stability diagrams superimpose, as seen in the above 
equation. The dashed line stability curves in Figure 1.9 represent other m/z’s stable 
trajectories. The “scan line” denotes the slope at which U and V are ramped. The angle of 
the slope can be adjusted to increase or decrease the resolution of ions with differing 
m/z’s, which is inversely proportionate to the signal intensity. Quadrupoles generally 
have a working m/z limit of 4000 and a maximum resolution of 2000.30 Additionally, the 
usage of RF only and no application of DC voltages allows for the passage of all ions 
with no resolution. This is referred to as an “ion guide” and is used to focus or transmit 
ions in larger, complex mass spectrometers. Quadrupoles are the most robust and cost-
effective mass analyzers and are widely employed. Further aiding to their recent wide-
spread adoption, modern mass spectrometers automatically make the RF and DC voltage 
adjustments for the operator depending on their desired m/z limits, easing their usage for 





Figure 1. 9 Mathieu stability diagram describing the stable trajectory of an ion through 




 Another mass analyzer that, recently, has become increasingly popular is the 
orbitrap. First developed by Makarov in 1999 and commercialized in 2005, the orbitrap is 
an electrostatic ion trap that uses the axial harmonic motion of ions to determine the 
m/z.30,39 The orbitrap, as depicted in the lower left side of the box diagram of the Thermo 
Fisher Q Exactive in Figure 1.10, consists of a pair of electrodes, shaped like a barrel cut 
in half, with a central spindle electrode in the z axis. In the case of positive ion mode 
detection, ions are injected through a hole in the outer electrode (ground), attracted by a 
negative kV voltage applied to the spindle. Once injected into the orbitrap, the ions adopt 
a circular/oval trajectory around the central spindle and oscillate along the z-axis as 













� + 𝐶𝐶 
Where r and z are the cylindrical coordinates, C is a constant, Rm is the radius, and k is 
the field curvature. The above equation can be utilized to derive how ions at a given m/z 
move within the orbitrap in an axial and radial direction, as well as their rotational 
frequency, however, only the frequency of the axial oscillations (ω) is dependent on the 





The axially rotation of the ions generates an image current as the ions rotate around the 
center electrode and oscillate between the two halves of the outer electrode. The image 
current generated as the ions axially oscillate while maintaining their orbital trajectories 
is then amplified and converted into corresponding m/z signals using a Fourier transform. 
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Orbitraps offer one of the highest resolutions among mass analyzers, rivaled only by FT-







Figure 1. 10 Thermo Q Exactive High Resolution Accurate Mass (HRAM) orbitrap mass 




Orbitraps also offer high mass accuracy as well, with the use of internal calibrants (lock 
masses) resulting in low single digit to sub-ppm accuracies. Drawbacks of the analyzer 
arise from the reduction in scan speed as resolution increases as the resolving power is 
proportional to the time in which the oscillations are recorded. At low resolution 
(17,500), ~8-10  scans can be performed in a second while at high resolution (140,000), 
only 1-2 scans can be acquired. Additionally, orbitraps, like FT-ICR analyzers, require 
ultra-high vacuum for optimal performance (10-10 mbar). 28,30,39–42 
 The Thermo Q Exactive  High Resolution Accurate Mass (HRAM) orbitrap mass 
spectrometer, depicted in Figure 1.10, was the orbitrap instrument utilized in this work. It 
is composed on a series of quadrupoles acting as either mass filters or ion guides 
(multipoles and flatpoles) followed by a “C-trap” that is used to collect and store packets 
of ions to either be pumped into an HCD cell for MS/MS fragmentation (see below) or 
pulsed directly into the orbitrap for mass analysis. The implementation of the C-trap also 
increases the duty cycle of the particular instrument as ion packets can be collected 
concurrently while the orbitrap is being utilized for mass analysis. At the low resolution 
end of the instrument (17,500), the duty cycle can approach up to 90% depending on the 
mass window utilized. The C-trap is functionally an RF-only quadrupole that employs 
varying potentials to collect, store, and thermally equilibrate ion “packets” prior to 
ramping the potential to pulse them to either the detector or the collision cell. The high 
mass resolution of the Q Exactive paired with it’s high efficiency and speed make it an 
invaluable tool for untargeted global metabolomics. 
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1.1.3 Tandem Mass Spectrometry 
Tandem mass spectrometry (MS/MS) is broadly defined as “the acquisition and 
study of the spectra of ions following m/z selection” and is usually coupled to a method 
of activation and molecular fragmentation.30 The primary application of MS/MS 
experiments is to use fragmentation patterns to provide structural elucidation of select 
precursor ions. Tandem mass spectrometry can be divided into two main categories: 
MS/MS in space or MS/MS in time. Tandem in space MS/MS instruments, such as beam-
type triple quadrupole mass spectrometers (QqQ) have specified regions for ion selection 
(uppercase “Q”) and ion fragmentation (lower case “q”, the reaction region). Whereas 
tandem in time MS/MS instruments, such as trapping-type quadrupole ion-traps (QIT), 
are capable of performing both the isolation and fragmentation in the same mass 
analyzer. Fragmentation mechanisms vary from instrument to instrument, but the most 
commonly used mechanism is collision induced dissociation (CID). In CID, selected ions 
are accelerated by an electric field to a high kinetic energy level. Neutral gas molecules 
(He, N2, Ar) pumped into the fragmentation chamber, prior to the ion selection process, 
collide with the precursor ions and the kinetic energy is converted into internal energy. 
Once resonantly excited, the precursor ions will undergo fragmentation, generally at the 
site of the most labile bond, through either homolytic fragmentation or heterolytic 
fragmentation. In homolytic fragmentation, each fragment retains one of the electrons 
associated with the corresponding most-labile bond. In heterolytic fragmentation, the 
electrons remain with only one of the fragments. Following fragmentation, the ions 
equilibrate and generally do not undergo further fragmentation as the applied excitation 
potential is specific to the precursor ions. 28,30,31  
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 In this work, the Q Exative HRAM orbitrap mass spectrometer was used for 
MS/MS experiments. The Q Exactive employs a type of CID known as “higher-energy 
collisional dissociation” (HCD). Conversely to traditional CID in an ion trap, HCD is 
non-resonant and can often cause both labile and stronger bonds to break during the 
fragmentation process. Because of this, more extensive fragmentation patterns can be 
observed when using HCD. Additionally, whereas CID in ion traps is performed in time, 
HCD acts more like MS/MS performed in space. Product ions are not equilibrated by 
collision cooling as they are in ion traps and can undergo further fragmentation as the 
process is not a slow ramping process like it is with ion traps. As depicted in Figure 1.10, 
selected ions are collected in the C-trap and then pulsed into the HCD-cell for 
fragmentation. After a period of time, the resulting fragments are then pulsed back into 
the C-trap, recollected, and then pulsed into the orbitrap for mass detection.28,41–46 
Separation Science 
The integration of front-end separation techniques to mass spectrometry has 
become increasingly common since the initial coupling of ion mobility in the late 30s and 
gas chromatography in the late 50s.28,30 Since then, high performance liquid 
chromatography (HPLC) and capillary electrophoresis (CE), among others, have also 
joined the classification of “hyphenated techniques” coupled to mass spectrometry. These 
separation methods aid in quantitation and discovery in separating complex mixtures so 
that analytes can be measured independently by the mass spectrometer. Separations 
provide a number of advantages in that time-resolved mass spectra can be acquired, 
sample analyses can be automated, matrix effects can be reduced, structural/stereo-
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isomers can be distinguished, and relative or absolute quantitation can be 
performed.30,31,47–49 For the work performed in this dissertation, method development 
primarily employed HPLC and CE separation methods, described in detail below. 
1.1.4 Liquid Chromatography 
Liquid chromatography (LC) is a chromatographic method that utilizes the 
chemical characteristics of analytes in solution and how they interact with a solid 
“stationary phase” packed in a stainless-steel column for separation. Flow rate and 
station-phase characteristics are used to broadly define the type of LC used. Higher flow 
rates (100-1000 µL/min) and larger particle sizes (>5 µm ) and column inner diameters 
(abbrev. ID,  >2.1 mm) define standard high performance liquid chromatography 
(HPLC). A reduction in particle size (<2,5 µm) , ID (1-2.1 mm) , and flow rates (<400 
µL/min) defines ultra high performance liquid chromatography (stylized as uHPLC, 
UHPLC, or UPLC depending on manufacturer, UHPLC used in this dissertation). Further 
decreases in the aforementioned parameters define capillary liquid chromatography (Cap-
LC) and nano liquid chromatography (Nano-LC), though the difficulty associated with 
their implementation makes them less widely used. Aside from the column, an external 
and easily changed part of an LC, LCs are modular instruments. These modules vary 
between instruments and applications, however, the average LC consists of a solvent 
reservoir system, a binary or quaternary pump, a solvent degasser, an autosampler, and a 
column oven/housing unit. Mobile phase, the solution pumped through the system 
responsible for changing how analytes react with the stationary phase, is pumped from 
the reservoir, mixed and degassed, and delivered to the column. The common effluent is 
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then routed to the ion source of the mass spectrometer (usually an API source, such as 
ESI) and mass spectral detection is performed. The mobile phase selection is dependent 
on the stationary phase and analytes being separated. For “reversed phase” (RP) 
stationary phases (Figure 1.11), water and an organic solvent such as acetonitrile or 
methanol are used. Separations are performed using either sloping gradients (changing 
ratios of aqueous and organic) or isocratic gradients (fixed ratios), depending on the type 
of separation being performed. The separation is performed as a function of how the 
analytes interact with the stationary phase and how they partition in and out of it versus 
the mobile phase. Stationary phases can also be selected based on specific chemical 
characteristics of the function group coupled to the silica particles that make up the 
stationary phase packing material (Figure 1.11). A fairly nonpolar analyte, for example, 
would be injected in a mixture onto the column under high aqueous mobile phase 
conditions. Under these conditions, the nonpolar analyte is going to be in equilibrium 
partitioning in and out of the stationary as it moved down the column, with the 
equilibrium favoring the stationary phase, or it being “retained”. As the gradient changes 
to a higher organic concentration in the mobile phase, the equilibrium will begin to shift 
towards favoring or being equal with the mobile phase. This principle allows this given 
analyte to be separated from more polar analytes that would not have interacted as 
favorably with the stationary phase under high aqueous conditions.30,31,47–49 
Two theories can be examined when evaluating chromatographic separations in 
terms of separation “plates” as a function of equilibrium, Plate theory and Rate 
theory.47,50,51 The plate theory assumes instantaneous equilibrium at each integral 











assessment and, theoretically, the more plates, the better the separation. The number of 
plates (N) can be calculated based on the retention time (tR) and full width at half of the 
maximum height (w1/2) of a peak:  





From here, the height equivalent of the theoretical plate (HETP) can be calculated as a 





 The HETP can also be calculated using the rate theory, however, here kinetic 
factors are taken into account when equilibrium is established rather than it being 
understood as instantaneous.50,51 Here, the van Deemter equation is utilized: 
𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻 = 𝐴𝐴 + 𝐵𝐵 + 𝐶𝐶 
Where A, eddy diffusion = 𝜆𝜆𝑖𝑖𝑑𝑑𝑝𝑝: (factor of the packed bed x particle diameter) 
Where B, longitudinal (axial) diffusion= 2𝛾𝛾 𝐷𝐷𝑀𝑀
𝑢𝑢
: (obstruction factor (usually 0.5) x 
diffusion coefficient/velocity of the mobile phase) 




Rearranged and simplified as:  










Plotting these parameters results in the van Deemter plot, which can be utilized to 
identify the best operating conditions for a given column. Generally, the lower the HETP, 
the more equilibrium partitions the analyte will experience and the better the separation 
will be.50,51   
1.1.5 Capillary Electrophoresis 
Electrophoresis is a type of separation method based on the rate in which charged 
species migrate as a function of an applied electric field.31,52,53 Electrophoretic 
separations can be performed on both the macro and micro scales, with the former being 
performed using a solid (paper) or semisolid (gel) medium and the latter being performed 
using buffer solution-fused silica capillaries. This microscale electrophoresis method is 
known as capillary electrophoresis (CE). This separation technique, though not as widely 
applied as LC methods, has been utilized by a number of industries due to its high 
resolving power (100,000+ theoretical plates – A and C factors of the van Deemter 
equation are eliminated), separation speed, and low sample volume requirements (nL 
range).52–55 A standard CE instrument setup can be seen in Figure 1.12 (top). Briefly, a 
fused silica capillary with an ID <100 µm is used to bridge two buffer reservoirs 
containing a background electrolyte solution (BGE).  In the case of positively charged 
analytes, a positively charged electrode is placed in the origin side BGE reservoir and a 
negatively charged electrode is placed in the detector side BGE reservoir. The capillary is 
filled with the BGE driven by both an applied pressure and an applied potential. Once 
filled, the origin side of the capillary is placed in a sample vial containing a sample 





Figure 1. 12 (Top) Standard capillary electrophoresis block diagram. (Bottom) Capillary 




The sample is injected either electrokinetically (voltage-driven), hydrodynamically 
(pressure-driven), or using both for a short period of time – i.e. 20 sec = ~ 5 nL. 
Following injection, the origin side of the capillary is reinserted into the origin side BGE 
reservoir and a high voltage is applied, initiating the separation. In standard CE 
experiments, a window is burned into the polyamide coating of the fused silica so a 
detector (UV, PDA, Fluorescence) can be implemented on opposite end of the capillary 
from the origin. Alternatively, rather than a reservoir on the detector end, CE can be 
easily coupled to a mass spectrometer with the inlet at ground acting as the cathode. The 
capillary is integrated into housing tubing within the mass spectrometer’s ionization 
source allowing for a bulk solution (1-5 µL/min) to be supplied at the end of the capillary 
for electrospray ionization.52,54–57  
Separations via CE can be performed many ways such as standard capillary zone 
electrophoresis (CZE), isotachophoresis (ITP), miceller electrokinetic chromatography 
(MEKC), and capillary electrochromatography (CEC). In this work, only CZE and ITP 
were applied (discussed below).31,52 The driving factors behind CE-based separations are 
electrophoretic and electroosmotic flow.  
 Electrophoretic flow (Figure 1.13 – bottom left) describes how ions 
migrate as a response to the applied potential.52 The electrophoretic mobility (µep) is 
directly proportional to velocity (νep) at which the ion moves in an applied electric field 
(Eapp) and inversely proportional to the frictional retarding force of the ion, which is a 
function of the ion’s size and shape and the viscosity of the BGE, as shown in the 
following: 
𝜈𝜈𝑒𝑒𝑒𝑒 = 𝜇𝜇𝑒𝑒𝑒𝑒𝐸𝐸𝑎𝑎𝑒𝑒𝑒𝑒 = 𝜇𝜇𝑒𝑒𝑒𝑒
𝐸𝐸𝑓𝑓
𝐹𝐹𝑓𝑓






Figure 1. 13 (Top) Fixed and diffuse layers of capillary electrophoresis, making up the 
"double layer" responsible for electroosmotic flow. (Bottom) Total flow of an analyte is 





Where Ef is the electrical field strength, q is the charge of the ion, r is the ion’s radius, 
ν is the ion’s velocity and η is the solution viscosity. For the case in which positively 
charged analytes are of interest, the BGE is acidic, and the origin side is positively 
charged, analyte cations will exhibit a forward moving electrophoretic mobility toward 
the detector, neutral analytes will not migrate, and analyte anions will migrate towards 
the origin anode.  
 Electrophoretic mobility is not the only driving force behind CE. Electroosmotic 
flow (EOF) also occurs and is the result of the formation of an electric double layer 
forming between buffer cation/anions and the silanol groups of the fused silica capillary. 
Following an initial wash with a high pH solution, such a NaOH, the surface silanols are 
deprotonated and negatively charged. Buffer cations, once introduced into the capillary, 
interact with the negatively charged silanols and form the fixed or “Stern” layer (see 
Figure 1.13). The cations only partially neutralized the negative charge of the capillary 
walls so a second, cation-rich layer, called the diffuse layer, forms and the two layers 
make up the aforementioned electric double layer. The cations in the double layer migrate 
toward the cathode and the ensuing motion generates a “bulk flow” phenomenon. This 
phenomenon also causes the solution to adopt a wall flow/flat profile as opposed to the 
parabolic profile observed from pressure-induced flow. The magnitude of the EOF is 
generally greater than the electrophoretic flow so even negatively charged analytes have a 
resulting net flow towards the cathode (Figure 1.13 – bottom middle and bottom right). 
The velocity of the EOF (νeo)  is defined as: 
𝜈𝜈𝑒𝑒𝑒𝑒 = 𝜇𝜇𝑒𝑒𝑒𝑒𝐸𝐸𝑎𝑎𝑒𝑒𝑒𝑒 =
𝜖𝜖𝜖𝜖
𝜋𝜋
𝐸𝐸    
Where ε is the dielectric constant of the buffer and ζ is the zeta potential.  
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The zeta potential describes the potential of the double layer on the capillary wall. It is a 
function of the pH of the BGE and is reduced as the pH decreases and the number of 
cations in solution increases.  
 The apparent mobility (µapp) of an analyte is the result of the summation of it’s 
electrophoretic and the electroosmotic flow of the solution with the apparent velocity 
(νapp)  being a function of the apparent mobility and the applied field: 
𝜇𝜇𝑎𝑎𝑒𝑒𝑒𝑒 = 𝜇𝜇𝑒𝑒𝑒𝑒+ 𝜇𝜇𝑒𝑒𝑒𝑒 
𝜐𝜐𝑎𝑎𝑒𝑒𝑒𝑒 = 𝜇𝜇𝑎𝑎𝑒𝑒𝑒𝑒𝐸𝐸 
 
1.1.6 Microfluidic Capillary Zone Electrophoresis 
The work performed in this dissertation involved the utilization of a microfluidic 
CZE-MS devices called the ZipChip. First designed in 2008 and later fabricated and 
commercialized by 908devices in 2016 for research use, this microfluidic CZE-MS 
device has been reported in literature for a variety of uses including the identification of 
post-translationally modified peptides, analysis of antibody conjugates and viral capsid 
proteins, and for the detection and quantification of pathogenic metabolites in marine 
life.58–65 This devices (Figure 1.14) consists of an etched rectangular glass slide with 
three wells (S, B, and SW) connected by corresponding channels to an intersection with a 
long serpentine separation channel. The serpentine channel meets with another well-
sourced channel (P) at the corner of the glass chip. Injections into this device are 
hydrodynamic. Pressure is then applied to the “S” well to load the sample into the cross 




Figure 1. 14 The 908 Devices "ZipChip" microfluidic CZE-MS device. Consists of an 
etched piece of glass with channels connecting to four wells: S - sample well, B - 





pumping it to the waste well (SW) and also concurrently applied at the “B” well, filled 
with BGE, to begin the formation of a sample plug in the beginning of the serpentine 
separation channel. After a period of time corresponding to a specified injection volume, 
pressure is exclusively applied to the “B” well to clear the channel intersection and 
endcap the sample plug in BGE. A subsequent potential is applied and the sample is 
electrophoretically separated through the serpentine channels before meeting with the “P” 
channel where bulk flow and an additional potential is provided to produce electrospray 
from the corner of the chip (Figure 1.15). Aside from the difference in scale of this device 
(10 cm separation channel) compared to traditional CZE (often >40-50 cm), this device 
also employs transient isotachophoresis (tITP, described below) for its separation 
mechanism.58–61 Additionally, for the standard HS or HR variety chips (10 cm vs 22 cm 
separation channel), the walls of the channels are chemically modified with 
aminopropylsilane effectively reducing the zeta potential to 0 as no negatively charged 
silanols exist for the double layer to form. This effectively eliminates the EOF, leaving 
tITP as the only separation mechanism. Isotachophoresis (ITP) is a type of 
preconcentrating electrophoretic mobility method driven by the usage of leading (LE) 
and trailing (TE) electrolytes. Ideally, analytes will have an intermediate ionic mobility 
compared to the LE (high mobility) and TE (low mobility). Once the potential is applied, 
the analytes will stack in between the LE and TE interface and focus as they migrate. 
While a reduction in separation efficiency is observed, if separation is observed at all, the 
compaction of the analyte band greatly increases the signal intensity and narrows the 
peak width. The lack of separation is obviously not ideal, however, the analyte band 
compaction and subsequent signal increase is a desirable feature of ITP, which lead to the 
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development of tITP. In tITP, the sample is dissolved in a solution containing the leading 
electrolyte and the BGE has relatively low conductivity. Upon the application of the high 
voltage, the analytes briefly travel with the LE, stacking behind it and 
preconcentrating/focusing, before the LE breaks away. Once the LE has broken away, the 
analytes are then able to be electrophoretically separated. The utilization of the tITP 
phenomenon greatly increases the sensitivity of the method and, coupled with the low 
flow rates associated with CE compared to HPLC, makes this method ideal for detection 
of trace analytes in complex mixtures. Another important factor for this device is its 
speed. Standard analyses can be performed in 3-6 minutes depending on the chip (HS vs 
HR) and applied field strength. This speed does not come at the cost of separation 
efficiency and the device is reproducibly capable of separating all 20 canonical amino 









CHAPTER 2. THE ANALYSIS AND CHARACTERIZATION OF TRANSGENIC LOBELIA 
CARDINALIS ALKALOIDS VIA HPLC-MS AND CZE-MS 
Segments of this dissertation chapter are taken from: Kelley, Z. D.; Rogers, D. T.; 
Littleton, J. M.; Lynn, B. C. “Microfluidic Capillary Zone Electrophoresis Mass 
Spectrometry Analysis of Alkaloids in Lobelia Cardinalis Transgenic and Mutant Plant 
Cell Cultures.” Electrophoresis 2019, 40 (22), 2921–292866 
Introduction 
Alkaloids, as stated in chapter 1, are a class of secondary metabolites characterized 
by the presence of at least one basic nitrogen.67,68  The class is further divided in to 
subsets regarding origin and nitrogen arrangement. The “typical” or “true” alkaloids are 
derived from amino acid precursors, such as tryptophan and histidine, and contain a type 
of heterocyclic nitrogen motif, as depicted in Figure 2.1, or a primary amine while still 
being of amino acid origin (see mescaline – tyrosine derived in Figure 1.4).68,69 
Additionally, there are “atypical” or “pseudo” alkaloids that, while sometimes still of 
amino acid origin, their nitrogen is the result of transamination.69  The biosynthetic 
pathways (simplified, Figure 2.2) for the synthesis of both typical and atypical alkaloids 
can often be tremendously complex, often involving 20+ enzymatic steps and with 
multiple diverging intermediate steps, leading to individual plant species producing a 
diverse variety of metabolites sharing similar central motifs.70,71,72 Given the diversity of 
alkaloids as a whole, the role of these metabolites in plants is also multifaceted. They can 
be utilized as predator defense/determent agents, nitrogen stores, nonspecific basic 
catalysts, anti-oxidants, and even as waste product or reactionary byproducts. 67,70,73,74  
Adding to the diversity of these molecules, the formation of an informal interaction of the 
















interaction, is also common to aid in the aqueous solubility and transport of the 
metabolites throughout the plant.2,75,76,29,77  
In addition to their role in plants, this diverse class of secondary metabolites is 
also of interest to humans for pharmacological applications as “natural” pharmaceuticals. 
The medicinal application of alkaloids can be seen in a wide variety of current products 
including quinine (Figure 1.2), an antimalarial, reserpine, an antihypertensive, and 
vincristine, an antitumor-agent.78,79  Additionally, many addictive or chronically abused 
stimulants and hallucinogens, such as nicotine, morphine and its derivatives, and cocaine, 
are also found within this group. Given their vast pharmaceutical applications paired with 
their complex structures that would be difficult to reproduce synthetically, these 
metabolites are often extracted, purified, and tested for pharmacological activity across a 
variety of targets. 
 The alkaloids in question for this chapter are those found in the cardinal flower, 
Lobelia cardinalis (Figure 2.3 - left). Lobelia cardinalis produces a binitrogenous 
alkaloid, lobinaline (decahydro-1-methyl-5,7-diphenyl-6-(3,4,5,6-tetrahydro-2-
pyridinyl)-quinoline - C27H34N2 – Figure 2.4), recently shown to have inhibitory activity 
on the human dopamine transporter (hDAT).72,80–82 Another member of the Lobelia 
genus, Lobelia inflata (Figure 2.3 – right) produces an alkaloid of proposed biosynthetic 
origin, lobeline, which has also been reported to have similar activity.83–85 Other than the 
hypothesis that lobeline and lobinaline share a biosynthetic precursor, sedamine, very 
little is known about L. cardinalis and its other secondary metabolites as few publications 







Figure 2. 3 Lobelia cardinalis (left) and Lobelia inflata (right). (Free use images. Image 






Figure 2. 4 Lobinaline - decahydro-1-methyl-5,7-diphenyl-6-(3,4,5,6-tetrahydro-2-




A natural pharmaceutical company based out of Lexington, KY, Naprogenix LLC, 
discovered this hDAT inhibitory activity in the mid-2000s.81,82  The focus of their activity 
screen centered around the search for atypical hDAT inhibitory secondary metabolites 
that could be used as low-to-zero-abuse liability cessation aids for people suffering from 
substance use disorders (SUD).89 Naprogenix has since genetically modified L. cardinalis 
to produce hairy root cultures expressing the human dopamine transporter (hDAT) using 
Agrobacterium rhizogenes-mediated transformation. The cultures were then further 
mutated via activation-tagging mutagenesis by the insertion of viral enhancer sequences 
into the hairy root cultures genome to induce random gain-of-function mutations.81,82 
These transgenic mutants were selected on media containing MPP+ (1-methyl-4-
phenylpyridinium) which is accumulated intracellularly by activity of the hDAT and 
targets the mitochondrial oxidative phosphorylation mechanism. This selection process is 
visualized in Figure 2.5. The hypothesis is that surviving progeny hairy roots were 
predicted to contain up-regulated or novel secondary metabolites with hDAT inhibitory 
activity. To test this, analytical methods were developed to identify those specific 
metabolites that are increased in MPP+-resistant mutants relative to wild type (WT). 
Here, samples of the surviving hairy root cultures were propagated, harvested, extracted, 
and then analyzed using the both LC-MS and a microfluidic CZE-MS device. 
Metabolomic profiles were generated from the analyses and used for determination of 
lead compounds to be targeted for the pharmacological screening as potential 
therapeutics for people suffering from SUDs. Novel metabolites were structurally 
characterized using tandem mass spectrometry (MS/MS) analyses and then selected 





Figure 2. 5 Naprogenix mutant transgenic Lobelia cardinalis selection workflow. A) 
Hairy root L. cardinalis plant cell. B) Transgenic L. cardinalis expressing the human 
dopamine transporter. C) Transgenic L. cardinalis post activation tagging mutagenesis. 
D) Cell death following exposure to MPP+ if no hDAT inhibitory metabolites are present 




Materials, Methods, and Instrumentation 
2.1.1 Extraction Protocol and Sample Preparation – Liquid-Liquid Extractions 
Both field grown Lobelia cardinalis plant material and mutant hairy 
cultures/culture extracts were provided by Naprogenix Inc. Field grown plant material 
was provided as dried, ground, and homogenized biomass. The biomass was extracted in 
5 to 25 g batches using 200 mL of ACS grade methanol per 5 g of plant material. 
Extractions were performed overnight (approximately 18 hours) in Erlenmeyer flasks 
with constant stirring. The solvent from the biomass extraction was recovered via 
vacuum filtration, reduced via rotary evaporation, and stored at 4o C. Transgenic hairy 
root cultures were provided as methanolic extracts and prepared by Naprogenix Inc as 
stated: Briefly, hairy root cultures were collected, rinsed to remove media with sterilized 
water, and lyophilized. The lyophilized roots were ground to a fine powder and 
transferred to a glass vial. The root powder was extracted with 5mL of MeOH per 100 
mg of roots, and the vials were agitated for 24 h. The methanolic extraction was repeated 
three times. The combined extracts were centrifuged at 20,000xg. The supernatant was 
collected and stored in a freezer at -20o C until analyzed.  
 Prior to analysis or preparative HPLC separation, methanolic extracts underwent 
liquid-liquid partitioning. The field grown plant material methanolic extracts were pooled 
and diluted with ACS grade methanol (Fisher Scientific) to a concentration of 500±50 mg 
of extracted material per 100 mL of methanol (final concertation of ~5 mg/mL) and 100 
mL aliquot was transferred to a 2 L separatory funnel. The methanolic extracts were 
further diluted with 200 mL of DI water and 25 mL of 1N HCl to a total volume of 325 
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mL. Following the addition of aqueous acid, a liquid-liquid partition was performed 4X 
with 400 mL of CHCl3 per partition. To break emulsions that appeared during the initial 
partitioning of more concentrated extracts, a saturated NaCl solution was added in 10 mL 
aliquots until the emulsion separated. Following each partition, the organic CHCl3 layer 
was collected in a 1 L round bottom flask and the CHCl3 was recovered via rotary 
evaporation. The remaining residue following rotary evaporation was discarded. The 
aqueous acid extract layer was then made basic (pH 12) using 50 mL of 1N NaOH. The 
basic aqueous solution was allowed to equilibrate at room temperature for 30 minutes and 
was then partitioned 4X with 400 mL of CHCl3 per partition. The CHCl3 layer was 
collected in a 500 mL round bottom flask and the volume was reduced via rotary 
evaporation. Following volume reduction, the basic CHCl3 extract was reconstituted in 
50 mL of ACS grade MeOH, 100 mL DI water, and 20 mL of HCl, total volume of 170 
mL, and transferred to a 1 L separatory funnel. The aqueous acid extract was partitioned 
2X with 250 mL of histological grade xylenes. The xylenes layer was removed and 
discarded. The aqueous acid extract layer was then made basic (pH 12) using 40 mL of 
1N NaOH and was extracted as listed above 2X with 200 mL of CHCl3 with the organic 
layer being collected after each partition. The resulting basic CHCl3 extract, hereafter 
referred to as the “ABCXC extract”, was collected, reduced to dryness via rotary 
evaporation, and stored in the freezer at -18o C. 
2.1.2 HPLC – Analytical and Preparatory Scale 
 Following liquid-liquid partitioning, dried ABCXC extracts were reconstituted in 
appropriate volumes of HPLC-grade MeOH at concentrations specific to the method 
being employed. For general analytical HPLC analysis, the extracts were diluted to 
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approximately 1 mg/mL. For preparative HPLC separations, the extracts were diluted to 
250 mg/mL. Both preparative and analytical HPLC experiments were performed using an 
Agilent 1100 series binary solvent pump coupled to an Agilent 1100 series VWD for UV 
detection. Injections were made using a Rheodyne injector with a 10 µL PEEK sample 
loop for analytical HPLC analyses (5 or 10 µL injections) or a 200 µL stainless steel 
sample loop for preparative separations (50, 100, or 200 µL injections). For both 
separation procedures, the 260 nm channel was monitored on the VWD detector. 
Analytical separations were performed using a Kromacil Eternity XT 5 µm C18 column 
(4.6x150 mm).  Preparative separations were performed using two different stationary 
phase pHPLC columns; for bulk separations, a Phenomenex Luna 10 µm C18 column 
(10x100 mm) was used, for high selectivity separations, a Restek Pinnacle BiPh 5um 
biphenyl column (10x150 mm) was used. For analytical separations, a binary gradient 
was employed over a 20 minute separation at a rate of 1 mL/min consisting of optima 
grade water (solvent A) and optima grade acetonitrile (solvent b) (Fisher Scientific), both 
with 0.1% formic acid, starting at 5% B for 2.5 minutes, increasing linearly to 95% B by 
12 minutes, being held at 95% B until 16 minutes, and then returning back to starting 
conditions, 5% B, by 18 minutes for equilibration. Preparative separations were 
performed using column-specific isocratic gradients. For the C18 column, 25% B at a 
rate of 5 mL/min was used for the entire 10 minute preparative separation. For the 
biphenyl column, 10% B at a rate of 5 mL/min was used for the entire 10 minute 
preparative separation. Both preparative columns were washed with 100% ACN w/ 0.1% 
for 20 minutes after every four preparative separations and were equilibrated at their 
respective organic content percentages for five column volumes following washings.  
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Fractions corresponding to analyte peak elutions were collected during the pHPLC 
separations. The collected fractions were basified to pH ~12 with 1N NaOH and 
extracted with an equal volume of CHCl3 exhaustively. The CHCl3 was removed under a 
stream of dry nitrogen and the purified material was stored in a freezer in sealed glass 
vials at -18o C. 
2.1.3 UHPLC-MS 
 Samples analyzed via UHPLC-MS were prepared several ways depending on the 
nature of the analysis being performed. Prior to the extraction protocols listed above, raw 
methanol extracts of both field grown plant material and transgenic hairy root material 
were analyzed to establish a baseline for comparison post-liquid-liquid partitioning. 
Aliquots of the methanolic extracts were diluted to 1 mg/mL with optima grade methanol. 
An additional dilution was made to approximately 50 ug/mL in 1 mL of the appropriate 
solvents corresponding to the HPLC gradient starting conditions (listed below). 
Chromatographic separations were achieved using a Shimadzu Nexera X2 modular 
UHPLC system (Torrance, CA) consisting of the following modules: SIL-30AC, LC-
30AD, CTO-20A, CBM-20A, and DGU-20A) coupled to either a Restek Pinnacle DB 
Biphenyl UHPLC column (1.9 µm, 2.1x50 mm) or a Kromacil Eternity XT C18 UHPLC 
column (2.5 µm, 2.1x50 mm). For the use of the Biphenyl column, chromatographic 
separation was achieved over 20 minutes using solvent A (0.1% formic acid) and B 
(0.1% formic acid in ACN) at 300 µL/min in a gradient flow method consisting of 
solvent B at 20% for 2 minutes, increasing linearly to 95% by 14 minutes, being held at 
95% until 17 minutes, and then returning to starting conditions by 18 minutes for 
equilibration. For the use of the C18 column, chromatographic separation was achieved 
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over 20 minutes also using solvent A (0.1% formic acid) and B (0.1% formic acid in 
ACN) at 400 µL/min in a gradient flow method consisting of solvent B at 5% for 2.5 
minutes, increasing linearly to 95% by 12 minutes, being held at 95% until 16 minutes, 
and then returning to starting conditions by 18 minutes for equilibration. The UHPLC-
MS analyses were performed on a ThermoScientific Q Exactive High Resolution 
Accurate Mass (HRAM) Orbitrap mass spectrometer. MS parameters for UHPLC 
separations consisted of a scan range of 150 to 2000 m/z, a resolution of 140,000, 
microscans set to 3 (~1.7 scans per second), and an AGC target of 3e6. Electrospray 
ionization was achieved using a sheath gas flow of 15 L/min, a spray voltage of +3500, 
an inlet capillary temperature of 350 oC, a HESI probe temperature of 280 oC. 
Additionally, initial exploratory analyses were performed using a Hewlett-Packard series 
1100 HPLC with an Agilent 300Extend-C18 column coupled to a Hewlett-Packard ESI-
LCMSD. Chromatographic separations were performed over 36 minutes using solvents A 
and B listed above at 750 µL/min in a gradient flow method consisting of solvent B at 
10% for 5 minutes, increasing linearly to 90% by 28 minutes, being held at 90% until 30 
minutes, and then returning to starting conditions by 32 minutes for equilibration. MS 
parameters for these exploratory separations consisted of a scan range of 100 to 600 m/z. 
Electrospray ionization was achieved using a sheath gas flow of 12 L/min, a spray 
voltage of +3500, and a nebulizer gas  temperature of 300 oC. 
2.1.4 Microfluidic CZE-MS analysis 
Dried methanolic extracts of wild type (WT) hairy roots, virally transformed 
hDAT mutants (DAT+) hairy roots, and induced gain of function DAT+ mutants (MUT – 
mutant LOB479) of L. cardinalis hairy roots were obtained by Naprogenix Inc. Extracts 
58 
 
were prepared using a scaled-down version of the liquid-liquid partition listed above as 
follows: Aliquots of the dried extracts were weighed and reconstituted in MeOH to 
produce 1 mg/mL solutions. A 250 μL aliquot of each sample was diluted in 200 μL of 
optima H2O and acidified with 50 mM HCl to pH 2. The acidified extracts were 
partitioned with 500 μL of CHCl3 and the organic layer was removed. The pH of the 
aqueous layer was increased to pH 10 with 100 mM NaOH and extracted again with 500 
μL of CHCl3. The organic layer was collected and reduced to dryness under a stream of 
dry nitrogen. The dried CHCl3 extracts were reconstituted in 250 μL of the 908 Devices 
metabolites diluent and transferred into autosampler vials with 300 μL inserts for 
analysis. Each sample was analyzed in triplicate. 
Microfluidic CZE-MS analyses were performed using an HS variety ZipChip 
housed in the ZipChip Interface (ZCI) mounted to the inlet of the mass spectrometer. 
Each sample was delivered via an accompanying autosampler to the sample well and 
loaded into the sample channel for 24 seconds (5.00 nL - default HS Metabolites 
method). The sample set was analyzed using the predefined standard HS Metabolites 
method, field strength: 1000 V/cm, pressure assist start time: 2.00 minutes. All 
separations were performed for 3.00 minutes with approximately three minutes of pre-run 
time to transfer the sample from the autosampler to the ZCI. The background electrolyte 
was refreshed after every three samples. The ZCI was coupled to a ThermoFisher Q 
Exactive HRAM Orbitrap Mass Spectrometer (Thermo Fisher Scientific, Waltham, MA, 
USA). Acquisition parameters included a full scan range from m/z 70 to 600, mass 
resolution of 17,500, microscans set to 1 (~8 scans per second), sheath gas flow set to 2.0 
psi, and an AGC target of 3e6. For comparison to traditional CE-MS, analyses were 
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performed on an abbreviated set of samples (triplicate sets of the WT and LOB479) using 
a Prince CE100 Capillary Electrophoresis system was coupled to a Finnegan LCQ Deca 
mass spectrometer. Electrophoretic separations were performed in a 67 cm fused silica 
capillary (Polymicro Technologies) with an ID of 50 µm and an OD of 186 µm. BGE for 
CE-MS (FA-BGE) was prepared as follow: 192.5 µL of formic acid was diluted to 
100mL in optima H2O and then brought to pH 2.85 with 50mM ammonium formate 
solution. The capillary was prepared by flowing 1N NaOH, optima H2O, EtOH, and FA-
BGE each for 3 minutes at 1000 mbar and then FA-BGE again for 20 minutes at 50 mbar 
with 25 kV applied. For sample analysis, the capillary was flushed with BGE for 3 
minutes at 1000 mbar. Following flushing, the sample was loaded for 0.20 minutes at 100 
mbar with 5 kV to mimic the sample loading conditions of the ZipChip. The separation 
was then performed over 20 minutes at 50 mbar with 25 kV applied. A sheath fluid 
consisting of 50/50 optima H2O and isopropanol was flown at the tip of the capillary in 
the ESI source at 1.5 µL/min. 
2.1.4.1 Analytical method validation – CZE-MS 
A purified lobinaline standard was obtained using the preparative HPLC method 
listed above. The subsequent purified lobinaline standard was used to create a calibration 
curve for quantification of lobinaline in the plant extracts. Additionally, percent recovery 
and the method detection limit (MDL) were assessed using this standard. For percent 
recovery, following assessment of the lobinaline concentration naturally found in the 
plant extracts, a known amount of lobinaline was spiked into six samples of dry plant 
material. Spiked material was extracted and analyzed as stated above. The determined 
concentration of the spiked extracts was compared to the theoretical concentration in 
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order to assess the recovery percentage. For the MDL determination, the procedure 
established by the Environmental Protection Agency (EPA), EPA 821-R-16-006, was 
followed. Briefly, seven replicates of lobinaline spiked into surrogate matrices (Sedum 
Acre dried plant extracts) at ten times (100 nM) the suspected limit of detection (10 nM) 
were compared to seven blank surrogate extracts. This procedure was repeated on three 
separate days. The resulting concentrations of lobinaline in the spiked population was 
calculated and the standard deviation (S) of the concentrations was used in the following 
equation. 
𝑀𝑀𝑀𝑀𝑀𝑀𝑠𝑠 =  𝑡𝑡(𝑛𝑛−1,1−𝛼𝛼=0.99)𝑆𝑆𝑠𝑠 
2.1.4.2 Data processing via MZmine2 software  
MZmine2 data processing was performed as reported by Olivon et al. with 
modifications.90 Data files (.RAW) were converted to .mzXML files using the open 
source MSConvert software prior to MZmine2 processing. For CZE-MS analyses, masses 
were detected from 0.70-2.50 minutes with an exact mass detector and a noise level of 
1.0e5. The mass list was then filtered with an FTMS shoulder peak filter using the 
Gaussian function and a mass resolution of 17,500. Chromatograms were built from the 
filtered mass lists from 0.70-2.50 minutes with a minimum duration of 0.00 minutes, a 
minimum height of 1.5e6, and an m/z tolerance of 0.002. The resulting chromatogram 
lists were then deconvoluted using a local minimum search with the following 
parameters: a chromatographic threshold of 10.0%, a minimum RT of 0.01 minutes, a 
minimum relative intensity of 15.0%, a minimum absolute height of 1.0e6, a minimum 
ratio of peak top/edge of 5, and a peak duration range of 0.01 to 0.10. Following 
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deconvolution, the electropherograms were then deisotoped with an m/z tolerance of 
0.002, RT tolerance of 0.1 absolutes minutes, and represented by the most intense ion. 
Alignment for comparison and data export was performed using the RANSAC alignment 
tool with tolerances consistent with previous processes along with a threshold value of 1 
and the minimum number of points set to 10%. Aligned lists were then gap-filled for 
peaks with a 25% intensity tolerance and again with the m/z and RT range gap filler. 
Three separate peak lists were then produced corresponding to 1) all features detected, 2) 
features present in at least two of the replicates within the population, and 3) features 
found in all three replicates for each population. The above workflow was also followed 
for HPLC-MS/UHPLC-MS analyses, however time windows were adjusted to 
accommodate the longer run times and wider retention time windows.  
2.1.4.3 Targeted and untargeted CZE-MS/MS analysis 
For microfluidic CZE separations coupled to MS/MS experiments, the separation 
times were increased to 6.00 minutes and the initial applied field strength was reduced to 
300 V/cm with a linearly increasing field strength gradient from 300 V/cm to 1000 V/cm 
over the 6.00 minutes. Pressure assist was initiated at the 3.00 minute mark. Untargeted 
MS/MS analyses were performed via the Xcalibur data-dependent acquisition (DDA, Full 
MS/dd-MS2) module. Briefly, full scan acquisitions were acquired as listed above. For 
the dd-MS2 parameters: a Top3 loop count with a 0.5 s dynamic exclusion was applied at 
17,500 resolution with a 1e5 AGC target, 8e3 AGC minimum, 50 ms maximum IT, 2.0 
m/z isolation window, and a fixed NCE of 30. Due to the ionization character of the 
alkaloids of interest, doubly charged ions and isotopes were also excluded. An exclusion 
list was also developed based on a blank full-scan analysis to prevent background ions or 
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those attributed to contaminants in the BGE or diluent from being selected by the Top3 
experiment. Targeted MS/MS analyses were performed via the Xcalibur Parallel 
Reaction Monitoring (PRM) module. An inclusion list formulated based on the average 
(n=6) retention times and durations for seven of the ions of interest was applied. All 
applicable MS/MS parameters applied for the DDA were also applied for the PRM 
experiment. Fragmentation was induced with either 35 or 40 normalized collision energy 
(NCE). All analyses were performed in positive ion mode only, as stated previously. 
Results and Discussion 
2.1.5 Method Development and Characterization 
 To test the hypothesis that novel metabolites or changes in the observed 
metabolite regulation were the source of the in vitro hDAT inhibition observed by 
Naprogenix Inc, a metabolomics mass spectrometry-based analysis protocol was 
developed to compare wild type, field grown L. cardinalis to transgenic mutants 
expressing hDAT. Prior to mutant screening and metabolomic characterization, 
preliminary range finding experiments were performed to develop efficient extraction 
procedures of the plant material and reproducible chromatographic and electrophoretic 
separations methods. Compared to the other member of the Lobelia genus, Lobelia 
inflata, few articles have been published that focus on analyzing L. cardinalis since the 
1960s.72,80,86 Due to the relatively unknown nature of this plant, developing a putative 
“metabolites of interest” list to compare features observed across the mutant species was 
crucial. Initial HPLC-MS (Agilent MS) analyses of methanol extracts of whole plant 
material yielded mass lists consisting of few features aside from the primary metabolite 
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produced by L. cardinalis, lobinaline (Figure 2.4). It was theorized that a majority of the 
sample weight was contributed to chemical species outside of the analytical window such 
as high-mass molecules (fats/waxes, peptides/proteins, macromolecules and chlorophyll) 
or species better suited for different ionization methods such as negative ion mode ESI 
(ex. glucosides and acidic molecules). To address this, additional extraction methods 
needed to be employed prior to analysis in order to increase the signals of the putative 
metabolites of interest, the alkaloids, without concentrating the other interfering 
metabolites and possibly shortening the life of the HPLC components (blockages in 
transfer lines, insoluble buildup on the front end of the column, binary pump degradation 
due to pressure fluctuations, etc). Due to the basic nature of the nitrogen containing 
alkaloids, an acidic/basic extraction was developed. A variety of acid/base combinations 
and organic solvents were evaluated to determine the most effective, efficient, and 
reproducible extraction procedure (discussed in further detail in section 2.3.2.1). It was 
determined that, for analytical comparisons of the alkaloid containing fractions of the 
cultures, using HCl and NaOH as the acidic and basic components, respectively, and 
extracting with chloroform yielded the most comprehensive result. Following the 
development of the extraction method, the next issue to be addressed was the analytical 
separation method to be employed and coupled to the mass spectrometer.  
2.1.5.1 UHPLC-MS method development and evaluation 
Following the acid/base extraction, the plant extracts were enriched in 
alkaloids/basic analytes and in a suitable state for characterization. Up to this point, all 
range-finding analyses were performed on a nominal mass instrument (Aglient MS) with 
a solving power of approximately 800 based on the full width at half max (FWHM) for 
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an ion at m/z 400. Since little was known about the secondary metabolites produced by L. 
cardinalis, a high-resolution accurate mass (HRAM) instrument, with a resolution of 
140,000 for an ion at m/z 400 and the capability to accurately determine the mass of an 
ion with higher precision (m/z 400 vs m/z 400.0000), was required to narrow down 
putative empirical formulas of unknown secondary metabolites. To address this, 
subsequent analyses were performed using the Thermo Q Exactive HRAM orbitrap mass 
spectrometer. To contribute further robustness to the analysis, chromatographic 
separations were performed using on a UHPLC system and column (Shimadzu Nexera) 
rather than an HPLC (Agilent 1100 series). The primary difference in UHPLC 
separations compared to HPLC separations is in the smaller particle size of the stationary 
phase material of the former compared to the latter used inside the column. Recalling that 
particle size is directly related to the A and C terms of the van Deemter equation, 
reducing the particle size from 5-10 µm (HPLC) to 1.9 µm (UHPLC) can have a drastic 
impact on the separation efficiency. As part of the instrument transition, column 
stationary phase was also evaluated. Preliminary investigations employed a column 
packed with a C18 stationary phase. Stationary phases consisting of phenyl ring or phenyl 
ring-like structures were evaluated to determine if pi-stacking interactions between the 
stationary phase and the phenyl rings of the lobinaline and lobinaline-like molecules 
would enhance separation efficiency. The stationary phases evaluated were biphenyl 
(BiPh), pentaflurophenylpropyl (PFPP), and phenylhexyl. The primary evaluation 
critique used was the separation of lobinaline (C27H35N2 - m/z 387.2795) from what was 
originally theorized to be an oxidized form of lobinaline (C27H35N2O – m/z 403.2740 – 
Figure 2.6). A variety of mobile phase conditions, both isocratic and gradient flows, were 
65 
 
evaluated and examples of the most efficient separations observed can be seen in Figure 
2.7. As displayed in Figure 2.7, in terms of peak shape, the C18 column was unparalleled 
presenting near baseline-resolved, gaussian distributed peaks. The BiPh column 
displayed improved separation between lobinaline and the putative N-oxide, however, the 
interaction with the stationary phase and the analytes resulted in band-broadening and 
very asymmetric peak shapes, which can complicate back-end data processing. For the 
PFPP and phenylhexyl columns, coelution of the two analytes and poor peak shape was 
observed independent of whether gradient or isocratic conditions were utilized. Under 
most chromatographic conditions, the analytes were retained on the PFPP and 
phenylhexyl columns for the duration of the analysis and elution was only observed at 
>90% organic (ACN with 0.1% formic acid). Due to the observations made during this 
comparison, it was determined that the C18 column was the most suitable stationary 
phase for the analyses. The coupling of the optimized UHPLC-HRAM-MS analysis to 
the acid/base extraction allowed for increased sensitivity and better separations of 







Figure 2. 6 Possible putative structures of the m/z 403.2744 ion used for the evaluation of 






Figure 2. 7 Combined reconstructed ion chromatograms displaying the separation of 
lobinaline (m/z 387.2795) from the putative oxidation product (m/z 403.2744) using four 




2.1.5.2 Characterization of Wild Type versus Mutant Strains – UHPLC-MS 
Though little primary literature exists regarding L. cardinalis metabolism, it is 
accepted that the plant produces lobinaline as a major secondary metabolite. Because of 
this, lobinaline content was utilized as the primary screening qualifier during preliminary 
GC-MS investigations performed by Naprogenix et al.81,82 Mutant strains were 
characterized according to the quantified lobinaline content and then further categorized 
as a function of their lobinaline content compared to the observed DA uptake inhibition 
corresponding to each strain. Through their approach using GC-MS, they determined 
that, though lobinaline content contributed to the observed activity, it could not be 
responsible for 100% of the activity observed. The primary objective of our analyses was 
to determine what, if anything other than lobinaline, was responsible for the increased 
DAT inhibitory activity observed. In addition to the wild type and transgenic mutant 
culture extracts, a population in which only the empty viral cassette was inserted (DAT-) 
and a population in which hDAT was inserted but no gain-of-function mutations were 
induced (DAT+) were also provided as comparison populations that had not undergone 
selection.  
Comparisons using UHPLC-MS primarily focused first on determining whether 
or not prevalent differences were readily evident in base peak chromatograms. No 
observable differences were noted between WT and the DAT- population, however, 
significant, baseline-resolved differences were apparent in DAT+ and further intensified 
in mutant strains compared to WT. Figure 2.8 displays stacked base peak chromatograms 
for WT, DAT+ and a mutant strain LOB479 using both the C18 and the BiPh columns. 





Figure 2. 8 (Top 3 traces): Base peak chromatogram of WT, DAT+, and Mutant L. 
cardinalis plant extracts using a C18 RP-HPLC column. (Bottom 3 traces): Base peak 





extract (1 mg/mL) so variations in responses of metabolites common to the sample-set 
are not attributed to differences in sample concentration, from a dry-weight basis. 
Focusing on the C18 base peak chromatograms, the major peak across all populations at 
~3.8 minutes corresponds to lobinaline. The mass spectrum for lobinaline can be seen is 
Figure 2.9. Note that, in the mass spectrum for lobinaline, both the [M+H+] ion, m/z 
387.2795, and the [M+2H+] ion, m/z 194.1436, can be seen in a ~1:2 ratio. This doubly 
charged phenomenon, attributed to lobinaline’s the two basic nitrogen (pKa – simulated 
using Chemicalize software - tetrahydropyridine nitrogen: 9.06, N-
methyldecahydroquinoline nitrogen: 10.22), was used as one of two motifs used to 
identify putative lobinaline-like molecules (discussed in further detail in section 2.3.2). 
The area counts for lobinaline increase 2-fold from WT to DAT+ and 5-10-fold from WT 
to the mutant strains. In addition to relative increases in lobinaline content, several other 
features were observed as baseline resolved peaks not readily apparent in WT cultures; 
4.63 minutes – m/z 258.2426, 5.32 minutes – m/z 272.2583, 3.52 and 7.49 minutes – m/z 
242.2115, and 4.31 minutes – m/z 403.2745 and m/z 202.1410. As stated in regards to the 
column selection process, the ion present at 4.31 minutes, m/z 403.2745, was putatively 
identified to have an empirical formula of C27H35N2O and displayed the same doubly-
charged motif as lobinaline (z=+2: m/z 202.1410). This further indicated that it was likely 
a lobinaline-like molecule with the addition of an oxygen, such as an N-oxide, though 
additional chemical and mass spectrometry-based assays needed to be performed to 
provide further evidence for confirmation (see section 2.3.2.3). The data processing 
software, MZmine2, was utilized to process the data in an attempt to identify trace 




Figure 2. 9 Mass spectrum of lobinaline, m/z 387 (top), m/z 403 (middle), and m/z 419 
(bottom) displaying both the single and doubly charged ions for all three analytes, a 




however, mainly due to variations in the baseline attributed to the chromatographic 
mobile phase gradient (see Figure 2.8, top trace, for example of this increase) and other 
inconsistencies, such variations in peak duration and peak asymmetries caused by 
interactions with the stationary phase, generating accurate peak lists representative of the 
WT and mutant cultures was not possible without significant, manual, post hoc 
correction. Additionally, the multiply charged nature of many of the analytes further 
complicated the process in that singly charged low mass species (~m/z 200) could be 
mistaken for the z = +2 species of higher mass ions (lobinaline z = +2: 194.1415), or vice 
versa. Though useful for qualitative identification of differences between the sample 
populations, such as the relative increase in lobinaline and its putative N-oxide, and 
initial development of peak lists containing features of interest, an alternative comparison 
method was necessary to determine the presence of trance analytes. To address the issues 
presented in the use of UHPLC-MS, the use of capillary electrophoresis was investigated 
due to the high sensitivity and separation efficiency associated with the technique and the 
reduced flowrate inducing a lower baseline, further aiding in chromatographic 
deconvolution. Also, since the primary focus of this analysis is on small, basic molecules, 
CE would be highly applicable as electrophoretic mobility is highly dependent on a 
molecule being charged in solution. 
2.1.5.3 CZE-MS method development and evaluation 
As an alternative approach to using UHPLC for separations and comparison, 
capillary electrophoresis was employed to semi-quantitatively assess the differences 
between mutant L. cardinalis and WT plant extracts. Both traditional “macro” CE-MS 
and microfluidic CZE-MS were evaluated for this approach (example base peak 
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electropherograms can been seen in Figure 2.10). Due to instrumental constraints with the 
“macro” CE-MS approach, i.e., incompatibility of the ionization source required to 
couple the CE instrument to the high-resolution mass spectrometer, the microfluidic 
CZE-MS approach was mainly utilized and the macro system was only employed to 
determine whether or not CE would be applicable to the analytes of interest.  Preliminary 
CE-MS trials resulted in sharp, intense, and symmetrical peak-shapes for the ions of 
interest previously identified using the UHPLC-MS approach, but little information in 
regards to other secondary metabolites was observed, most likely due to the low 
sensitivity of the instrument the CE was coupled to. The electrophoretic characteristics 
observed of the analytes of interest, however, suggested that utilization of the CZE-MS 
would most likely be an effective. As depicted in Figure 2.10, the CZE-MS approach 
provided the same sharp, gaussian, and resolved peaks observed in the macro approach 
but also introduced other features that were previously unnoticed amongst the baseline 
noise. In addition, complex separations could be performed using the microfluidic CZE-
MS (3 minutes plus sample delivery) approach ~5-7x faster than using the macro-CE 
approach (20 minutes plus sample delivery).  
In order to make statistical comparisons, triplicate extracts from WT Lobelia 
cardinalis hairy roots were analyzed and compared DAT+ mutant culture extracts and 
extracts from a representative hDAT mutant culture that suggested to overproduce 
protective alkaloids other than just lobinaline. Example base peak electropherograms for 
each strain (WT, DAT+, and “Mutant”) are shown in Figure 2.11. Prior to any data 
processing, notable differences were observed between the WT sample compared with 






Figure 2. 10 Base peak electropherograms of the Mutant L. cardinalis extract using 






Figure 2. 11 Base peak electropherograms of WT, DAT+, and Mutant L. cardinalis 




peaks for the DAT+ and mutant were observable in the base peak electropherogram. It is 
also noteworthy that all of the observed peaks elute between the 0.7 and 1.5-minute 
marks making the entire separation approximately ten-times faster than the time required 
for a standard HPLC separation of similar material.  
 To assess the robustness of this approach, intra-day precision of the microfluidic 
CZE separation method was also evaluated. A WT extract was analyzed in analytical 
triplicate immediately preceding the first blank analysis of the day (t=0) and then again in 
triplicate approximately twelve hours later (t=12) with ~60 analyses in-between on the 
same HS chip. Twelve hours was chosen as the limit due to the manufacturer stating the 
BGE and diluents expire after twelve hours due to pH instability. For this assessment, the 
area count and retention time of the lobinaline (m/z 387.2795 – C27H35N2) peak was 
compared. At t=0, the average lobinaline area count was 2.4e10 with an RSD of 14% and 
at t=12, the average area count was 2.5e10 with an RSD of 3%. Using a paired, two-tailed, 
student t-test (α = 0.05) there was no statistical difference between these two means 
(p=0.70). A similar trend was observed in the average retention times of the lobinaline 
peak at 0.76 min (RSD = 1%) and 0.75 min (RSD = 2%) for the t=0 and t=12, 
respectively. Here, again, no statistical difference was observed via the t-test (p=0.48). 
This result suggests that the data acquired using this CZE-MS approach will not require 
the same post-hoc manual correction that the UHPLC-MS approach required during the 
data processing step.  
2.1.5.4 MZmine2 data processing 
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The .RAW data files corresponding to the triplicate analyses of the WT, DAT+, 
and Mutant extracts were converted to .mzXML files and processed using the MZmine2 
software following the workflow visualized in Figure 2.12 to increase the depth of 
metabolite coverage. Using MZmine2 as a data-mining software, peak lists were 
generated to allow for direct comparison between the strains both in the number of 
features detected and in area counts corresponding to each of those features. Prior to peak 
list generation, however, mass detection and chromatogram building must be performed. 
For this data set, a low noise level was set in order to ensure that low intensity signals 
corresponding to potential analytes in the samples were not discarded during processing. 
Any features associated with background noise that were included in the mass list due to 
the low noise level were processed out in a later step based on their peak duration. Here, 
the CZE-MS approach was considerably more advantageous than the UHPLC-MS 
approach as the baseline noise levels remain consistent throughout the analysis due to the 
ESI spray conditions remaining consistent. Masses were also only detected during the 
elution window starting with the elution of the leading electrolyte from the separation 
channels at approximately 0.70 minutes. Following mass detection and noise filtering, the 
resulting mass lists were converted into “chromatogram lists” for processing. Analyte 
band compaction during the separation and focusing process in the separation channels 
resulted in sharp, narrow electropherographic peaks with durations less than 0.1 minutes, 
therefore, the duration parameter in the chromatogram builder module was set to 0.0 
minutes as the software utilizes single decimal increments. The resulting peak lists were 
then deconvoluted and deisotoped to remove the aforementioned background and noise-
related features and any features that are part of an isotopic distribution. The filtered 
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electropherograms were then aligned using the RANSAC aligner tool to allow for direct 
comparison of each feature based on common retention times and peak durations. Any  
individual feature discarded in a prior process was then reclaimed using the gap-filling 
modules. Lastly, any feature not present in at least two replicates was filtered out using a 






Figure 2. 12 MZmine2 workflow displaying the changes in the number of detected peaks 




2.1.5.5 Characterization of Wild Type versus Mutant Strains – CZE-MS 
Using MZmine2, 139 unique, resolved peaks were detected that appeared in at 
least two replicates of the same sample. This strict filtering approach was utilized to 
reduce noise/spike related peaks and possible laboratory contaminants that were not 
common to all the samples, especially those within each triplicate set. The WT, DAT+, 
and mutant sample sets contained 136, 139, and 137 peaks, respectively observed in at 
least two of the triplicate samples (full feature list with associated area counts appendix 
1). This master peak list was then used to select several known or putatively identified 
molecules of interest, such as those previously discussed, for a statistical comparison list. 
Lobinaline and lobinaline-like derivatives, henceforth referred to as “lobinalines” were 
initially set as top priority molecules due to the hDAT inhibitory activity of lobinaline 
reported previously.81,82 The categorization of “lobinalines” was based on the calculated 
empirical formulas of the detected features and the common motif that they all share in 
the capability to become doubly charged molecules during electrospray ionization 
experiments. Figure 2.9 shows an example mass spectrum of lobinaline (Figure 2.9 – 
C27H34N2 MW=386.2722, m/z for z: +1 = 387.2795, m/z for z: +2 = 194.1438), the 
putative N-oxide version of lobinaline (Figure 2.9B - C27H34N2O, m/z for z: +1 = 
403.2740, m/z for z: +2 = 202.1410) and the putative bi-N-oxide (Figure 2.9C - 
C27H34N2O2, m/z for z: +1 = 419.2693, m/z for z: +2 = 210.1387) displaying this 
common charge state motif. Additionally, features considered to share similar 
biosynthetic precursors to lobinaline, such as putative sedamine-like derivatives, and 
those found in relatively high abundance within the samples (i.e., visible in the base 
peak) were also added to the comparison list. Table 2.1 displays the final comparison list 
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of all the selected features with the corresponding average area count and relative 
standard deviation. Correlating putative structures, as suggested by MS/MS 
fragmentation patterns (discussed in more detail below), can be observed in Figure 2.13. 
Average area counts for the lobinalines generally display an increasing trend from 
the WT to the mutant sample sets. This observation fits with the overarching hypothesis 
that lobinalines are protective agents against MPP+ toxicity used in L. cardinalis mutant 
selection. The observed abundance increases for the N-oxide (m/z 403.2740 – peak 3) 
and bi N-oxide (m/z 419.2693) versions of lobinaline are very promising since N-oxides 
tend to increase hydrophilicity, making both molecules excellent targets for further study.  
 Structures for both m/z 130.1595 (Figure 2.11/2.13 - peak 3) and m/z 200.2362 
(Figure 2.11/2.13 - peak 4) are putative and drawn as primary amines for simplicity.  
Alternatively, secondary or tertiary amine structures would be equally probable.  It 
should be noted that m/z 129 [M+•] has been previously reported in a methanolic plant 
extract analyzed by GC-MS therefore our observation of m/z 130.1595 [M+H+] was not 
deemed a laboratory contaminant.91 Lastly, the lobeline-like molecules, peaks 5-11 
(Figure 2.11/2.13) also displayed a generally increasing trend. Though lobeline (8,10-
diphenyllobelionol - C22H27NO2), the primary alkaloid produced by Lobelia inflata, itself 
was not observed in these samples and has not been found in extracts of intact plant 





Table 2. 1 Average area counts and %RSD for each of the most abundant features 







Figure 2. 13 Putative structures of interest. Group A represents lobinaline and lobinaline-
like molecules. Group B consists of conjugated monoamines. Structures shown are 
putative as multiple varying chain lengths are possible for both molecules. Group C 
consists of lobeline-like molecules which are consistent with similar molecules found in 




Molecules very similar to these have been reported in the literature to have activity both 
on the DAT and on nicotinic acetylcholine receptors (nAChRs)17,18.  
Preparative HPLC was used to isolate and purify a sample of lobinaline that was used to 
develop calibration standards for analysis using the microfluidic device (Figure 2.14).  
Based on the resulting calibration curve, the WT, DAT, and mutant extract samples were 
found to contain 83±13 µM, 168±13 µM, and 256±15 µM lobinaline, respectively 
(calculations for error in concentration values can be found in appendix 2). To translate 
these concentrations into a whole plant basis, 1.64 g (wet weight) of hairy roots yielded 
68 mg of methanol extractable material or 4.14% of the total mass of extractables.  
Lobinaline comprised 3.2% of the methanol extractable material for WT or 0.13% of the 
plant (wet weight basis).  Similarly, lobinaline comprised 6.5% of the methanol 
extractable material for DAT (0.27% plant basis), and 9.8% of the methanol extractable 
material for the mutant (0.41% plant basis).  
  Additionally, the purified standard was also used to assess both the 
percent recovery of the extraction method and the method detection limit. The percent 
recovery was determined to be 99±22% based on the recovery of lobinaline spiked into 
three separate WT samples and three separate mutant samples (6 total samples). The 
variation observed in the recovery is most likely due to percent moisture (not determined) 
in the plant material. For the MDL determination, lobinaline was spiked into powdered 
Sedum acre plant material at a concentration of 100 nM. Following the EPA guidelines 
for MDL determination, the MDL for this method was determined to be 74 nM. To make 
a global comparison with WT, variations in isolation, extraction, and analysis of all 









Borrowing from quantitative western blot analysis, we evaluated the use of a “loading 
control” to normalize our data.  All nine data sets (3 each from WT, DAT+, and mutant) 
were compiled and the variance for each of the detected peaks was calculated.  The 
putative monoamine (m/z 200.2363 – peak 5) was found to have the lowest variance and 
was used as a normalization standard. Several bar graphs displaying normalized area 
counts for the prioritized features can be seen in Figure 2.15. Normalized area counts for 
all 139 features can also be seen in the appendix 1 list. Statistical analyses were 
performed on the prioritized list using the GraphPad Prism 8 software. Tukey’s multiple 
comparison test was utilized as a post-hoc test for the selected features of interest. 
Statistically significant differences were observed for pairwise comparisons in fourteen of 
the sixteen prioritized features. Figure 2.15 also displays the post-hoc test result in 
significant differences denoted by stars () under the corresponding bar graphs. From 
the resulting data set and statistical analyses, multiple putative features have been 
selected as the potential source of the observed hDAT inhibitory activity.   
Following the screening for ions of interest and evaluation of the microfluidic 
device, tandem mass spectrometry methods were developed to acquire evidence to 
support the putative structures. Here, both targeted and untargeted MS/MS was applied 
for analysis of the representative mutant plant extract (Mutant). Prior to any MS/MS 
experiments, adjustments to the separation method were made to increase the time in 
which ions were present to allow for adequate sampling of each ion. The applied field 
strength drives the separation event and analyte band compactions in the microfluidic 
chip therefore lower field strengths were utilized to broaden the analyte peaks. At the 





Figure 2. 15 Normalized area counts of the sixteen prioritized peaks -  denotes 





wide, approximately 21 scans, under the most inclusive MS acquisition parameters. 
Decreasing the field strength to 300 V/cm increases the peak to over 6 seconds wide 
consisting of 74 scans. This also changes the retention time, however, increasing it from 
0.76 minutes to 2.87. Reducing the field strength to this level also caused the slower 
moving ions to remain within the separation channel during the allotted analysis time and 
elute in subsequent analyses, regardless of the application of the pressure assist feature. 
To address this, a field strength gradient was used. By increasing the field strength 
linearly from 300 to 1000 V/cm over the 6 minute separation, peak widths were at least 
doubled and no carry-over was observed. The development of this separation method 
allowed the data-dependent analysis (DDA – untargeted MS/MS) and parallel reaction 
monitoring (PRM – targeted MS/MS) experiments to be performed. For the targeted 
MS/MS PRM inclusion list development, seven of the ions of interest were selected: 
lobinaline and the mono- and bi- N-oxide versions and the lobeline-like molecule. 
Tandem spectra can be found in appendix 3. Six full scan acquisitions were acquired to 
record peak durations for each ion of interest. Using the average durations, the peaklist 
table was constructed to minimize multiplexing (cycling between more than four ions at 
once) while also preventing under-sampling (number of MS/MS scans for each ion: >5). 
To compare the efficiency of these parameters, the average number of MS/MS scans for 
each feature under both the PRM and DDA experiments was compared to the average 
number of scans in which that feature was present in the full scan acquisition. Table 2.2 
displays this comparison.  
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Table 2. 2 Comparison of the number of times each feature was selected for both the 






The PRM experiment resulted in >40% coverage of the ions compared to their prevalence 
in the full scan experiments. Those with <25% coverage most likely eluted from the 
separation channels during multiplexing events, specifically when alternating between 
three or four ions at once, or outside of the calculated window. The latter is more likely, 
due to retention time inconsistencies being prevalent in CE mobility experiments when 
the capillary walls do not have a permanent coating, which is the case for the employed 
device. Generally, with the PRM approach, under-sampling did not occur as each ion was 
analyzed more than five times with the exception of m/z 419 and the first eluting m/z 242 
isomer in the third trial. Conversely, the DDA analysis did not yield similar results. 
Despite the usage of the exclusion list and a relatively short dynamic exclusion time, on 
average only five of the nine ions of interest were sampled adequately. In some cases, 
those with low abundance, such as m/z 419, were missed entirely. These results suggest 
that microfluidic CZE is better suited for the targeted MS/MS approach rather than the 
untargeted MS/MS approach, an aspect where UHPLC-MS outperforms CZE-MS. While 
useful for major metabolites with substantial peaks in the sample, the untargeted 
approach is not recommended for the identification of trace components via MS/MS with 
the microfluidic device as even broadened bands are missed by the selection algorithm.  
 The resulting findings from this analysis led to the hypothesis that the lobinaline 
N-oxide molecules, both the mono- and bi-N-oxides, were likely the source of the hDAT 
inhibitory activity. The reasoning behind this hypothesis is multifaceted. Primarily, novel 
inhibitory activity was observed by Naprogenix in their assays using lobinaline, however, 
lobinaline is a highly non-polar molecule and has very poor solubility in water (simulated 
Log Kow = 4.8, XLOGP3 and 5.6, Chemicalize). The N-oxidation of alkaloids often 
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results in an increase in solubility. When performing their primary screening assays using 
whole plant extracts, a highly aqueous buffer was used. Since the mutant strains contain 
relatively higher quantities of the more hydrophilic lobinaline N-oxides, a higher 
concentration of the lobinaline-like alkaloids was available to interact with the 
transporter. Additionally, when characterizing their extracts, GC-MS was employed. The 
high temperature of the GC inlet will convert N-oxides back to the free-base forms, just 
as it would produce a dehydration product for an underivatized hydroxyl group. Due to 
the non-covalent nature of an N-oxide association, N-oxides cannot be derivatized. This 
aspect caused the N-oxide molecules to go undetected during their analyses leading to the 
impression that the activity was not attributed to lobinaline. As this newly discovered 
class of lobinalines was of interest for further hDAT inhibitory assays, and the 
concentration of this class of secondary metabolites was comparatively high compared to 
other identified metabolites, they were selected as the target of subsequent extractions, 
purifications, and characterization assays.  
2.1.6 Extraction, Isolation, and Analysis of Lobinalines 
As the lobinaline and lobinaline-like molecules were identified as the probable 
source of hDAT inhibitory activity, purification was required to produce high quality 
purified material to be used in further in vitro assays, performed by Naprogenix, to 
confirm if they are biologically active. Due to the high concentration of lobinaline in the 
plant (3.8% w/w of the methanol extracts of the WT plants), purification of lobinaline 





Figure 2. 16 HPLC chromatogram from the pHPLC purification of lobinaline and 




Following a large-scale acid/base chloroform partition, using a C18 preparative column 
and an isocratic gradient, >95% pure lobinaline can be obtained by collecting the leading 
half of the largest peak in the chromatogram (Figure 2.16). Two to three subsequent 
passes of the collected fraction through the column yields a >99% pure lobinaline 
standard. This, however, is not the case for the other lobinaline-like molecules. Assuming 
equal response factors given the similarities between the analytes, lobinaline is anywhere 
from ten to one thousand times more concentrated in the plant material than the other 
secondary metabolites. Additionally, pHPLC conditions provided inadequate separation 
of lobinaline from the other analytes of interest with the primary target, the mono-N-
oxide, always eluting as a shoulder on the tail of the lobinaline peak (Figure 2.16). This 
aspect requires additional passes through the column to purify the N-oxide compared to 
the number required to purify lobinaline and, due to the comparatively lower 
concentration, results in low µg quantities once >90% purity is achieved owing to 
diminishing returns. To address this, modifications were made to the front-end liquid-
liquid partitioning and reimplementation of the biphenyl column, at the preparative level, 
was applied.  
2.1.6.1 Large-scale Extraction and Purification 
In order to simplify the process of producing large quantities of purified material, 
specifically, purified lobinaline N-oxide, the liquid-liquid partitioning step was re-
evaluated. Though the previous acid/base chloroform (ABC) method was ideal for 
analytical purposes, the concentration of lobinaline in the basic extract was at least one to 




Figure 2. 17 (Top to bottom): RIC of lobinaline (m/z 387) in the DCM partition layer, 
RIC of the lobinaline N-oxide (m/z 403) in the DCM partition layer, RIC of lobinaline in 
the xylenes partition layer, and RIC of the lobinaline N-oxide in the xylene partition layer 
showing that the N-oxide is more concentrated than lobinaline in the DCM layer than it is 




A series of modifications were tested and made to the workflow in order to selectively 
extract lobinaline from the target molecules. Organic solvents of varying polarity were 
evaluated against chloroform in terms of the relative ratios of the N-oxide to lobinaline as 
determined by UHPLC-MS analysis. The solvents evaluated were: methylene chloride, n- 
butyl chloride, diethyl ether, toluene, xylenes, and ethyl acetate. Most of the solvents 
(methylene chloride, n-butyl chloride, and diethyl ether) yielded near identical ratios of 
the N-oxide to lobinaline to the use of chloroform except toluene and xylenes with the 
latter, xylenes, resulting in ratios as high as 10:1, N-oxide to lobinaline (Figure 2.17 – 
top), though averaging between 0.5:1 and 1:1. Note that due to the high boiling point of 
xylene, it is used during the first half of the partition against aqueous acid, as the organic 
layer in that step is discarded. The basic partition is still performed with chloroform. This 
method is hereafter referred to as the “XC” partition. It is believed that increase in the 
ratio of the N-oxide to lobinaline is most likely attributed to not only the highly nonpolar 
nature of both of the phenyl ring-based solvent and lobinaline, but also to pi-stacking 
interactions between the two phenyl rings of lobinaline and the solvent itself. Analysis of 
the xylene layer displayed low levels of the lobinaline N-oxide compared to lobinaline 
(Figure 2.17 – bottom), confirming that, though this approach is not explicitly specific for 
lobinaline, the N-oxide group contributes significantly to the molecule’s comparatively 
more polar nature and equilibrium favors the aqueous layer.  Reproducibility, however, 
was difficult when using toluene/xylene as the initial organic partitioning solvent. The 
variation observed was believed to be due to the complexity of the matrix, consisting of 
fats/waxes, sugars, and chlorophyll, interfering with the system equilibrium during the 
pH changes and xylene partitioning step, i.e. formation of an emulsion. The ABC 
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partition, using chloroform for both the acidic and basic partition, consistently yielded 
reproducible results, as confirmed above during the CZE-MS method validation. 
Additionally, even when scaled-up, the end chloroform and basic aqueous layers were 
relatively clear aside from a deep yellow color observed in the aqueous layer. 
Conversely, the end aqueous base layer, when using xylene as the initial solvent for the 
acidic partition, was near opaque and brown/gold.  In an attempt to address the 
irreproducibility of the partition, the ABC partition was coupled to the XC partition. For 
this approach, the chloroform from the basic ABC extraction was reduced to dryness and 
the residue was reconstituted in aqueous acid before undergoing the XC extraction – 
“ABCXC”.  To assess the reproducibility, a triplicate partition evaluation using the same 
stock extract and performed simultaneously yielded 0.35:1, 0.3:1, and 0.65:1, N-oxide to 
lobinaline. Though the resulting ratios were on the lower end of the distribution (average 
– 0.42:1 compared to 1:1-10:1 when using the XC method, alone), the end ABCXC 
chloroform fractions were more reproducible, concentrated in lobinalines at a 
manageable relative concentration, and contained few detected constituents outside of 
other members of the “lobinalines” and “lobeline” classes of compounds. The 
implementation of the ABCXC partition greatly reduced the difficulty associated with 
using pHPLC to separate the N-oxide from lobinaline, especially since few other analytes 
were present in the extracts. Additionally, as depicted in Figure 2.7, using an HPLC 
column with a biphenyl stationary phase displayed better separation of lobinaline from 
the N-oxide, though sacrificing peak shape. As separation is more significant for pHPLC, 
a biphenyl preparative column was also utilized to reduce the risk of diminishing returns 
resulting from coeluting peaks. Figure 2.18 displays an example of a standard separation 
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using the C18 pHPLC column (top) and the biphenyl pHPLC column (bottom). For the 
example C18 chromatogram, lobinaline elutes at 6.18 min and the N-oxide elutes and 
6.38 min and for the example Biphenyl chromatogram, lobinaline elutes at ~4.75-5.5 min 
and the N-oxide elutes, with separation of two putative isomers, at 6.52 and 7.09 min. 
Under the applied conditions, the biphenyl column clearly outperforms the C18 for this 
specific application in that sufficient separation of the N-oxide from lobinaline is 
observed. Coupling of the ABCXC partitioning method to the use of the biphenyl 
preparative HPLC column has led to nearly 200 mg of pure, natural N-oxide and >1 g of 





Figure 2. 18 (Top) Base peak chromatogram of the pHPLC purification of lobinaline and 
lobinlaine N-oxide using the C18 column post ABCXC partitioning. (Bottom) Base peak 
chromatogram of the pHPLC purification of lobinaline and lobinlaine N-oxide using the 




2.1.6.2 N-Oxide Characterization 
Since little literature exists in regards to L. cardinalis secondary metabolites, initial 
classification of the previously undetected m/z 403.2740 ion as an “N-oxide” was 
hypothesized based on the calculated empirical formula. Supporting evidence of the 
oxygen being present in the molecule as part of an N-oxide interaction, rather than a 
hydroxyl, was provided through the lack of derivatization with BSTFA and, therefore, the 
ion not being detected via GC-MS, however, further evidence was required. Both 
chemical and analytical methods were employed to test this hypothesis. 
 For chemical reaction-based evidence, the first experiment performed was a 
reduction reaction using Zn dust and HCl. Though unable to unequivocally determine if 
the oxygen was present as an N-oxide and not a hydroxyl group, the Zn/HCl reaction was 
intended to confirm that that the oxygen was not involved in the ring structure of the 
molecule. Using a column purified standard of the putative N-oxide (~95%), the reaction 
resulted in near full conversion to the free base as depicted in Figure 2.19. Note that the 
retention time of the lobinaline produced in the reduction reaction matches the retention 
of the small lobinaline impurity detected in the “before” sample, suggesting homology of 
the two analytes. In addition to this reaction, the inverse was also performed in 
chemically converting lobinaline to the putative N-oxide. This reaction was performed 
using the peroxy acid metachloroperoxybenzoic acid (mCPBA). Due to the two basic 
nitrogen atoms in lobinaline, this reaction produced both the N-oxide of interest, a mono-
N-oxide, and the bi-N-oxide (structure A8 in Figure 2.13, m/z 419.2693, z = 




Figure 2. 19 (Top to bottom): RIC of lobinaline prior to Zn/HCl reduction of the N-oxide 
showing trace levels, RIC of the N-oxide prior to Zn/HCl reduction, RIC of lobinaline 





This putative bi-N-oxide is also found in plant material, however, at concentrations 1-2 
orders of magnitude lower than the mono-N-oxide and, therefore, several orders of 
magnitude lower than lobinaline. Figure 2.20 displays this reaction in four reconstructed 
ion chromatograms. The top trace, for simplicity, represents the “before” pure lobinaline 
sample with the channels corresponding to the mono and bi-N-oxides also selected 
showing that they are not present in the sample. The bottom three traces present 
lobinaline, the mono-N-oxide, and the bi-N-oxide respectively. As depicted, assuming a 
1:1 relative response factor, the N-oxide signal is approximately 3/4th that of lobinaline 
whereas it was not present in the before sample. In addition, the putative N-oxide 
produced has the same retention time as that of the natural N-oxide found in the plant 
material (Figure 2.21). This was also observed when another lab member, Masoumeh 
Dorrani, reacted pure lobinaline with hydrogen peroxide and ammonium bicarbonate. 
The reaction performed by lab member Dorrani yielded complete conversion of 
lobinaline to the putative N-oxide, and bi-N-oxide when coupled with a rhenium-based 
catalyst, and the resulting compounds have also been isolated for pharmacological testing 
to compare them to the results observed using natural N-oxide.  
 In addition to the aforementioned chemical confirmation experiments, several 
analytical experiments were also performed to characterize the putative N-oxide. The first 
regarded the hydrophobicity of the analyte. A common characteristic of N-oxides is 
increased hydrophilicity compared to their free-base counterparts. Lobinaline has a 
reported simulated Log Kow of 4.8 (XLOGP3) and 5.6 (Chemicalize), inferring it is 




Figure 2. 20 (Top to bottom): combined RIC of lobinaline, lobinaline N-oxide, and 
lobinaline bi-N-oxide prior to mCPBA treatment showing one major peak, RIC of 
lobinaline post-mCPBA conversion, RIC of the lobinaline N-oxide post-mCPBA 





Figure 2. 21 Comparison of the RICs for the natural lobinaline N-oxide and the semi-




The addition of an N-oxide would drastically increase the polarity of the molecule, 
comparable to that of a quaternary ammonium salt. To test this, the Log Kow was 
determined following the OECD method 117 guidelines for Log Kow determination via 
HPLC relative retention time using isocratic separations with varying organic 
percentages. The system was evaluated using a seven point calibration curve consisting 
of the experimental determined Log Kw values and the accepted Log Kow values of 4-
methylbenzyl alcohol, p-cresol, 4-methoxyphenol, ethylbenzene, anisole, benzyl 
benzoate, and benzyl alcohol – R2 = 0.9724. Using this curve, the Log Kow of the N-oxide 
was determined, from the observed Log Kw, to be 1.29 ± 0.19, drastically lower than that 
of lobinaline.  
Tandem mass spectrometry was also utilized to characterize lobinaline and the 
putative N-oxide analytes. The fragmentation pattern of lobinaline was compared to the 
fragments produced from the N-oxide precursor ions in order to determine if any 
fragments could provide evidence to the location of the oxygen within their respective 
molecular structures. Though N-oxide bonds are generally the most labile bonds in the 
system, and therefore are usually dissociated immediately when subjected to MS/MS 
experiments, their presence could cause shifts in the relative abundances of observed 
fragment ions. Additionally, if the oxygen atoms were involved in a covalent bond rather 
than as an N-oxide, such as a hydroxyl/phenol or methoxy group, fragment species 
corresponding to those precursors would likely be present. Figure 2.22 displays stacked 





Figure 2. 22 Tandem MS/MS spectra of lobinaline (m/z 387 - top), the lobinaline N-oxide 




As depicted in Figure 2.22, lobinaline displays a characteristic cross-ring cleavage 
through the decahydroquinoline ring resulting in the m/z 387 → 186 and m/z 387  → 200 
fragmentations to be the predominant fragment ions observed. Additionally, m/z 387 → 
304, representing the loss of the tetrahydropyridine ring is also observed as a major 
fragment along with a variation of the aforementioned cross-ring cleavage resulting in 
m/z 387 → 212. These possible fragmentation patterns can be seen in Figure 2.23. In 
viewing and comparing the MS/MS spectra of the three precursor ions, it appears that 
there are a number of different fragment ions in the N-oxide/bi-N-oxide spectra compared 
to the lobinaline spectrum, however, almost all of the ions overlap. The overt difference 
between the spectra is actually predominantly in the relative abundances of the ions 
rather than in their presence/absence. Lists of the top 50 fragment ions for each precursor 
were generated and compared using excel (only 2 decimals shown to account for slight 
variations in mass defects resulting from the loss of the lock mass during MS/MS 
experiments) – Table 2.3. Fragment ion lists were compared pair-wise (387 v 403, 387 v 
419, and 403 v 419) and fragments that were not present in both sets were denoted as 
seen in table 2.3. Two of the differences can be attributed to the loss of water when the 
N-oxide bond is dissociated, 419 → 401 and 403 → 385. Again, possible structures for 
the fragments highlighted in table 2.3 can be seen in Figure 2.24. Interestingly, three low 
abundance fragment ions of the putative bi-N-oxide were calculated to each contain 





















The m/z 372 (structure 9, Figure 2.24) and m/z 228 (structure 10-1 and 10-2, Figure 2.24) 
fragments, also present in the m/z 403 peak list, contained only one oxygen based on 
their calculated empirical formula and the m/z 419 → 247 fragment was calculated to 
contain two oxygens according to it’s calculated formula. N-oxides can undergo 1,2 
rearrangement, known as the Meisenheimer rearrangement, (structure 10.2, Figure 2.24) 
when exposed to a heat source, such as the HESI probe or the inlet capillary, therefore it 
is possible that the rearrangement could have occurred to stabilize the N-oxide interaction 
and produce those fragments, especially given their low relative abundance. Furthermore, 
if the oxygens were present as formal bonds, fragments corresponding to the 
characteristic cross-ring cleavage would likely be present with the addition of an oxygen. 
Though m/z 202.12 (m/z 186 + 16) is present for both N-oxides, it is also present in 
lobinaline, therefore it is likely not attributed to the addition of an oxygen, Likewise, a  
m/z 216 (m/z 200 +16) fragment is not present. Though not conclusive evidence to 
completely rule out the possibility of the oxygen atoms being involved in formal bonds, 
the lack of apparent fragmentation patterns consisting of the addition of oxygen 
compared to those found in lobinaline, as well as the supporting data collected from the 
semi-synthetic production of the N-oxide, supports the interactions being present as N-
oxide bonds.  
Conclusion 
The aim of this chapter was to develop a metabolomic profiling method to 
characterize wild type and transgenic mutant L. cardinalis secondary metabolites. This 
was performed by developing an extraction and analysis protocol centering around the 
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utilization of a microfluidic CZE-MS device. This microfluidic CZE-MS device allowed 
for both a fast and sensitive high-throughput method for the screening of secondary 
metabolites, specifically plant alkaloids. Previous alkaloid MS screening assays 
traditionally rely on HPLC or GC as a separation method. These methods can be, not 
only time consuming, but also be unsuitable for the separation certain compounds and 
lack the capability of isomeric separation. Here, the utilization of the microfluidic chip 
displayed that more efficient separation can be achieved in approximately half the time or 
more compared with other methods. When coupled with processing software like 
MZmine2, the process is further streamlined resulting in a fast, comprehensive assay for 
plant secondary metabolites. These characteristics are particularly valuable for the use 
described here in which it is essential to rapidly compare alkaloid profiles in many 
different plant extracts in very small sample volumes. This method enables the 
identification and separation of novel putatively bioactive metabolites from transgenic 
mutant plant cells. The metabolites identified in this work, the lobinaline mono- and bi-
N-oxide, have become a novel source of lead compounds for the pharmaceutical industry 




CHAPTER 3. MASS SPECTROMETRY-BASED METHOD DEVELOPMENT FOR THE ANALYSIS 
OF PHENOLIC SECONDARY METABOLITES 
Introduction 
Phenolic plant metabolites are the most widely abundant secondary metabolites found 
within the plant kingdom and consist of a wide variety of subclasses, each with unique and 
specific roles.11,92 The general requirement for the classification is an aromatic ring with 
an associated hydroxyl group (phenolic), however, many natural phenols are much more 
conjugated. Figure 3.1 displays generalized carbon backbones of simple monomeric 
phenolic secondary metabolites. In nature, these metabolites are often cyclic with bridging 
oxygens as well (see Figure 3.1 - C6-C3-C6 flavonoid substructure), aiding to the diversity 
and complexity of the class. In addition to existing as single subunit metabolites, these 
molecules are also polymerized into varying sized polyphenolic oligomers such as 
procyanidins (2-3 flavonoids), tannins (5+ gallic acids linked to a glucoside with further 
conjugation), and lignin, one of the three primary structural components of woody plants 
(100+ varying linkages of three monolignol subunits). Aside from the structural aspect of 
phenolics in lignin, plant phenolics also act as defense agents against both biotic (antibiotic 
and antifeeding activity) and abiotic (antioxidant and UVB-blocking) insults.11,92–94 
Additionally, smaller phenylpropanol-derived phenols act as attractants for pollinators due 
to the color and scent that they confer to the plant.11,94 Conversely to alkaloids, as seen in 
chapter 2, many monomeric phenolics can share a degree of homology between unrelated 
species.94 Two examples of this would be resveratrol, a stilbene, and quercetin, a flavonoid, 
which can be found in a large variety of plants, many of which are commonly consumed 










Aiding to the homology, most phenolics are generally biosynthesized through fairly 
conserved pathways.94 The primary pathways include the shikimate pathway, converting 
shikimic acid to tyrosine or phenylalanine, followed by the phenylpropanoid pathway, 
which converts the resulting Tyr and Phe to courmaic or cinnamic acid, respectively, and 
the polyketide pathway. These biosynthetic pathways (Figure 3.2) generated most of the 
aforementioned phenolic classes such as flavonoids, stilbenes, and lignins (shikimate and 
phenylpropanoid) and anthraquinones (polyketide).  
 In addition to phenolic secondary metabolites roles in plants, they are also of 
interest to humans as natural pharmaceuticals, as discussed with alkaloids in chapter 2. 
Stilbene compounds have a variety of applications as antioxidants, as well as cancer 
chemo-preventive agents.98,11 Flavonoids also have been evaluated as anti-cancer, anti-
inflammatory, and cardiovascular disease therapeutics.11,96,98 Additionally, most phenolic 
compounds all share a varying degree of antimicrobial activity, another desirable 
application of the metabolite class.11,98 Their commonalities across various edible plants 
and fruits and existence in fruit-based beverages, such as wine, has led to their increased 
consumption in recent years due to the discovery of the benefits associated with them.96 
In recent years, another subclass of phenolic metabolites, the cannabinoids produced by 











Cannabinoids, the phenolic secondary metabolites of Cannabis sativa, Cannabis 
indica, and Cannabis ruderalis, have been increasingly the subject of much scientific, 
political, and ethical controversy, especially in the past decade. The most commonly 
studied and abundant cannabinoids (Figure 3.3) present in the Cannabis plant are 
cannabidiol (CBD), cannabigerol (CBG), cannabinol (CBN), cannabichromene (CBC), 
and  Δ9 -tetrahydrocannabinol (Δ9THC) and their corresponding carboxylic acid  
precursors as they exist in the plant.99–101 The medicinal aspect of cannabinoids has been 
the driving factor of their interest in recent years. Cannabinoids such as CBD, CBN, 
CBG, and CBC have shown degrees of activity including anti-inflammatory, analgesic, 
anticonvulsant, antipsychotic, and antibiotic activity, making the class very 
pharmacologically attractive as a whole.95,99,101–104 Unfortunately, the reason for the 
controversy that has plagued the use of Cannabis throughout history is the psychoactive 
attributes of one of the primary cannabinoids, Δ9THC.99  This psychoactive attribute has 
led to legality constraints placed on cannabis cultivars. In states where the recreational 
use of cannabis is still illegal, such as here in KY, a legal classification of the plants is 
placed according to their Δ9THC content. According to the 2018 KY farm bill, which 
legalized the use of specific cannabis products, cannabis extracts and products can be 
deemed as “hemp” products if they contain less than 0.3% Δ9THC w/w%.99,103,105,106 This 
determination can be made using a number of analytical techniques, mainly LC-UV, GC-
MS, or LC-MS.99,103 In accordance with the initial passing of the bill in KY, a mass 
influx of local testing companies were established to accommodate the equally large 





Figure 3. 3 Twelve of the cannabinoid class of phenolic secondary metabolites produced 




With no standardized analysis method and the only guideline being a Δ9THC content 
limit, inter-lab variation quickly led to many products entering the market outside legal 
limitations due to poor analytical method construction, inexperience, and driving factors 
such as selected use of agencies consistently under-reporting results to drive produces to 
market. The focus of the first aspect of the work found in this chapter was to utilize 
example methods corresponding to the three commonly employed analytical approaches, 
LC-UV, GC-MS, and LC-MS. The hypothesis of this aspect of the chapter was that the 
sources of variation, specifically intra-laboratory and inter-instrumental variation, could 
be determined and reduced and, if reduction was not possible, then the mechanisms 
responsible could at least be understood and accounted for to minimize variation. Given 
that the cannabinoid industry is projected to be a $20+ billion dollar industry by 2022, it 
is absolutely crucial that accurate, reproducible, and sensitive methods are developed and 
adopted on a federal level to assist in the further ethical and scientific development of the 
industry.99 
The second aspect of this chapter focuses more on the global metabolomic 
analysis of phenolics rather than just of a specific subclass like the cannabinoids. Here, 
the development of new analytical methods for the analysis of Polygonum multiflorum 
was performed. This research, also in collaboration with Naprogenix LLC (Lexington, 
KY) (see chapter 2), focuses on the characterization of p. multiflorum extracts in search 
of potential novel compounds resulting from the expression of alpha-synuclein in 
transgenic p. multiflorum hairy roots. Literature suggests that the phenolic compounds 
produced by p. multiflorum (Figure 3.4), such as TSG, emodin, and physcion, may 
present an inhibitory effect on the aggregation of alpha-synuclein into Lewy bodies, 
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which are believed to be one of the primary causes of Parkinson’s disease.107–109 In 
employing the transgenic plant technology described in chapter 2, Naprogenix is 
currently in the process of developing these transgenic p. multiflorum alpha synuclein 
hairy root cultures to develop novel therapeutics to potentially treat or halt the 
progression of the disease. As these cultures are still in development, the focus of this 
work was to analyze whole WT plant extracts to develop a baseline metabolomic 
database for future comparisons. In addition to database development, further 
development of CE-MS methods for the high-throughput characterization and analysis of 
these phenolic compound-rich extracts was also developed. Despite the chemical 
attributes of these metabolites making them unideal for electrophoretic separation, the 
hypothesis was that certain modifications could allow for the application of capillary 
electrophoresis for the analysis of these extracts.  Both the potential downstream 
pharmaceutical application of this work and the analytical application of CE-MS for 
phenolic analytes, which are typically difficult to analyze via CE, are important aspects 












Materials, Methods and Instrumentation 
3.1.1 Cannabinoid Potency Testing Evaluation 
Analytical cannabinoid reference standards, cannabidivarin (CBDV), 
tetrahydrocannabivarin (THCV), cannabichromene (CBC), cannabigerol (CBG), 
cannabinol (CBN), cannibindiolic acid (CBDA), cannabinidiol (CBD), 
tetrahydrocannabinolic acid (THCA), and ∆8 and ∆9-tetrahydrocannabinol (∆8/∆9-THC), 
were purchased from Caymen Chemical (Ann Arbor, MI) as 1 mg/mL solutions as 
defined by U.S. Drug Enforcement Administration (DEA) guidelines. Optima H2O, 
acetonitrile, methanol and formic acid were purchased from Fisher Scientific (Waltham, 
MA). Hemp biomass and an ethanol hemp extract were donated by a local processor in 
Lexington, KY. Additional ethanol extracts were provided by Eastern Kentucky 
Extractions (Jenkins, KY). Three commercial CBD products were also obtained: a 
tincture gel pill and MCT oil tincture from Ananda Hemp (Cynthiana, KY) and a CBD 
lotion from BluLeaf Naturals (Lexington, KY).  
Cannabinoid potency profiles were generated using three instrumental 
approaches: HPLC-UV, GC-MS, and UHPLC-MS. HPLC-UV analyses were performed 
using a Hewlett Packard 1100 series UV detector and binary pump coupled to a 
Rheodyne manual injector. Separations were performed using a Kromacil C18 column 
(4.6 x 150 mm) with a 5 µm particle size. An isocratic gradient consisting of 20% water 
with 0.1% formic acid and 80% ACN with 0.1% formic acid at 1.5 mL/min for 12 
minutes was employed for the separation. For UV detection, 280 nm was monitored. GC-
MS analyses were performed using a Hewlett Packard 6890 series GC coupled to an 
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Agilent 5973 MS detector. A DB-5HT column (15 meter, 0.10 µm film thickness, 0.250 
mm ID) was used with an injector temperature of 260 oC with a 50:1 split and a column 
over temperature gradient starting at 50 oC for 3 minutes, increasing by 50 oC to 100 oC 
and then holding for 1 minute, then increasing by 15 oC per minute to 280 oC. The oven 
was held at 280 oC for 5 minutes (22 minutes total) before returning to starting 
temperatures for the next analysis. For MS analysis, ions corresponding to the ten 
aforementioned standards were monitored in time dependent SIM mode in which the 5 
most abundant fragment ions were used for quantitation. For UHPLC-MS analysis, 
separations were performed using a Shimazdu Nexera X2 UHPLC system with a 
Kromacil EternityXT C18 column (2.5 µm, 2.1x100 mm). The chromatographic 
separation consisted of solvent A (0.1% formic acid in H2O) and B (0.1% formic acid in 
ACN) in a gradient flow method starting with solvent B at 55% for 2 minutes, increasing 
linearly to 95% over 6 minutes, being held at 95% for 2 minutes, and then returning to 
starting conditions for equilibration. The UHPLC-MS analyses were performed on a 
Thermo Scientific Q Exactive Orbitrap High-Resolution Accurate Mass (HRAM) Mass 
Spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) equipped with a heated 
electrospray ionization (HESI) ionization source. Data acquisition was performed in the 
positive ion mode with a mass range of m/z 100-800 the following parameters: 10 L/min 
sheath gas flow and 4 L/min auxiliary gas flow, inlet capillary temperature of 280 oC and 
auxiliary gas temperature (HESI probe temperature) of 280 oC, 3kV spray voltage, scan 




For unprocessed sample preparation, dried hemp plant buds were ground with a 
mortar and pestle to a powder and extracted with ethanol exhaustively. The ethanol was 
filtered via vacuum filtration to remove residual insoluble biomass and reduced to 
dryness via rotary evaporation. The resulting extract was reconstituted in Optima 
methanol at 1 mg/mL and analyzed via HPLC-UV without further dilution (5 µL 
injections). For UHPLC-MS analyses, samples were further diluted to 10 µg/mL in 50/50 
ACN/H2O with 0.1% formic acid (5 µL injections). For GC-MS analysis, a 50 µL aliquot 
of the 1 mg/mL extract was reduced to dryness in an autosampler vial insert under a 
stream of nitrogen. The sample was reconstituted with 50 µL of a 50/50 BSTFA/pyridine 
solution and incubated for 20 minutes at 60 oC for derivatization. Following 
derivatization, the samples were analyzed without further dilution (5 µL injections). For 
processed sample preparation, 500 mg (wet weight) of ground biomass was dried in an 
oven at 60 oC for 30 minutes. The dried biomass was suspended in 5 mL of ACN with 
2% formic acid in a 15 mL polypropylene tube. The suspension was diluted with 5 mL of 
DI water and shaken for 1 hour at room temperature. A QuEChERS extraction was 
performed using the Waters DisQuE AOAC method extraction salts (sodium acetate and 
magnesium sulfate). To the 10 mL solution, 1.5 g of the DisQuE salts were added. The 
extraction was vortexed for 1 minute and separated via centrifugation. The ACN layer 
was collected and filtered with a 0.22 µm nylon filter. The filtered ACN extract was then 
loaded onto a prewashed Waters Oasis HLB SPE cartridge. The first 500 µL of flow 
through from the cartridge was discarded and the remaining 4.5 mL of the “flow through” 
was collected and reduced to dryness under nitrogen. The SPE cartridge was washed with 
3 mL of MeOH and the eluent was collected, added to the dried “flow-through” sample, 
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and also reduced to dryness. The dried, post-SPE extract was reconstituted in 5 mL of 
ACN and stored at -18 oC overnight to precipitate fats and waxes in a “fat crash”. The 
post-“fat crash” extract was dried under nitrogen then decarboxylated via heating in an 
oven at 120 oC for 24 hours. Following the heat conversion, the samples were 
reconstituted as listed above and analyzed. Aliquots (50 µL) from each treatment step 
were also collected for quantitation to assess sample loss.  
For potency profiles, calibrations curves were generated for the ten standards 
listed above spanning at least three orders of magnitude; 10 – 1000 µg/mL for GC and 
HPLC-UV, and 10 ng - 100 µg/mL for UHPLC-MS. Provided ethanol extracts were 
prepared for analysis as stated above for the ethanol extracts. The tincture encapsulated in 
the gel pill was removed with a syringe and transfer to an amber autosampler vial. Both 
the MCT tincture and gel pill tincture were diluted 1:10 (1:100 for UHPLC-MS). For the 
lotion analysis, the DisQuE extraction listed above was used, with modifications. Briefly, 
one “pump” of lotion (~2 mL, suggested usage amount) was suspended in 5 mL of DI 
H2O in a 15 mL polypropylene tube. The aqueous sample was further diluted with 5 mL 
of ACN. Approximately 1.5 g of the DisQuE salts were added to the tube and the sample 
was vortexed for 1 minute. Following vortexing, the sample was centrifuged in a clinical 
centrifuge for 10 minutes. The top ACN layer was collected and stored overnight at -18 
oC to crash out any residual fats/waxes. The resulting ACN solution was reduced to 
dryness under nitrogen gas, reconstituted in 1 mL of optima MeOH, and diluted 1:10 for 
HPLC-UV and GC-MS (derivatized as stated above) analysis and 1:100 for UHPLC-MS 
analysis. Calculated concentrations were generated on a mg cannabinoid per 1 mg 
extract/product basis.  
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3.1.2 HESI Source Induced Degradation of CBDA and THCA 
 Prior to the performance of the degradation assay, the four cannabinoid standards 
were analyzed individually to confirm purity and again as a mixture via UHPLC-MS as 
stated above. Following purity confirmation via chromatographic separation, CBDA and 
THCA were analyzed individually to assess the rate of instrumental temperature-induced 
degradation. Each carboxylic acid cannabinoid was evaluated using both an infusion flow 
rate-based approach (5 µL/min – designated as “low flow rate”) via direct infusion and an 
LC flow rate-based approach (300 µL/min – designated as “high flow rate”) utilizing 
flow-injection analysis (FIA).  
For the low flow rate analysis, the standards were individually infused at a 
concentration of 5 µg/mL in 50/50 ACN/H2O with 0.1% formic acid. Degradation 
induced by either the HESI probe or the inlet capillary was evaluated independently by 
varying the temperature of one component while holding the temperature of the other 
constant. For evaluation of the HESI probe, the inlet capillary temperature was held 
constant at 150 oC while the HESI probe was incrementally increased from 50 oC to 250 
oC in 25 oC increments. Following each temperature increase, the system was allowed to 
reach equilibrium as determined by a stabilization in the TIC variation (<5% variation). 
Once stabilization was established, 15 scans were acquired and averaged to determine the 
ratio of the intact mass (m/z 359) to the degradation products (m/z 341 and 315). A 
similar approach was followed for the evaluation of degradation induced by the heat of 
the inlet capillary where the HESI probe temperature was held at ambient temperature, 
approximately 40 oC, and the inlet capillary temperature was increased from 150 oC to 
300 oC in 25 oC increments.  
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For the high flow rate analysis, a flow injection analysis (FIA) approach was 
utilized by coupling a rheodyne injector to the line supplying a representative mobile 
phase, 50/50 ACN/H2O with 0.1% formic acid, to the mass spectrometer by the UHPLC 
as defined above. Again, both the degradation induced by the HESI probe and the inlet 
capillary were evaluated independently. For evaluation of the HESI probe, the inlet 
capillary temperature was held constant at 250 oC, to accommodate for the desolvation 
required by increased flow rate, while the HESI probe was incrementally increased from 
250 oC to 400 oC in 25 oC increments. Three separate injections were performed at each 
temperature increment with time in-between to allow for the signals corresponding to the 
intact mass (m/z 359) to reduce to pre-injection baseline levels. Degradation rates were 
determined using the ratios of the area counts associated with the peaks corresponding to 
the intact carboxylic acid mass (m/z 359) and the two degradation products (m/z 341 and 
315). The inlet capillary was evaluated using the same temperature increment patterns as 
the HESI probe (250 oC to 400 oC) with the probe being maintained at 250 oC to 
accommodate the increased flow rate.  
 Additionally, solvent composition aiding in the rate of degradation under the high 
flow rate conditions was evaluated by analyzing the carboxylic acid cannabinoids in both 
50:50 and 75:25 ACN or MeOH to H2O with 0.1% formic acid. For this analysis, only 
the HESI probe was evaluated with the inlet capillary temperature being held as 250 oC 
while the probe was increased from 250 oC to 400 oC in 50 oC increments. 
3.1.3 Polygonum Multiflorum Extraction and Analysis 
Standards of the following P. multiflorum  secondary metabolites were purchased 
from Sigma Aldrich  (St. Louis, MO): tetrahydroxystilbene glucoside (TSG), 
127 
 
rhaponiticin, polydatin, resveratrol, quercetin, emodin, and physcion. The following 
lignin model compounds were synthesized and provided by Lynn group member Poorya 
Kamali: H, G, and S monolignol, H, G, and S monolignol ethyl esters, and the G-β-O-4-
G dimer. Commercial p. multiflorum plant material was provided by Naprogenix 
(Lexington, KY). The P. multiflorum plants were removed from the potting soil and the 
roots were cut from the stem. The stems and leaves (~250 mg) were rinsed with DI water 
and separated at the axial bud. For the root preparation, the branch roots were removed 
from the primary taproots and discarded. The taproot (100-200mg) was washed 
thoroughly with DI water and again with 50% EtOH to remove residual soil. The roots, 
leaves, and stems were cut into <1 cm sections and individually ground to a paste with a 
mortar and pestle and liquid nitrogen. The ground roots, stems, and leaves were extracted 
with up to 20 mL 80% EtOH (~10 mg/mL), individually, overnight on a magnetic stirrer. 
The extracts were centrifuged and filtered with a 0.22 µm syringe filter. Samples were 
analyzed both individually and pooled via UHPLC-MS analysis. Separations were 
performed using a Shimazdu Nexera X2 UHPLC system with a Kromacil EternityXT 
C18 column (1.9 µm, 2.1x50 mm). The chromatographic separation consisted of solvent 
A (H2O) and B (ACN) in a gradient flow method starting with solvent B at 5% for 2.5 
minutes, increasing linearly to 95% by 12 minutes, being held at 95% for 4 minutes, and 
then returning to starting conditions by 18 minutes for a 2 minute equilibration, 20 
minutes total. The UHPLC-MS analyses were performed on a Thermo Scientific Q 
Exactive Orbitrap High-Resolution Accurate Mass (HRAM) Mass Spectrometer (Thermo 
Fisher Scientific, Waltham, MA, USA) equipped with a heated electrospray ionization 
(HESI) ionization source. Data acquisition was performed in the negative ion mode with 
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a mass range of m/z 100-1000 the following parameters: 10 L/min sheath gas flow and 4 
L/min auxiliary gas flow, inlet capillary temperature of 280 oC and auxiliary gas 
temperature (HESI probe temperature) of 280 oC, 3kV spray voltage, scan resolution of 
140,000 with a 3 Hz scan rate, a 3e6 AGC target, and a maximum IT of 200 µs. For 
targeted PRM MS/MS analyses, the above method was utilized and an inclusion list was 
generated based off of the observed RTs. Selected NCE levels were determined 
experimentally via infusion of the individual standards at 10 ug/mL concentrations in 
50% methanol. 
3.1.4 Dansylation of Polyphenolic Compounds 
Cannabinoid and p. multiflorum standards were prepared at 1 mg/mL 
concentrations in MeOH with the exception of emodin and physcion which were 
prepared in acetone. For each dansylation reaction, 500 µL of the standard solution was 
added to a glass 1.5 mL autosampler vial with 250 µL of a 10 mg/mL dansyl chloride 
(approximately 5-fold molar excess) solution in ACN and 500 µl 50 mM Na carbonate 
buffer (pH 9.4). The reaction mixture was incubated at 60 oC for 2 hours in a water bath. 
Following incubation, unreacted dansyl chloride was quenched with 5 µL methylamine 
and incubated, again at 60 oC for 30 minutes. Once the reaction was quenched, the 
products were extracted with chloroform and ethyl acetate and reduced to dryness prior to 
analysis. The products were verified using UHPLC-MS and tandem mass spectrometry, 
as stated above, and via flow injection analysis, also as stated above – see “high flow-rate 
analysis”. Dansylated standards were also analyzed via CE/CZE-MS using the 908 
Devices ZipChip, see below.  
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3.1.5 Modified microfluidic CZE-MS 
For modified microfluidic CE-MS analyses of unmodified and dansylated 
polyphenolic compounds, the 908 Devices Zipchip was employed. A prototype “bare” 
HR chip (HRB) in which the capillary walls were stripped of the aminopropyltriethoxy-
silane coating was supplied by 908 Devices. For negative ion separation of unmodified 
polyphenolics, a basic BGE was developed consisting 10% isopropyl alcohol, 10 mM 
ammonium acetate, 0.04% ammonium hydroxide, pH 8.5. For lithium assisted positive 
ion separation, a Li-based BGE and sample diluent were developed consisting of 20% 
isopropyl alcohol, 10% ACN, 100 µM LiCl for the BGE and  80% methanol, 10 mM 
LiCl for the diluent. Basic separations were evaluated on the HRB chip using a field 
strength ranging from -145 V/cm to -100 V/cm with 1 nL sample injections. Li-assisted 
separations were evaluated on both the HS and HRB chips. For HS separations, field 
strengths employed ranged from 0 V/cm to 1000 V/cm with 1nL injections. For HRB 
separations, field strengths employed ranged from 0 V/cm to 500 V/cm with 0.5 nL 
injections. Pressure assist was utilized for all separations. All analyses were performed 
using a Thermo Q Exactive HRAM mass spectrometer with the same parameters as listed 
above except the mass range was adjusted to m/z 100 to 1000.  
Results and Discussion 
3.1.6 Cannabinoid Potency Testing Evaluation 
The goal of the first part of this chapter was to evaluate the use of HPLC-UV, 
GC-MS, and UHPLC-MS in regards to their application for cannabinoid potency testing.  
As HPLC-UV is considered the “gold standard” for potency testing, the results from both 
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mass spectrometry-based approaches were compared to the HPLC-UV results in terms of 
calculated concentration accuracy, reproducibility, sensitivity, and selectivity. 
 Calibration curves were generated, using each approach, for quantitation of the 
selected cannabinoids (Figure 3.3) representing the most common and abundant 
cannabinoids found in CBD/cannabis products. Figures 3.5-3.7 display resulting 
chromatograms for samples containing equimolar concentrations of the cannabinoid 
standards (3.5 – HPLC-UV, 3.6 – GC-MS, 3.7 – UHPLC-MS). Representative calibration 
curves can also be seen for each method displaying CBD and THC. All three methods 
displayed great linearity for the calibration curves with R2 values all greater than 0.95 
with most greater than 0.99. Differences in limits of quantitation (LOQs) for each method 
were observed at this point with the HPLC-UV at 100 ng/mL, the GC-MS at 10 µg/mL, 
and the UHPLC-MS at 10 ng/mL.  The UHPLC-MS method displayed the greatest 
sensitivity due to the high resolving power of the instrument allowing for the accurate 
mass detection and limiting the impact of noise-related mass peaks near the analyte’s 
m/z. Due to the nature of the analytes, specifically the carboxylic acid cannabinoids, the 
sensitivity could have been further increased if the analysis was performed in negative 
ion mode, however, to maintain consistency with the industrial standard HPLC-UV 






Figure 3. 5 (Top) Base peak chromatogram for the separation of ten cannabinoid 
standards using HPLC-UV detection. (Bottom) Calibration curve for THC and CBD 






Figure 3. 6 (Top) Base peak chromatogram for the separation of ten cannabinoid 
standards using GC-MS detection. (Bottom) Calibration curve for THC and CBD 






Figure 3. 7 (Top) Base peak chromatogram for the separation of ten cannabinoid 
standards using UHPLC-MS detection. (Bottom) Calibration curve for THC and CBD 




Unexpectedly, the HPLC-UV approach appeared to be more sensitive than the GC-MS 
approach. A possible explanation for this could be the intense absorbance response of the 
cannabinoids at the selected wavelength, 280 nm, due to the aromatic ring moieties of the 
analytes. This could also be due to the high heat of the inlet of the GC causing 
degradation of the analytes. As depicted in Figure 3.6, at equimolar concentrations, the 
peaks corresponding to CBDA and THCA are much lower than those corresponding to 
their naturally decarboxylated counterparts, CBD and THC. Though the BSTFA 
derivatization (Figure 3.8) is intended to prevent decarboxylation, the reaction may not be 
as effective on the acids as it is for the phenolic -OH groups, thus leading to an easily 
dissociated, unprotected carboxylic acid. Differences were also observed in the selectivity 
of the chromatographic methods used, as well. At equimolar concentrations, baseline 
resolution of specific analytes could not be achieved, regardless of any method 
modifications tested. For both HPLC and UHPLC, the THC isomers could not be fully 
resolved from each other. Generally, for mass spectral approaches, this is less of an issue 
as RICs can be generated, as seen in Figure 3.7, but in this case, both analytes have the 
exact same m/z. From an application standpoint, ∆8-THC is, on average, at trace levels in 
plant extracts, if present at all, therefore this drawback was not deemed to be detrimental 
for either method. The selectivity can be improved for the ∆8/∆9 isomers, however, by 
altering the mobile phase conditions. This is not ideal as it drastically affects peak shape 
and selectivity of the method for other analytes (coelution, peak tailing, etc). In the event 
that ∆8-THC is detected, the sample would need to be analyzed twice, once using the 











Additionally, it is worth noting that for GC-MS, CBC and ∆8-THC coelute at higher 
concentrations. Though both analytes share the same m/z for their molecular ion ([M+•]= 
m/z 386), their fragmentation patterns differ, allowing for chromatographic 
deconvolution – CBC: m/z 386 → 304, 303, 246, 231; ∆8-THC: m/z 386 → 343, 330, 
303, 265, 246. The ionization process utilized by GC-MS, which induces this 
fragmentation, is ideal for the analysis of analytes like the cannabinoids. The 
phytocannabinoid family consist of several structural isomers (CBD/THC/CBC, 
CBDA/THCA/CBCA/, CBDV/THCV, etc), however, their fragmentation patterns can be 
found in common databases such as the NIST database to ease the process of 
identification and chromatographic deconvolution.  
 To assess reproducibility and potency profile accuracy, all three methods were 
applied to the EtOH extracts and commercial products. Table 3.1 displays the 
quantitation results, on a mg cannabinoid per mg extract/sample basis following analysis 
and corrections for dilutions. In terms of mg total cannabinoids per mg sample, the results 
were similar across all three methods with the exception of the GC-MS results in regard 
to the tincture and gel pill samples. Though both samples totaled the lowest in total 
cannabinoids, <50 ug/mg, the GC-MS results were nearly twice that observed for the 
HPLC-UV and UHPLC-MS methods. This can most likely be attributed to a matrix-
effect as the samples were diluted, rather than extracted, from products containing high 
concentrations of oils like MCT oil. Compared to the other products, however, the 
calculated total cannabinoid profile of these two products was approximately 10X lower 











The primary application of the cannabinoid potency screenings performed by 
various testing agencies is to determine the legality of cannabis-products, as ∆9-THC is 
considered an illicit substance. In order for a product to be considered legal in the state of 
KY, according to the 2018 Farm Bill, it cannot contain more than 0.3% total THC w/w%. 
For this calculation, the quantified mass of THCA is multiplied by 0.877 to take into 
account its conversion to ∆9-THC in the body and added to the calculated THC 
concentration: 
𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑇𝑇𝑇𝑇𝑇𝑇 = ∆9𝑇𝑇𝑇𝑇𝑇𝑇 + (𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 ×  0.877) 
A similar equation is used for CBD concentration calculations with its respective 
carboxylic acids. Table 3.2 displays the w/w% calculated for CBD and THC in the 
products using all three methods with this displayed graphically in Figure 3.9. For 
products like the in-house made EtOH extract and the commercial EtOH extracts, being 
slightly above the 0.3% total THC is common as the extracts will be further diluted when 
converted into final commercial products. An interesting trend was observed in that, for 
the HPLC-UV method, all the calculated total THC resulted from THCA whereas with 
both GC-MS and UHPLC-MS, no THCA was detected and only ∆9-THC was detected at 
concentrations above the limit of quantification. For GC-MS, it is possible for 
interconversion of THCA to ∆9-THC to occur in the inlet of the GC, as stated above, or 





Table 3. 2 CBD and THC quantitation as w/w% for the extracts and samples. Red texts 





              
 
Figure 3. 9 (Top) CBD (left) and THC (right) w/w% percentages with error bars associated with standard deviation. (Bottom) CBD 
(left) and THC (right) w/w% percentages normalized to HPLC-UV results with error bars associated with standard deviation. 
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This would not be the case for UHPLC-MS, however, as any decarboxylation that would 
occur as a result of heat would be after chromatographic separation during the 
electrospray process, therefore it would not contribute to the observed THC response. As 
RICs were used for quantitation in UHPLC-MS, corresponding to the intact mass, any 
post-column degradation would have an effect on the observed THCA and CBDA 
response, however, discussed further in section 3.1.7. If post-column degradation were 
the case, as hypothesized, it would explain why the THC and CBD content, as 
determined by UHPLC-MS, is significantly lower than that calculated by the other two 
methods for a majority of the samples. As depicted in Figure 3.9, there is little agreement 
between the total CBD and total THC concentrations determined by each method, 
especially evident when normalized to the HPLC-UV results. Compared to GC-MS, 
HPLC-UV underrepresented CBD statistically (p<0.05) in all samples except the in-
house extract and the lotion, and THC in the in-house extract (not detected), one of the 
commercial extracts, and greatly (7X) in the lotion. In using HPLC-UV to produce a 
potency profile for the lotion, the product would be considered legal to sell, however, 
according to the GC-MS results, the product contains 5X the legal concentration of total 
THC. Though likely more accurate for THC determination that HPLC-UV, the method 
lacked precision, as apparent in the relative size of the error bars in Figure 3.9. As stated 
previously, this is likely due to conversion of THCA to THC during the derivatization 
process and conversion of underivatized THCA to THC in the inlet of the GC causing 
inconsistent responses for both analytes. For UHPLC-MS potency profiling, the opposite 
is observed from GC-MS. The cannabinoid profiles were similar to those generated using 
HPLC-UV and the RSDs were all relatively low, suggesting both accuracy and precision 
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for this method, when compared to the HPLC-UV results. Here, again, we see that, for 
the lotion, the total THC concentration was determined to be outside the legal limit 
whereas it was below the limit when UV detection is used. The total THC content 
determined using the UHPLC-MS method may even be underrepresenting the THC 
content as THCA was detected using the UV method and not using the MS method, due 
to possible degradation or poor ionization efficiency.  
 Though standard HPLC with UV detection is preferred in the cannabis industrial 
for cannabinoid profiling, it is clear that it may not be an accurate enough method for 
determining low levels of THC in a product. Though deemed below the legal limit both 
by an accredited testing agency and using our HPLC-UV method, the CBD lotion was 
determined to have well over the legal concentration of total THC using both mass 
spectrometry-based methods. Unfortunately, the cannabinoid profiles generated using 
both of the MS approaches did not display statistical similarity, with the GC-MS 
potentially overestimating the results, with poor reproducibility, and the UHPLC-MS 
method, while more sensitive to the low-level cannabinoids like CBG and CBDV, 
potentially slightly underestimating the results. In order for accurate profiles to be 
generated, either ancillary methods need to be developed and employed to confirm results 
generated by the UV method, or the reason for the UHPLC-MS method underestimation 
needs to be determined and corrected. The latter is addressed in the section below.  
3.1.7  Source-Induced degradation of CBDA and THCA 
During initial investigations and cannabinoid profiling method assessments 
involving the carboxylic acid cannabinoids, THCA and CBDA, evidence of instrument-
induced thermal degradation was observed. This was initially discovered when plotting 
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reconstructed ion chromatograms (RIC) of CBD and THC (m/z 315.2318) post analysis 
of a sample containing all four of the cannabinoids, CBDA, CBD, THCA, and ∆9-THC. 
Two low intensity peaks corresponding to CBD and THC, m/z 315.2318, were observed 
to be co-eluting with the m/z 359.2216 peaks despite also being resolved as standalone 
peaks. This trend was confirmed when analyzing the carboxylic acid cannabinoid 
standards independently via UHPLC-MS. Upon further investigation of the mass 
spectrums of CBDA and THCA, an ion at m/z 341.2112 was also observed for both 
cannabinoids generating similar peaks to the carboxylic acids when plotted as a 
reconstructed ion chromatogram (Figure 3.10 - RICs, Figure 3.11 - example mass 
spectrum of THCA). The appearance of these two ions was hypothesized to be induced 
by the usage of high temperatures provided by the heated electrospray ionization (HESI) 
probe in aiding desolvation during the ionization process when coupling the UHPLC to 
the mass spectrometer. To determine the source of the degradation, the carboxylic acid 







Figure 3. 10 (Top) RICs for m/z 359, 341, and 315 from a mix sample consisting of 
THCA, CBDA, CBD, and THC. (Middle) RICs for m/z 359, 341, and 315 from a sample 
consisting on THCA only. (Bottom) RICs for m/z 359, 341, and 315 from a sample 







Figure 3. 11 Mass spectrum of the THCA peak displaying THCA (m/z 359), THC (m/z 315), and an unknown degradative 
product (m/z 341). 
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 Evaluation of the rate of the instrument-induced degradation was first performed 
at low flow rates utilizing an “infusion” approach for assessment. Though infusion is not 
typical for cannabinoid profiling, the low flow rate (5 µL/min) through the HESI probe 
maximizes the time in contact with the heating element – approximately 13 seconds (0.22 
minutes) for a 130 mm HESI probe. This approach was intended to elucidate the 
maximum extent degradation would occur when employing the HESI probe to aid in 
desolvation. The rate of degradation was determined by recording the ratio of the 
intensity of the intact mass ion to the intensities of the degradation product ions. Fifteen 
scans were acquired at each temperature increment to allow for adequate sampling when 
averaging the intensities. Perturbations in the total ion current (TIC) were present during 
the temperature increase and for a short time immediately following the temperature 
stabilization, therefore sufficient time was allotted at each temperature increment to allow 
for the TIC variation to stabilize to ~5% variation. In addition to the assessment of the 
HESI probe inducing degradation, the mass spectrometer inlet capillary temperature was 
also examined. For the inlet capillary assessment, the HESI probe temperature control 
was disengaged and allowed to reach ambient temperature, however, the probes’ 
proximity to the inlet capillary prevented the probe temperature from reaching 
temperatures lower than ~40 oC. Figure 3.12 displays graphs plotting the ratio of the 





Figure 3. 12 Low flow rate (infusion) degradation analysis. Top left: THCA degradation 
with varying inlet capillary temperature. Top right: CBDA degradation with varying inlet 
capillary temperature. Bottom left: THCA degradation with varying HESI probe 




At low flow rates, varying the inlet capillary temperature resulted in minimal 
degradation of the carboxylic acids to their degradation products, even at the maximum 
temperature employed, 300 oC. The highest observed ratio of the degradation products to 
the intact carboxylic acid was ~0.16:1 for CBDA. The slight upward increase in the 
degradation trend observed for the low flow inlet capillary experiment is believed to be 
due to an increase in response brought about by improved desolvation rather than by an 
increase degradation, though this is difficult to prove given that standards the degradation 
products representing the loss of H2O (-18.0105) are not commercially available and the 
total degradation is largely attributed to an increase in their total signal. Conversely, the 
HESI probe had the opposite effect. Near the mid-temperature range, ~225 oC, the 
decarboxylated product intensity increased with the ratio reaching as high as ~10:1 for 
THCA and ~50:1 for CBDA at the maximum temperature. The rate of the loss of H2O 
remained relatively constant at higher temperatures when varying the HESI probe 
temperature. This product was believed to be the result of the loss of H2O following 
protonation occurring at the carboxylic acid functional group (Figure 3.13), which would 
have dissociated at those temperatures, generating an acylium ion. Gas-phase conversion, 
at high temperatures, of carboxylic acids to acylium ions has been reported in literature, 
therefore it was hypothesized that the cannabinoid acids may be forming these ions 
during the high temperature electrospray and desolvation process.110–113 To test this, 
MS/MS analyses were performed on the cannabinoid acids, their putative acylium ions, 
and their free forms to compare fragmentation patterns. Figure 3.14 displays all six 





3.13 dehydration and decarb structures 
 
 
Figure 3. 13 THCA and CBDA (m/z 359) structures and their heat induced degradation 






Figure 3. 14 MS/MS spectra of the cannabinoid acids (m/z 359) , the acylium ion (m/z 
341), and the free cannabinoid (m/z 315) for THCA (top three traces) and CBDA (bottom 




As this analysis was acquired using a HRAM mass spectrometer, empirical formulas are 
able to be generated for selected ions within 5 ppm of their theoretical mass. 
Fragmentation patterns for the carboxylic acids and the putative acylium ions displayed 
homology for both the THC and CBD classes of molecules. Note that most of the 
empirical formulas for the fragments ions corresponding to THCA, CBDA, acylium THC 
(aTHC), and acylium CBD (aCBD), have been calculated to contain three oxygen, while 
the fragments for THC and CBD mostly contain two. This would suggest that the 
phenolic -OH groups, shared by all six ions, are likely not the most labile bonds in the 
system and that the single oxygen loss in fragment species observed for THCA, CBDA, 
aTHC, and aCBD is likely attributed to the carboxylic acid. Carboxylic acids are usually 
extremely labile, as depicted in the loss of the -COOH frequently observed in the 
previous section, therefore it would be expected that the fragment ions observed during 
MS/MS analysis of THCA and CBDA would be calculated to contain only two oxygen 
atoms. Further evidence for this phenomenon can be observed in the following 
fragmentation pattern, observed for both CBD and THC species: THC/CBD: m/z 
315.2320 (C21H31O2) → 259.1691 (C17H23O2) and CBDA/THCA: m/z 359.2216 
(C22H31O4) → 285.1486 (C18H21O3), a difference of H2O. The hydrogen atoms can be 
accounted for in that CBD/THC would have one hydrogen where the carboxylic acid 
attaches and the other would be lost in the acylium (C≡O+) formation as the functional 
group is inherently charged and an [M+H+] species would not exist. This evidence 
suggests that the occurring is actually due to the formation of an acylium ion during the 
gas-phase ionization process. 
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This approach, utilized for the evaluation of the HESI probe and the inlet capillary, was 
then applied to a higher flow rate (300 µL/min – Figure 3.15) to assess if their effects 
were evident on the carboxylic acid cannabinoids under conditions that emulate the 
industry standard approach for cannabinoid profiling using HPLC. At this flow rate, the 
time in which the analytes are in contact with the heating element of the HESI probe is 
greatly reduced from ~13 seconds (0.22 minutes) to ~0.2 seconds (0.004 minutes). To 
accommodate for the increased flow rate, the minimum temperature for both the HESI 
probe and the mass spectrometer inlet capillary were greatly increased (250 oC) to 
prevent moisture interaction with the interior components (S-len) of the instrument. Flow 
injection analysis was utilized for this assessment allowing for area counts to be used for 
the ratio determination rather than averaged scan-to-scan ion intensities. The reduced 
time in contact with the HESI probe, even at the maximum employed HESI probe 
temperature, resulted in reduced rates of degradation, as anticipated. At the typical 
temperature ranges suggested for HESI probes at this flow rate, the ratio of the 
degradation products to the intact acids averaged at ~0.2:1 with the ratios reach as high as 
0.4:1 at the maximum temperature. Contrary to the observations made during the infusion 
experiment, the inlet capillary temperature had an increased effect, especially for CBDA 
with ratios as high as ~4:1 for the acylium ion.  
To further assess the carboxylic acid cannabinoid dehydration and acylium ion 
formation phenomenon, variations in solvent composition were also considered. Due to 
the non-polar characteristic nature of the cannabinoids, higher organic percentages in 
mobile phases are required to promote elution from standard reversed phase HPLC 




Figure 3. 15 High flow rate (LC flow) degradation analysis. Top left: THCA degradation 
with varying inlet capillary temperature. Top right: CBDA degradation with varying inlet 





Additionally, due to economic factors, methanol is often utilized as the organic 
component for HPLC separations rather than acetonitrile. Therefore, the high-flow rate 
experiment was repeated at a higher organic percentage, 75% ACN rather than 50%, and 
again with 50/50 and 75/25 MeOH: H2O w/ 0.1% formic acid. Acetonitrile has a higher 
heat capacity (~92 J/mol*K than both water (~75 J/mol*K) and methanol (~81.5 
J/mol*K) thus it was hypothesized that higher ACN percentages would reduce the rate of 
degradation for the ACN/water analyses however, the rate of degradation observed for 
the methanol/water experiments would be increased when compared. Figure 3.16 (ACN) 
and 3.17 (MeOH) displays the graphical representations of the degradation rates of the 
acids with varying mobile phases. As hypothesized, increased ACN concentrations 
reduced the degradation rates from 0.25:1 to 0.2:1 for THCA and 0.4 to 0.25 for CBDA, 
at the maximum temperature. The hypothesized outcome was not observed, however, for 
the MeOH experiment. Despite having a lower heat capacity than acetonitrile, the rates of 
degradation were not only lower than those observed when using acetonitrile, but also 
consistent across organic concentrations: THCA – 0.16:1 for both 50% and 75% MeOH, 
CBDA – 0.25:1 for both 50% and 75%. There are multiple possible explanations for this 
phenomenon. The first involves the protic nature of MeOH as opposed to the aprotic 
nature of ACN. Given that the solvent composition includes 0.1% formic acid, 
approximately pH 2.7, according to Shi and Middlemiss, the gas and liquid-phase 
conversion of carboxylic acids to acylium ions is driven towards the products at low pH, 
however, in the presence of an alcohol, such as methanol, a Fischer Esterification can 
occur.113 This would result in the formation of a stable ester as opposed to or in 
conjunction with the formation of the acylium ion. For both acids, m/z 373.2373 would 
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be observed if formation of the ester occurs in the presence of methanol. This can be 
observed in Figure 3.18 wherein an example of the FIA series for CBDA in 75% 
methanol can be seen. The top three RIC traces represent CBDA, the ester ion, and the 
acylium ion, respectively. The bottom two traces show CBDA in 75% ACN displaying 
no evidence of the m/z 373.2373 ion outside of baseline noise. This ester ion appears at 
ratios as high as 0.06:1 for CBDA and 0.07:1 for THCA. Though low in comparison to 
the acylium ion and decarboxylated product, this observation adds an addition factor to 
be taken into consideration when quantifying cannabinoid acids. In addition to 
esterification, methanol also has a higher vaporization enthalpy, 38.3 kJ/mol versus 33.8 
kJ/mol for ACN. During the electrospray process, ionization efficiency, which also 
contributes to signal intensity, is dependent on the rate of desolvation of the ions as 
charged species. As the formation of the acylium ion is hypothesized to be a gas-phase 
event, the reduced vaporization enthalpy would imply that, when using ACN, the 
analytes are desolvated earlier than they are when using MeOH. This would not only 
have an impact on the rate of acylium formation, it could also induce an artificial 
inflation of the observed ratios, as the relative signal intensities would be higher when 
using ACN than MeOH. The possible formation of the ester product and the acylium ion 
and the overall reduction in the signal response paired with the overall poor elutropic 
strength of MeOH (1 εo) compared to ACN (3.1 εo) would suggest that, though even at 
the lowest operating temperatures, the acylium ion appears, ACN is still the better suited 
solvent for cannabinoid profiling. As quantitation of the byproduct is currently not 
possible due to the lack of a commercial standard or method of synthesis, the best course 
of action would be for profilers to treat the acylium ion, and other degradative products, 
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as one would for the doubly and singly charged ions of a molecule possible of forming 
such species, in quantitation and use a summation of the area counts to represent the 





Figure 3. 16 ACN - High flow rate (LC flow) degradation analysis. Top left: THCA 
degradation with varying inlet capillary temperature at 50% ACN. Top right: THCA 
degradation with varying inlet capillary temperature at 75% ACN Bottom left: CBDA 
degradation with varying inlet capillary temperature at 50% ACN Bottom right: CBDA 





Figure 3. 17 MeOH - High flow rate (LC flow) degradation analysis. Top left: THCA 
degradation with varying inlet capillary temperature at 50% MeOH. Top right: THCA 
degradation with varying inlet capillary temperature at 75% MeOH Bottom left: CBDA 
degradation with varying inlet capillary temperature at 50% MeOH Bottom right: CBDA 





Figure 3. 18 (Top to bottom): Top three traces - FIA segment RIC for m/z 359 (CBDA), 
m/z 373 (putative CBDA methyl ester), and m/z 341 (acylium ion) for MeOH mobile 
phase. Bottom two traces – FIA segment RIC for m/z 359 (CBDA) and m/z 373 (methyl 




3.1.8 Polygonum multiflorum screening method development 
In a similar manner to the work found in chapter 2, this chapter section focuses on 
the development of a screening method for plant extracts, In this case, those from 
Polygonum mulitflorum. It is hypothesized that P. multiflorum may produce secondary 
metabolites that interact with alpha-synuclein and may be used to treat Parkinson’s 
disease.107-109 Unlike with L. cardinalis in chapter 2, p multiflorum has been well 
characterized in literature and its main secondary metabolites are commercially available, 
however, difficulty can be encountered in the metabolomic analysis of P. multiflorum as 
most of its secondary metabolites are polyphenolics. Polyphenolics are nonpolar with 
poor aqueous solubility and exist as neutrals in most analytical applications. Though 
better suited for negative ion mode mass spectral analysis, the goal of this work was to 
develop an ancillary or alternative method that could be used to analyze both the 
polyphenolics and investigate other unknown metabolites using positive ion mode mass 
spectrometry.  
Prior to advanced method development, seven commercial standards (trans-TSG, 
polydatin, rhaponiticin, resveratrol, emodin, physcion, and quercetin) were used to 
evaluate ionization methods and optimize UHPLC-MS separations, as extraction methods 
have already been thoroughly investigated in literature.98 As stated previously, typically 
for polyphenolics, negative ion mode ESI to produce [M-H]- ions is employed. For this 
specific application, however, negative ion mode lead to multiple analytical issues such 
as enhancement of common contaminant signals (i.e. SDS and plasticizers), poor 
separation as organic modifiers are not typically used in HPLC separation, and poor 
MS/MS fragmentation. Poor MS/MS fragmentation is detrimental to this research as the 
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mutant P. multiflorum cultures that are to be developed and provided by Naprogenix and 
analyzed using this approach in the future will have undergone a similar mutation and 
selection process that the L. cardinalis cultures were in chapter 2. In doing so, it is 
possible that the cultures will produce novel secondary metabolites or upregulate 
previously trace secondary metabolites in response to the mutagenesis that will need to be 
characterized using tandem mass spectrometry. In work performed by fellow Lynn group 
lab members analyzing lignin monomers and dimers, i.e. polyphenolic compounds, the 
use of lithium chloride to produce [M+Li]+ species has been successful in producing 
better MS/MS fragmentation patterns. In applying this technique, the P. multiflorum 
standards were analyzed using Li, Na, K, and NH4 chloride salts to assess cationization 
efficiency, as well as fragmentation. Figure 3.19 displays an example of the MS/MS 
spectra of trans-TSG corresponding to the [M-H]-, [M+H]+, and [M+Li]+ ions. As 
depicted in the Figure, little structural information can be derived from the [M-H]- and 
[M+H]+ MS/MS spectra aside from the loss of the glucose yielding the free stilbene – 
[M+H]+: C14H13O4+ - m/z 245.0808 and [M-H]-:  C14H11O4-  - m/z 243.0663. When 
performing the MS/MS experiments on the Li+ adducts, an extensive fragmentation 
pattern can be seen, as observed during the lignin MS/MS analyses. In utilizing post-
column addition of 10 mM chloride salts at 10 uL/min, the area counts corresponding to 
the standards forming adducts with the different cations was compared. Table 3.3 
displays these area counts and also the area counts corresponding to the [M-H]- and 
[M+H]+ ions. A decrease by over an order in magnitude can be observed when switching 
from negative to positive ion mode, thus limiting limits of quantification and detection 




Figure 3. 19 MS/MS spectra for TSG: Top - [M-H]- at 15 NCE, Middle - [M+H]+ at 10 










Additionally, cationization adducts were only observed for the stilbene glucosides, with 
Li+ being either the most responsive or similar in response to the [M+H+] species. This 
was expected, however, as the stilbenes and lignin dimers are very similar in structure. 
Interestingly, no interaction was observed for resveratrol with any of the cations, despite 
it being the free stilbene of polydatin. This would suggest that the Li+ interaction is most 
likely either stabilized by the presence of the glucoside or the interaction is occurring 
with the glucoside exclusively. No cations outside of the [M+H]+ ions were observed for 
the flavonoid or the anthraquinones, which may be explained by the fact that both classes 
are relatively planar molecules. This is not necessary problematic, however, as the 
flavonoids and anthraquinone standards produced more extensive fragmentation patterns 
at higher NCEs than the stilbenes and, in the event that putative novel flavonoids or 
anthraquinones are detected, they can be characterized without the requirement of adduct 
formation. Through this approach, screens would be performed once using negative ion 
mode, in order to ensure low concentration analytes are not missed, with standard 
UHPLC separations, and then again switching the polarity and using post column LiCl 
with a targeted MS/MS peak list to identify novel metabolites. Though applicable, the 
increased time resulting from the requirement of two analyses per sample makes this 
method less than ideal for high-throughput metabolomics screenings. 
To establish a baseline peak list for downstream comparison, using compiled lists of 
known secondary metabolites found in p. multiflorum, trimmings of WT plants (~200 mg 
dry weight) were collected from Naprogenix, extracted, and analyzed. Using MZmine2 
paired with METLIN and KEGG for database searching, an extensive peak list, 
consisting of over 120 identified primary and secondary metabolites, was constructed for 
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cross referencing in the event that novel peaks are detected. The list was broken down 
into analytes found in root, stem, leaf, and/or whole plant extracts, as well, to aid in 
prioritizing analyte procuration from specific tissue sections in down-steam extractions. 
This list can be seen in appendix 4.  
In order to couple the analysis with characterization, specifically in a high-
throughput manner, as utilized in Chapter 2, the use of CZE/CE-MS was explored for this 
application as well. Given that polyphenolics generally exist as neutrals at most pH’s in 
solution, standard CE would be difficult to employ as neutrals would migrate with the 
EOF and not separate. High pH buffers could be employed for standard CE analysis, such 
as phosphate or borate BGEs, however such involatile salts can cause irreparable damage 
to mass spectrometers. For CE coupled to MS analysis, typically, positive ion mode 
acquisitions with low pH BGEs consisting of volatile salts are used. Extracts and 
standards were introduced to the ZipChip CZE-MS setup described in chapter 2 and the 
previously developed method was applied, as is. As expected, no peaks were observed. 
The cationic coating on the walls of the CZE HS chip effectively reduces the zeta 
potential and eliminates all electroosmotic flow. Additionally, since the analytes are 
neutral, no electrophoretic mobility is observed either. Pressure can be applied at the head 
of the BGE well to act as a “pseudo-electroosmotic” flow strictly in terms of providing a 
bulk flow in the separation channels. When pressure is applied at the origin side of the 
chip, the analytes are eventually forced out, concurrently, after approximately 10 
minutes. This mass coelution is obviously disadvantageous as it greatly complicates any 
mass spectral data from being interpreted differently than an infusion or flow-injection 
analysis. Additionally, seemingly due to interactions with the wall coating increasing the 
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impacts of longitudinal diffusion, the pressure eluted peaks are multiple minutes wide 
and often result in carry-over, making quantitation, or even relative quantitation, difficult. 
To address this, collaboration with 908 Devices was established and the manufacturer 
provided a proto-type blank “HR” chip. Aside from being stripped of the cationic 
coating, the separation channel was also twice as long (10 cm vs 22 cm), overall making 
the application more akin to traditional CE. To correct for the added length, the 
maximum allowed applied field strengths are half that applicable to the HS chips: 500 
V/cm vs 1000 V/cm. Though the switch to a bare chip allows for more “CE”-like, rather 
than CZE, separations and eliminates interactions with the wall coating, the analytes 
being neutral would still cause them all coelute with the reestablishment of the 
electroosmotic flow. Lithium chloride was added to the BGE and diluent, both 
independently and simultaneously, to test if interactions with the cation would allow for 
electrophoretic mobility to be observed. Though migratory and peak shape improvements 
were observed, as seen in Figure 3.20 for polydatin and rhaponitcin, the least and most 
conjugated stilbene glucosides respectively, the migration shifts were believed to be 
associated with Li cation migration rather than true Li adduct electrophoretic migration, 
causing the analytes to continue to coelute. Negative field strengths coupled with a 
NH4OH separation BGE (pH 8.5) and diluent were also evaluated, however, only positive 
potentials can be applied to the ESI spray well of the chip requiring analyses to be 
acquired in the positive ion mode. Both Li and standard BGEs were tested in the spray 
well, however, no ions were detected regardless of applied voltages. It is possible that 
any electrophoretic migration occurring is quickly neutralized at the separation channel-





Figure 3. 20 Reconstructed electropherograms of [M+Li]+ for polydatin and rhaponiticin 




As no BGE, diluent, or surface modifications tested resulted in adequate separation of the 
analytes, modification of analytes was evaluated. 
Borrowing from the common use of derivatizing analytes for GC-MS, derivatizing 
with dansyl chloride was investigated for this application. Dansyl chloride is commonly 
used as a fluorescence signal amplifier in protein analysis and reacts with primary amines 
and alcohols, under basic conditions, to produce sulfonamide or sulfoxide adducts with 
terminal tertiary amines. For this application, the tertiary amine of the dansyl group 
provided a cationization site (pKa 2.4) for positive ion separation and positive ion mode 
mass spectral analysis. Since previous work has been performed using the cannabinoids 
and dansyl chloride, also being phenolics, they first were evaluated to determine if 
electrophoretic separation was achievable with molecules that are generally highly non-
polar, neutral, and poorly suited for positive electrophoretic separations.114 Figure 3.21 
displays the general dansylation reaction and Figure 3.22 displays both the cannabinoids, 
both monodansylated (A) and bidansylated, if possible (B), as well as the p. multiflorum 
metabolites, both monodansylated (C) and bidansylated, if possible (D). The reactions 
were performed using standards to assess reaction conditions and also on cannabis 
extracts as a surplus of extract material was available. The methods developed using the 
cannabis extracts will be applied to the p. multiflorum extracts when they are available in 
the future. Various reaction times, temperatures, and molar ratios were evaluated and it 
was determined that a 10-fold molar excess of dansyl chloride to reactant for 2 hours at 
60 oC resulted in >99% conversion to the monodansylated or bidansylated species based 



































successfully monodansylated, however, for analytes like CBD and resveratrol containing 
hydroxyl groups with near equivalent pKa’s, bidansylation was possible and observed. 
Initial evaluations of dansylated cannabinoid standards (A) as well as dansylated 
cannabinoid extracts (B), Figure 3.23, provided evidence of not only electrophoretic 
mobility, but adequate separation of the selected analytes as well. Peak shape degraded 
between the dansylated standards and the dansylated extract, most likely due to the 
extract undergoing minimal cleanup and processing prior to analysis. Though 
preliminary, this data provides evidence that this approach would likely be applicable to 
the p. multiflorum extracts in the future.  
In order to adequately assess method development for the dansylated p. multiflorum 
CE-MS analysis, multiple separation and sample preparation conditions were evaluated, 
namely, sample diluent concentration, the usage of pressure assist, and the chip wall 
coating. Since the HS and HR chip channels are different lengths and the software 
prevents the same field strengths from being applied to different chips, retention time was 
not used as a comparison metric. Figure 3.24 displays RICs for the variously dansylated 
polygonum analytes using the HRB chip. Due to the multiple phenolic sites found on 
several of these analytes, like TSG, dansylation can occur at multiple locations. Due to 
the steric hindrance incurred by the addition of the bulky nonpolar naphthalene group of 
the dansyl modifier, generally one dansylation was observed at the most terminal 


















Though adding another layer of complication to the analysis, the fact that they are all 
baseline resolved from one another despite being very similar structural isomers 
simplifies the downstream data-processing as no forced chromatographic deconvolution  
calculations are required, the individual peak area counts can simply be summed for 
absolute or relative quantitation. When applying the dansylated polygonum analytes to 
the HS chip with the cationic coating, however, the addition of the dansyl group to the 
stilbenes did not have the same effect that it did for the cannabinoids. In assessing the use 
of pressure assistance and varying leading electrolyte concentrations (0-100µM), very 
few conditions resulted in any detectable signals for the dansylated stilbenes. It would 
appear that they interact strongly with the cationic wall coatings of the HS chips, a 
feature encountered during the non-dansylated attempts without the addition of the Li+ to 
the BGE. This observation provides clear evidence that if this dansylation approach is 
used for downstream CE-MS applications, the HRB will be a requirement.  
In further comparison of the of the HRB and HS chips, as the HRB showed a clear 
advantage for stilbene analysis, the chips were compared using relatively less conjugated 
phenolic compounds. Here, the chips were evaluated using dansylated lignin ester 
monomers and a lignin dimer model compound. Conversely to the application of the HS 
chips with the stilbenes, the lignin compounds were successfully analyzed using both 
chips across all applied conditions with the exception of turning off the pressure assist 
(Figure 2.35). The deactivation of pressure assist was a problem for both chips as stable 
spray was the limiter for this applications and droplets were repeatedly building up on the 
chip spray corner, causing ESI spray instability. In further investigations of the most ideal 
methods for analyzing these dansylated compounds, analytical factors such as peak 
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duration, peak asymmetry factors, and peak tailing factors were calculated and compared. 
Also, while theoretical plate counts for CE are not typically used as they are more 
applicable and better describe true chromatographic methods, the number of theoretical 
plates were calculated for each chip strictly for comparison of the CE methods. This 
approach was chosen as it normalizes differences observed between the two chips that 
could have arisen from the fact that the separation channels are different lengths using the 
equation: 















Figures 3.26 displays a graphical depiction of the changes in peak durations and 
migration times as a function of chip and electrolyte/organic solvent concentration. 
Additionally, the changes in the number of theoretical plates for each method is 
graphically depicted. These results clearly show that the true CE separations using the 
bare chip outperform the coated chip for this application. Additionally Figure 3.27 shows 
the asymmetry and tailing factors associated with each method. Again, here ideal 
conditions can be observed for the HRB chip using 75% diluent with 25% ACN in which 
both factors come close to 1 - a truly gaussian distributed peak. Note that the high 
aqueous, high salt condition (right-most points) does not contain a high enough organic 
solvent composition (0% organic) for these nonpolar analytes and solubility issues to 




Figure 3. 25 RICs for dansylated-lignin model compounds using the bare long channel 






Figure 3. 26 Four charts: Changes in migration time (top) and  peak duration (bottom) for 
dansylated-lignin model compounds using the bare long channel chip – HRB (left) and 
the standard coated chip – HS (right). Bottom graph: Changes in the number of 





Figure 3. 27 Changes in asymmetry factors (top) and tailing factors (bottom) for 
dansylated-lignin model compounds using the bare long channel chip – HRB (left) and 




At this concentration, blockages in the separation channels were also observed, 
furthermore suggesting that this condition is not suitable for analysis. Though p. 
multiflorum hairy root extracts are not yet available to test the dansylation+HRB CZE-
MS method, the preliminary results from analyzing dansylated p. multiflorum standards 






In this chapter, the difficulty in the analysis of phenolic secondary metabolites was 
the primary focus. Unlike the basic nitrogen containing secondary metabolites found in 
chapter 2, these nonpolar, neutral molecules presented an issue in that the methods 
primarily used for their analysis, such as GC-MS, HPLC-UV, and even standard 
UHPLC-MS, can lack sensitivity, accuracy, and can present unusual problems that were 
not previously encountered. In the first half of this chapter, the hypothesis was that the 
discrepancy in cannabinoid profiling methods could be understood and either prevented 
or corrected. It was shown that the current industry standard method, HPLC-UV, lacked 
the sensitivity to accurately quantify low concentrations of THC in products that were 
determined to be over the legal limit using other methods. Additionally, the lack of mass 
spectral detection can lead to coeluting peaks being grouped incorrectly during 
quantification. The use of GC-MS for profiling, while better suited for these types of 
molecules, also presented unavoidable issues in that the labile nature of the carboxylic 
acids on certain cannabinoids, a critical component of the legal-limit equation, resulted in 
large RSDs and poor precision. Even the use of the more sensitive high-end instrument 
presented analytical challenges in that source induced degradation was observed. Though 
the most manageable, provided that temperatures are monitored, this observation raised 
the need for an alternative method to be developed as all three standard methods were 
unreliable. In the second part of this chapter, the hypothesis was that certain 
modifications could allow for the application of capillary electrophoresis for the analysis 
of P. multiflorum extracts. The framework for this alternative method was developed to 
be applied to both cannabis and p. multiflorum extracts. The use of the microfluidic CZE-
MS device coupled with dansylation of the analytes and the prototype bare, long channel 
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chip displayed promising results as a future application once the product is commercially 
available. Due to restrictions in the number of performable analyses (limit 125 per chip) 
and the lack of p. multiflorum hairy root cultures, testing of the applications could only be 
applied to cannabis extracts and p. multiflorum standards, however, both applications 
displayed promising results and ideal applicable conditions were determined so that 




CHAPTER 4. PHARMACOKINETIC AND METABOLOMIC ANALYSIS OF AN ALZHEIMER’S 
DISEASE THERAPEUTIC IN RAT SERUM VIA MICROFLUIDIC CZE-MS 
Introduction 
 Pharmacokinetic profiles are often used to describe the absorption, distribution, 
metabolism, and excretion (ADME) of the pharmaceutical therapeutic in 
question.115,116,117 Pharmaceutical therapeutics can be administered into the body various 
ways, with the method and the medium of administration and certain molecular 
characteristics (ie Lipinski’s rule of five) having a significant effect on the ability for it to 
accumulate in target areas and tissue.81,115,117 Once administered, they can be absorbed 
and circulated, however, transportation into to their target tissues require mechanisms to 
allow them to cross numerous biological obstacles (ie crossing blood-brain barrier). 
During the absorption and transportation stages, the body can chemically modify or 
metabolize the therapeutics to make them more easily transported, or, in some cases, 
increase their efficacy. In most cases, these metabolic reactions produce intermediates 
with less pharmacologic activity than the parent compound, however, it is also possible 
that these metabolites can be toxic and lead to an adverse effect.115,117,118 Following 
adsorption, distribution, and metabolism, the end product is excreted through the liver, 
kidneys, skin, lungs, and/or intestines. Pharmacokinetic profiling helps to provide a 
quantitative description of the behaviors and interactions of therapeutics to better 
understand how they function, interact, and metabolize.117 These profiles are developed 
by analytically monitoring variations in the circulating concentration of the therapeutic of 
interest as a function of time following administration and are performed as a critical 
component of clinical and pre-clinical evaluations.119,120 Method development for the 
formation of pharmacokinetic profiles typically focuses on high-throughput, highly 
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sensitive techniques.33,34 These methods generally employ HPLC coupled to either UV or 
MS detection and are developed with the primary focus of resolving one or two analytes 
of interest.121–123 When involving MS, the industry standard approach utilizes targeted 
MS/MS analyses using triple quadrupole (QqQ) mass spectrometers due to their 
sensitivity and specificity.124–128 Targeted approaches allow for the preceding HPLC 
methods to be more focused on fast, high-throughput separations at the cost of 
chromatographic resolution and qualitative aspects, such as primary and secondary 
metabolite detection or changes in metabolite expression over time.129,130 While this 
approach is advantageous for the determination of a potential therapeutic concentration in 
vivo, the sacrifice of metabolic information can lead to the requirement for further testing 
at a future stage of development to evaluate changes in metabolism induced by the 
candidate therapeutic. To address this untargeted analysis, a method for the use of a 
microfluidic capillary zone electrophoresis (CZE) device, coupled to a mass 
spectrometer, was developed and evaluated for a metabolomics-inclusive high-
throughput pharmacokinetic approach. 
The primary focus of this metabolomics-inclusive pharmacokinetic CZE-MS 
application centers on a potential Alzheimer’s disease therapeutic in the preclinical 
development stage. This therapeutic, BNC-1 (Figure 4.1), was designed by CoPlex 
Therapeutics LLC (Lexington, KY) and consists of a functionalized naphthyridine and 
has been shown to reduce amyloid burden and improves markers of synaptic integrity in 
mouse models (Lovell et al., 2016, US Patent No. 9968574).131 The hypothesis of this 
chapter was that the capillary electrophoresis mass spectrometry method could be 
modified and applied to perform a global, metabolomics-inclusive DMPK analysis. To 
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test this, serum sample extracts from male and female Sprague Dawley rats, treated with 
varying doses of BNC-1, were obtained from CoPlex and analyzed using both LC-MS the 
novel CZE-MS approach. Pharmacokinetic data generated using traditional UHPLC-MS 
approaches were statistically compared to the CZE-MS approach. Additionally, the 
metabolomic data obtained from the CZE-MS approach was examined to identify 






 Figure 4. 1 Structures for BNC-1 (2,4-dimethyl-5-oxo-5,6-





Materials, Methods, and Instrumentation 
4.1.1 Sample Preparation  
Administration of BNC-1 and tail vein blood collection and extraction/sample 
preaparation was performed by CoPlex Therapeutics as follows: Serum was extracted 
from the collected blood and provided for analysis. Both male and female Sprague 
Dawley rats, five each, were treated with 2,4-dimethyl-5-oxo-5,6-
dihydrobenzo[c][2,7]naphthyridine-1-carboxylic acid, methyl ester (BNC-1, C16H14N2O3 
– Figure 4.1) by gastric gavage at the following concentrations: 1, 12.5, 25, and 50 mg/kg 
(additionally, a 5 mg/kg dosage was administered intravenously to rats that did not have 
the gastric gavage administered). Blood was collected from the tail vein at 0.25, 0.5, 1, 2, 
4, 8, 12, and 24 hour intervals by processed into serum by centrifugation.  A 50 µL 
aliquot of serum was diluted with 50 µL internal standard (50 µM stock, N-methyl 
version of BNC-1 - C16H12N2O4) in acetonitrile, 50 µL ammonium acetate (500 mM) and 
150 µL of acetonitrile, mixed by vortex and centrifuged to remove proteins. Calibration 
standards were prepared similarly: 50 µL of preconcentrated BNC-1 stock solutions in 
acetonitrile were diluted with 50 µL internal standard in acetonitrile, 50 µL ammonium 
acetate (500 mM) and 150 µL of acetonitrile to 0.5, 2, 10, 25, 50, and 100 µM. Quality 
control spike/duplicate samples were prepared consisting of 50 µL horse serum with 50 
µL internal standard in acetonitrile, 50 µL of  BNC-1 in acetonitrile (10 µM final 




4.1.2 UHPLC-MS and Microfluidic CZE-MS analysis 
 UHPLC-MS analyses were performed by CoPlex Therapeutics as follows: 
UHPLC separations were performed using a Shimadzu Nexera X2 UHPLC system with a 
Kromacil EternityXT C18 column (2.5 µm, 2.1x50 mm). Analyses were performed using 
5 µL sample injections. The chromatographic separation consisted of solvent A (0.1% 
formic acid in H2O) and B (0.1% formic acid in ACN) in a gradient flow method at 300 
µL/min starting with solvent B at 5% for 2 minutes, increasing linearly to 95% over 10 
minutes, being held at 95% for 5 minutes, and then returning to starting conditions for 2 
minutes equilibration, 20 minutes in total. UHPLC-MS analyses were performed on a 
Thermo Scientific Q Exactive Orbitrap Mass Spectrometer (Thermo Fisher Scientific, 
Waltham, MA, USA). Parameters for the UHPLC-MS analysis consisted of a scan range 
of m/z 70 to 800, resolution of 140,000, microscans set to 3 (1.7 scans per second), 
sheath gas flow set to 10 psi and the AGC target was maintained. Electrospray was 
generated with a 3.0 kV spray voltage and desolvated with a HESI auxiliary gas flow of 4 
psi (280 oC) and an inlet capillary temp of 280 oC. 
 For the CZE-MS analysis, a 50 µL aliquot of the treated sample extract, analyzed 
by UHPLC-MS, was diluted with 50 µL of the 908 Devices metabolites diluent 
immediately prior to analysis.  Capillary zone electrophoresis mass spectral analysis was 
performed by the authors using the 908 Devices ZipChip interface (ZCI) following the 
method stated in in Chapter 2, with minor modifications. Briefly, 50µL of each sample 
was manually transferred to the sample well of a HS chip in the ZCI before analysis. The 
sample was loaded into the sample channel for 20 seconds as defined by the default HS 
Metabolites method (5.00 nL injection). Samples were analyzed using the HS 
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Metabolites background electrolyte (BGE) and method for separation and a field strength 
of 1000V/cm was applied to the chip for the duration of the 3 minute separation. The 
samples were recollected from the sample well following analysis and then a sample well 
washing was performed by the CZE interface for 2 minutes, totaling 6 minutes from 
injection to washing, per sample. BGE refreshes were performed every 30 minutes. CZE-
MS analyses were performed on a Thermo Scientific Q Exactive Orbitrap Mass 
Spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). The CZE-MS acquisition 
parameters consist of a full scan range from m/z 70 to 600, resolution of 17,500, 
microscans set to 1 (8 scans per second), sheath gas flow set to 2.0psi, and a AGC target 
of 3e6. Additionally, data dependent MS2 (dd-MS2) acquisition was also utilized for 
metabolite structural elucidation following the microfluidic CZE separation. For dd-MS2 
acquisition, the CZE method was modified to employ a voltage gradient starting at 300 
V/cm and increasing linearly to 1000 V/cm over 6.00 minutes. All dd-MS2 spectra were 
acquired using a fixed normalized collision energy (NCE) of 30 and a Top3 filter with a 
0.5 minute dynamic exclusion. 
 
4.1.3 Data processing 
 Resulting data sets from both the UHPLC-MS PK study and the microfluidic 
CZE-MS PK comparison were processed using MZmine2 following the workflow stated 
in chapter 2 and in Kelley et al 2019.66 Briefly, RAW files were directly imported into the 
processing software. Following importation, the data sets were processed with the 
following modules: mass detection, ADAP chromatogram builder, chromatogram 
deconvolution, deisotoping, alignment using the RANSAC aligner with gap-filling, and, 
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additionally, normalization to the internal standard. Both UHPLC separations and CZE 
separations were processed using the same modules, however, the time limit parameters 
for total run time, maximum and minimum peak width, and retention/migration times 
were adjusted. UHPLC-MS time windows were selected based on the average durations 
of BNC-1 and the internal standard. CZE-MS time window allowances were selected 
based on the average duration of the widest peak observed in each separation.  Resulting 
aligned datasets putatively identified using MassBank and Chemspider. Statistical 
analysis for the comparison of the two methods was performed using Graphpad Prism 8. 
Pharmacokinetic data was generated using the PKsolver add-in for Microsoft Excel. 
Results and Discussion 
4.1.4 Method Assessment  
4.1.4.1 Pharmacokinetic method comparison 
 Using data from both the CZE and UHPLC-based methods, the BNC-1 
concentration in each rat serum extract was determined. Figure 4.2 displays examples of 
stacked chromatograms from the UHPLC separations (top) and stacked 
electropherograms from the CZE separations (bottom) of the first collection time point of 
the 50 mg/kg dosage (M50-15min). The peaks for BNC-1 can be seen at 3.80 minutes for 
the UHPLC separations and 1.92 minutes for the CZE separations with the internal 
standard peaks at 5.41 and 1.77 minutes for each method, respectively. Prior to any 
chromatographic peak extraction or data processing by MZmine, observable differences 
in the base peak chromatograms/electropherograms are apparent for each method. This 
aspect attributed to the nL flow rates employed for the CZE-MS approach compared to 
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300 µL/min for the UHPLC-MS approach. This reduced baseline greatly aids in post-
analysis data processing, especially in determining peak width and noise level parameters 
for MZmine2. As the only consistently observable peak in the baseline of the UHPLC-
MS analysis was internal standard, it was used in determining peak width allowances. 
Using the ratio of a constant concentration of internal standard and varying 
concentrations of BNC-1, calibration curves were generated for each method (Figure 
4.3A). Calibration standard solutions were generated using both the method described 
above (50 µL BNC-1 stock solutions, 50 µL IS, 50 µL 500 mM NH4OAc, and 150 µL 
ACN) and a second time replacing 50 µL of the ACN with 50 µL of serum to assess for 
matrix effects. Plotting resulting ratio of BNC-1 and the internal standard using both 
sample conditions resulted in an R2=0.9995 implying that, due to the nonpolar nature of 
BNC-1, the extraction method and presence of serum did not result in any observable ion 
suppression or other matrix effects. Additionally, recovery of the internal standard was 
evaluated in comparing the average area counts of the internal standard peaks across all 
calibration solutions, both with and without serum (n=36) and the internal standard 
diluted in ACN (n=3) and a recovery of 96±6%  was observed. Subsequently, the 
concentration of BNC-1 was determined in each serum extract without correction.  Figure 
4.3B displays four examples of the concentration of BNC-1 determined with each method 
in the serum extracts as a function of time for varying dosages. The difference in 
administration methods rationalizes the higher BNC-1 serum concentration observed in 
the 5 mg/kg treatment than that observed in the 25 mg/kg gavage treatment. The apparent 




Figure 4. 2 Example of the same sample (male, 50 mg/kg, 15 minute collection time) 
analyzed using both methods. (Top) UHPLC-MS stacked base peak chromatogram and 
RIC for BNC-1 (RT: 3.80 min, m/z 283.1077 and the internal standard (RT: 5.41, m/z 
297.1026). (Bottom) CZE-MS stacked base peak electropherograms and RIC for the 






Figure 4. 3 A – Calibration curves generated for UHPLC (right) and CZE (left) 
separations by analyzing the response ratios from calibration standards containing a fixed 
concentration of an internal standard and varying concentrations of the target compound, 
BNC-1. Error bars represent SD from triplicate analyses. B – Four examples of overlaid 




Using PKsolver, pharmacokinetic data was generated from the [BNC-1] versus time data. 
An example of the PKsolver data for the 50 mg/kg BNC-1 dosage can be seen in Table 
4.1. For cases where the Cmax was reached at t=12hrs, some PK data could not be 
calculated as three points indicating the elimination of the therapeutic in serum are 
required. The largest variations were observed in the calculation of the AUC0-t values, 
however, in most cases, the RSD was below 20% when comparing the values calculated 
by both the CZE and UHPLC methods. Additionally, when compared to the UHPLC-MS, 
the relative error (RE) for the PK results generated via CZE-MS were all below 10% with 
the only outlier being λz (terminal rate constant), at ~20%. Being that this parameter is 
both small, increasing the impact of small differences (0.10 and 0.12) and directly related 
to another parameter displaying slight variability, t1/2, this observation alone does not 
discredit the similarity between the results generated using the two vastly different 
separation methods.  
Statistical analyses were performed using GraphPad Prism 8. Regression analysis 
of the calculated BNC-1 concentrations resulting from both methods displayed significant 
linearity with an R2 = 0.9205 (Figure 4.4A). A slope of 1.032 (y-axis: UHPLC-MS 
results and x-axis: CZE-MS) indicates that, while corresponding [BNC-1] calculations 
generated by each method are similar, the results generated by CZE method are, on 
average, slightly lower (<5-10 µM variation) than those generated using the UHPLC 
method, however, only four points fell outside of the confidence interval.  This was also 




Table 4. 1 Pharmacokinetic data corresponding to the 50 mg/kg dosage resulting from 
using both separation methods and generated using PKsolver.  
Paramete
r Unit CZE UHPLC 
AVERAG
E SD RSD RE 
Tmax h 8 8 8 0 0.00% 0.00% 
Cmax μM 124.9 118.85 121.88 4.28 3.50% 5.09% 
t1/2 h 5.99 6.65 6.32 0.47 7.40% -9.92% 
Cl (mg/kg)/(μM)/h 0.02 0.02 0.02 0 1.50% 0.00% 
AUC0-t μM*h 1969.95 1964.5 1967.23 3.86 0.20% 0.28% 
AUC0-∞ μM*h 2160.12 2204.9 2182.51 31.66 1.50% -2.03% 
AUC0-t/0-∞  (unitless) 0.91 0.89 0.9 0.01 1.60% 2.25% 
AUMC0-∞ μM*h^2 26048.68 28000.7 27024.69 1380.28 5.10% -6.97% 
MRT0-∞ h 12.06 12.7 12.38 0.45 3.70% -5.04% 
λz 1/h 0.12 0.10 0.11 0.01 7.40% 20.00% 
Vd (mg/kg)/(μM) 0.20 0.22 0.21 0.01 5.90% -9.09% 






Figure 4. 4 A – Linear regression plot of the serum BNC-1 concentrations resulting from 
the use of the CZE method plotted against the same samples analyzed using the UHPLC 
method. B – A ratio Bland-Altman plot comparing the serum BNC-1 concentrations 




Though three data points (~2% of the total data) were observed outside of the limits of 
agreement and not deemed to be outliers, a strong correlation was observed. The 
similarity observed in the calculated BNC-1 concentration data suggests that the two 
methods could be interchangeable for this application without impacting the results of the 
trial. Furthermore, an additional feature of the microfluidic CZE-MS approach compared 
to the UHPLC-MS approach is the speed of the separation mechanism. The CZE’s 
employment of transient isotachophoresis (tITP) allows for the separations to be 
performed in 3 minutes, compared to 10-20 minutes per UHPLC-MS analysis. 
Depending on the sample injection method applied, the total run times for the CZE-MS 
analyses range from 4 minutes (active – manual injections) to 6 minutes (passive – 
autosampler injections) from the time the signal pulse is sent to the instrument to the time 
that the sample well is washed, 10-15 samples per hour. For the UHPLC-MS analyses, 
only 2-5 samples could be analyzed per hour once the column equilibration and needle 
washing times are factored into the total run-time. Given that PK sample sets can often be 
large (100+), this high throughput aspect would be advantageous. 
4.1.4.2 Evaluation of the CZE-MS approach 
In an evaluation of the CZE-MS approach, triplicate analysis of a low-dosage (1 
mg/kg) serum extract analyzed consecutively with sample well washes between analyses 
displayed high reproducibility. A maximum RSD of 13% (low: 2%) was observed 
corresponding to the sample where the BNC-1 serum concentration peaked (tmax = 8 
hours) during the time course (Figure 4.5). This variation is likely due to the BNC-1 
concentration approaching the onset of overloading for the device (~100-200µM, analyte 




Figure 4. 5 Calculated BNC-1 concentration resulting from triplicate analysis of a serum 




Additionally, both inter-day and intra-day reproducibility were assessed as large sample 
sets, such as the set analyzed in this work (n=96), can often take an extended period to 
analyze. Figure 6 displays a stacked extracted electropherogram of the two serum extracts 
from the same dosage set (50 mg/kg), one determined to have a low BNC-1 concentration 
(sample collected after 15 min) and one with a high BNC-1 concentration (sample 
collected after 8 hours), analyzed at time zero – 6A (low) and 6C (high), after 12 hours 
(data not shown), and 24 hours after the diluted samples were produced and the CZE 
system was initially primed – 6B (low) and 6D (high). This was performed to assess 
variation as a function of concentration and time. Calculated concentrations can be seen 
in Table 4.2. Although resulting calculated concentrations remain consistent (RSD <5%) 
despite an order of magnitude increase between the two samples, the observed CZE 
migration times (MT) varied. The BNC-1 peak resulting from samples analyzed on a new 
chip with fresh BGE eluted at approximately 1.9 min while the same peak eluted at 
approximately 2.3 min after 24 hours using the same chip and BGE. This is most likely 
due to degradation of the BGE (consisting of ACN, IPA, H2O, and formic acid) or sample 
diluent (MeOH, H2O, NH4OAc, and formic acid) as the manufacturer recommended 
lifetime of the BGE and diluent is 12 hours. Additionally, the cationic wall coating of the 
chip separation channels and the hydrophobic coating at the spray corner wear over time 
during analyses, therefore only 125 separations can be performed on each chip. Although 
a shift in migration is observed, migration of BNC-1 relative to the internal standard 





Figure 4. 6 Extracted electropherograms corresponding to a low [BNC-1] sample at two 
time points (0 and 24 hours 6A-B) and a high [BNC-1] sample at two time points (0 and 






Table 4. 2 Area counts of BNC-1/internal standard and resulting BNC-1 concentrations corresponding to triplicate analysis of a low 
concentration serum extract (50 mg/kg dosage, 15 min) and a high concentration serum extract (50 mg/kg dosage, 8 hours)  analyzed 
over twelve hour intervals. 
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Due to the consistency in concentration dependent response, no normalization was 
applied to later samples during the MZmine2 processing in regards to observed response, 
however, migration time allowance windows were increased to 0.5 minutes to allow for 
the grouping of similar features despite a difference in MT >10% of the total run time.  
4.1.5 Changes in Metabolic Activity 
 In addition to the monitoring of BNC-1 concentration as a function of time, the 
CZE-MS method also provided metabolomics data on a number of analytes as a function 
of [BNC-1] concentration. Using MZmine2, over 80 baseline resolved peaks were 
detected consistently within the 96-sample data set. The detected features were processed 
using both the MassBank and Chemspider database tools in MZmine2 and METLIN 
externally. The final resulting data set comprised of 38 putatively identified metabolites, 
all 20 amino acids, and 26 features with multiple (n>3) possible identities that would 
require further experimentation to determine (denoted as their most probable calculated 
empirical formula). Normalized response changes corresponding to each feature from the 
t = 15 min mark to the tmax can be seen in appendix 5 for the female rats (left columns – 
denoted as F-dosage) and for the male rats (right columns – denoted as M-dosage). For 
simplicity, percent changes are expressed as: “-” indicating percent decreases greater than 
-25% compared to t=15 min, “NC” (no change) indicating percent changes between -25% 
and +25%, “+” indicating percent increases greater than +25% but less than +100% 
compared to t=15min, and “+++” indicating increases greater than +100% compared to 
t=15min. This approach may be useful in providing evidence to how therapeutics affect 
metabolite expression. For example, m/z 146.1648, putatively identified as spermidine, 
appears to be down-regulated in eight of the ten rats, regardless of dosage. Spermidine 
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has been noted in literature to be upregulated in patients with AD.132–134 Additionally, it 
has been reported that polyamines, such as spermidine, play a role in amyloid-beta 
fibrillation and increased MAPK function related to the progression of AD symptoms.135–
138 Preliminary evidence from in vivo and in vitro assays performed by CoPlex 
Therapeutics involving BNC-1 suggest that the potential therapeutic modulates MAPK 
activity, specifically TAK1 kinase, also known as MAP3K7.131,139  
This approach can also be used to evaluate the metabolism of the therapeutic itself. 
An unidentified metabolite, m/z 299.1028, appeared to be exceptionally increased in all 
samples where the [BNC-1] reached the Cmax, and subsequent samples in the time-course, 
when compared to t=15min, regardless of initial dose. To obtain evidence to identify this 
metabolite, tandem mass spectrometry was utilized. By employing a voltage gradient 
method, as discussed in Chapter 2, untargeted MS/MS data-dependent acquisition (DDA) 
and targeted MS/MS (PRM) experiments could be performed. The usage of voltage 
gradients allows for slight broadening of the analyte peaks in order to adequately sample 
each target in the untargeted tandem experiments. The employment of a linear voltage 
gradient from 300 V/cm to 1000 V/cm over a six-minute run time allowed for an 
approximate doubling of each peaks’ width (ranges from 1.5x to 2.0x). An untargeted 
approach was chosen to determine if fragment ions or fragmentation patterns observed 
for other selected precursor masses were in common with those produced by the 
unidentified metabolite at m/z 299.1028 (putatively calculated as [M+H+] = 
C16H15N2O4). In utilizing this method, similar fragmentation patterns were observed for 
m/z 299.1028 and BNC-1 (Figure 7); BNC-1: m/z 283 → 251(-32), m/z 283 → 223(-60), 
unidentified metabolite: m/z 299 → 281(loss of H2O), m/z 281 → 249(-32), and m/z 281 
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→ 221(-60). This evidence suggests that m/z 299.1028 is most likely an oxidized 






Figure 4. 7 Left - Electropherogram of a set constant voltage (1000 V/cm) CZE-based separation (top) and the 
same sample analyzed using a voltage gradient (300 V/cm to 1000 V/cm over six minutes - bottom). Right – 




In this work, the hypothesis was that the capillary electrophoresis mass spectrometry 
method could be modified and applied to perform a global metabolomics inclusive 
DMPK analysis. Here, the development and usage of a CZE-MS method for high-
throughput pharmacokinetic analysis was compared to a traditional UHPLC-MS analysis 
method. Traditional approaches heavily rely on streamlining data acquisition at the cost 
of separation efficiency and usually result in the absence of information pertaining 
analytes other than the target of interest. The CZE-MS approach provided 
pharmacokinetic data in approximately six minutes per sample, including sample delivery 
and transfer line clearing, without sacrificing separation efficiency or limiting the scope 
of the analyses. Statistical comparison of the pharmacokinetic results generated by both 
methods suggests that they are interchangeable for this type of analysis. The CZE method 
proved capable of not only fast and efficient pharmacokinetic analysis, but also highly 
reproducible results. Both the intra-day and inter-day reproducibly of the CZE-MS 
method was comparable to that characteristically displayed by UHPLC-MS approaches. 
Additionally, the CZE method provided metabolomic data alongside the pharmacokinetic 
experiments that was not present in the UHPLC data set. Further data analysis and 
mining with processing software like MZmine2 allows for fast comparisons and easy 
evaluations of large, complex data sets. This aspect can be useful in understanding the 
primary method of action for a potential therapeutic or in how the target is metabolized. 
The ease of performing both targeted and untargeted MS2 experiments to this CZE-based 
separation is also very advantageous for metabolomics assays.  
 
 
CHAPTER 5. CONCLUSIONS 
Metabolomics mass spectrometry focuses on the analysis of small molecules (<1500 
Da) associated with the metabolic processes of an organism. The applications of 
metabolomics methodologies cover a wide assortment of diverse subjects. Metabolomic 
profiles can help analysts understand how an organism responds to disease or external 
stressors, how a potential therapeutic in preclinical trials metabolizes and affects 
metabolic expression, and what causes certain phenotypic expressions to manifest. While 
the mass spectral analysis of primary metabolites, like amino acids and nucleic acids, is 
well defined, the analysis of secondary metabolites, specifically those produced by plants, 
such as alkaloids and polyphenolic compounds, can be challenging. These challenges 
arise in the vast, complex diversity of these secondary metabolites, often unique to a 
specific genus or species. The primary focus of this dissertation was the development of 
multifaceted metabolomics mass spectrometry methods for the analysis of both primary 
and secondary metabolites from different biological sources. 
The second chapter of this dissertation focused on the bottom-up method 
development for a metabolomics profiling assay to be applied to a relatively unknown 
target, Lobelia cardinalis. It was previously discovered that extracts from L. cardinalis 
displayed substantial dopamine transporter inhibitory activity. As no recorded history of 
abuse of this plant has ever been reported, as is the case for many dopamine transporter 
inhibitors, this discovery presented a promising source for naturally derived cessation-
aids to help combat the global substance abuse disorder crisis. Working in tandem with 
Naprogenix LLC, wild type and mutant L. cardinalis extracts were provided for 
metabolomic profiling. The hypothesis of chapter two was that mutant survivor strains 
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likely over-expressed novel hDAT inhibitors compared to wild type plants. If this was the 
case, the novel metabolites would be extracted and purified to be tested individually to 
verify activity. To test this hypothesis, a metabolomics screening approach was 
developed and applied. In this work, both liquid chromatography and capillary 
electrophoresis were applied to determine the best separation method for this application. 
The analytical complexity attributed to the secondary metabolites observed suggested that 
the capillary electrophoresis approach was the best option due to increase sensitivity, 
increased selectivity, reduced sample volume/concentration, and reduced analysis time.  
Additionally, given that these secondary metabolites were predominantly alkaloids, 
capillary electrophoresis was suggested as it is ideal for small, positively charged 
analytes. The application of capillary electrophoretic separations coupled to mass 
spectrometry was not only applied to characterize wild type L. cardinalis and putatively 
identify secondary metabolites naturally produced, but also to identify changes in the 
secondary metabolite profile of transgenic plants comparatively. Using the metabolomic 
information discovered from this analysis, a metabolite was identified and subsequently 
isolated, characterized, and provided to Naprogenix for preclinical trials. This secondary 
metabolite, the N-oxide of the main secondary metabolite produced by the plant, 
lobinaline, exists at concentrations ten to one hundred times lower than its free base 
counterpart in the plant. Extreme difficulty was encountered when trying to purify the 
metabolite given its chromatographic similarity to lobinaline during preparative HPLC 
purification. Utilizing differing physical characteristics of the two metabolites, mainly 
difference polarity, an extraction method was developed and perfected using xylene to 
selectively separate lobinaline from the N-oxide, resulting in a hundred-fold enrichment 
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of the N-oxide. This led to the production of a substantial quantity of the material to be 
provided to Naprogenix for pharmacological testing. Additionally, a method for the semi-
synthetic production of an analytically identical version of the metabolite via N-oxidation 
using mCPBA was also developed. The impact of this chapter centers around the 
application of this technology for future pharmaceutical discovery. Despite many of the 
advances in modern medicine, there is still a plethora of diseases and conditions, 
especially substance abuse disorders, that plague the world on a regular basis. Since 
naturally derived pharmaceuticals can potentially treat some of these conditions, like the 
lead compound discovered in this work and its impact on potentially treating addiction, 
this metabolomic profiling method is pivotal in streamlining the process of identifying 
lead compounds for prioritizing and easing the difficult task of purification. Preliminary 
investigations, performed by Naprogenix, in testing the purified material have been 
promising in that strong inhibitory activity is being observed, supporting the hypothesis 
that the upregulated metabolites were likely the source of the activity and that these 
changes in regulation could be observed using the developed capillary electrophoresis 
mass spectrometry metabolomic profiling assay. As more than one lead compound was 
identified, the future developments of this work would be to continue the isolation and 
purification process of the other prioritized analytes for pharmacological evaluation.  
The third chapter of this dissertation focused on two aspects. The first aspect was 
evaluating the common approaches used for secondary metabolite profiling of Cannabis 
plant extracts and products. The secondary metabolites of the Cannabis species, the 
cannabinoids, have recently been the subject of numerous analytical investigations, as 
they present many analytical challenges. This aspect analyzed how using different 
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analytical tools for the same application can lead to different results. Given the legal 
precedent of the specific application at hand and the tight constraints set to determine 
such legality, these analytical variations can result in a product being denoted as legal by 
one lab and illegal by the other, allowing illegal products to enter the consumer market. 
The hypothesis of this aspect of the chapter was that the sources of variation, specifically 
intra-laboratory and inter-instrumental variation, could be determined and reduced and, if 
reduction was not possible, then the mechanisms responsible could at least be understood 
and accounted for to minimize variation. With the influx of cannabis/hemp products 
entering the market since the passage of the 2018 KY farm bill, illegal products entering 
the market has become a common and detrimental issue. An unknowing consumer could 
risk using these products and potentially losing their careers or facing legal penalties if 
they were to test positive for these illicit substances. This was the primary motivation 
behind this aspect of the research. Three methods of varying complexity, HPLC-UV, GC-
MS, and UHPLC-MS, modeling the industry standard approaches, were developed and 
utilized for cannabinoid profiling. Inter-instrumental variations were observed as both 
potential over- and under-calculation of the cannabinoid concentrations. Interestingly, a 
previously unreported phenomenon was observed when generating the cannabinoid 
profiles using the UHPLC-MS method; the temperature-induced formation of an acylium 
ion and decarboxylation product during the ESI process for the cannabinoid acids. 
Though no possible instrument temperature variations or solvent compositions where no 
formation of the degradation products was observed could be determined, the discovery 
of its formation could lead to better quantitation in the future to prevent illegal products 
from passing the cannabinoid profiling step. Implementation of temperature monitoring 
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and multiple ion signal summation when developing the quantitation method was 
determined to be the best response to the phenomenon. The second aspect of this chapter 
focused on providing an alternative or ancillary method to perform metabolomics 
analyses on sources that are already well-characterized. Here, more substantial method 
evaluations could be performed as a vast wealth of data exists in the literature on this 
topic. In this specific case, Polygonum multiflorum extracts were the analytical subject. 
This plant produces a vast number of different phenolic compounds, many of which have 
been suggested to have a degree of pharmacological activity. One particular aspect in 
focus is the potential use of p. multiflorum extracts to treat Parkinson’s disease, as it is 
theorized to reduce alpha synuclein toxicity. Through similar a collaboration described in 
chapter 2, Naprogenix is in the process of developing a similar plant model to the L. 
cardinalis-hDAT mutants but using p. multiflorum and alpha synuclein. The focus of this 
aspect was to develop a metabolomic database for future characterizations as well as lay 
down the framework to apply the technology developed in chapter 2 to this application to 
speed up the discovery and evaluation process, further streamlining the potential target 
selection and isolation process. Given the impact that Parkinson’s disease has on the 
world population and the current lack of adequate therapies, this application displays 
extreme importance due to its role and potential impact in the search for future 
therapeutics. The secondary metabolites of p. multiflorum are polyphenolic and not 
alkaloids, as in chapter 2, therefore applying the capillary electrophoresis method to them 
was particularly challenging, however the hypothesis was that certain modifications 
could allow for the application of capillary electrophoresis for the analysis of these 
extracts. In collaboration with the manufacturer of the capillary electrophoresis device 
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being utilized, a prototype device was procured to allow for separation of these analytes. 
Chemical modifications using dansyl chloride and the use of cation-assisted 
electrophoresis were developed and evaluated against standards and surrogates, given the 
current lack of the subject plant material. Though the method cannot be tested on actual 
P. multiflorum material currently, successful electrophoretic separations of the dansylated 
polyphenol standards and dansylated surrogate (Cannabis extract) material suggests 
promising application in the future. The future applications for this chapter are to apply 
the optimized dansylation and capillary electrophoresis methods to the future extracts. 
Unfortunately, the capillary electrophoresis device used was a prototype with a 
constrained number of allotted analyses, so procurement of additional devices is also 
required for continuation. 
The fourth chapter focuses on taking the technology developed in chapters two and 
three and applying them to another tangential application, drug metabolism 
pharmacokinetics (DMPK), a critical component of clinical trials. DMPK helps scientists 
to understand how the potential therapeutics discovered or developed, as was the focus of 
chapters two and three, interact and metabolize once internalized and processed by an 
organism. The information obtained in performing DMPK analyses is absolutely critical 
to understanding and predicting how a drug will not only interact with its intended 
targets, but also with its unintended targets. The hypothesis of this chapter was that the 
capillary electrophoresis mass spectrometry method could be modified and applied to 
perform a global metabolomics inclusive DMPK analysis. In this application, the 
metabolomics focus was switched from primarily secondary metabolites to primary and 
secondary metabolites, as well as xenobiotic metabolites. The DMPK results generated 
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using the capillary electrophoresis mass spectrometry approach were statistically similar 
to those generated using the standard LC-MS approach, however, extensive 
metabolomics data was also acquired. By utilizing this developed method, 
pharmacokinetic profilers can not only streamline the extensive DMPK process, thus 
streamlining the entrance of much-needed therapeutics into the market, but also easily 
monitor changes in metabolite expression of both endogenous metabolites and exogenous 
xenobiotic metabolites linked to the therapeutics themselves. The target of interest in this 
specific application is an Alzheimer’s disease therapeutic that shows a great deal of 
potential as a prophylactic treatment and halting agent of the disease. Again, another 
condition that affects millions of people with no reliable treatment. Using this approach, 
crucial therapeutics like the one in question can be quickly screened and characterized to 
speed up the arduous process of entering clinical trials.   
The research found within this dissertation centering around the usage of mass 
spectrometry for metabolomics method development displays great adaptability across a 
number of applications, especially within the drug-discovery and testing process. Here, 
the development of various methods using capillary electrophoresis mass spectrometry 
was performed, applicable to the metabolomics-based discovery, quantitation, and 
evaluation of various, drastically different types of analytes. Capillary electrophoresis, 
though fairly well known, is under-utilized in both industrial and pharmaceutical 
industries. Analyses can be difficult to perform when compared to chromatographic 
methods like HPLC and GC. This has led to capillary electrophoresis being a solution 
looking for a problem. Through this research, it appears that the problem it is the ideal 
solution to is high throughput metabolomic mass spectrometry screening. In this work, it 
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was demonstrated that, not only did the capillary electrophoresis methods generate 
statistically similar quantitative data to traditional chromatographic approaches, it 
outperformed in terms of separation efficiency, analysis time, and required sample 
volume. The low nL flow rates associated with capillary electrophoresis also reduce 
background noise, easing back-end data processing leading to cleaner, more accurate 
metabolomic profiles to be generated. As further developments are made in the field of 
capillary electrophoresis mass spectrometry, it is possible that an industry shift may occur 
towards the more frequent implementation of these methods for crucial steps in the 





APPENDIX 1: NORMALIZED AREA COUNTS FOR THE FEATURES DETECTED 
IN WT, DAT, AND MUTANT L. CARDINALIS PLANT EXTRACTS. 
Normalized Data set for all 139 features - average area count for m/z 
200.2363: 2.00E+08         
row m/z WT-1 WT-2 WT-3 DAT-1 DAT-2 DAT-3 Mutant-1 Mutant-2 Mutant-3 
90.0918 1.728 1.771 1.316 0.706 0.757 0.622 0.815 0.957 0.742 
91.0542 1.794 0.847 0.735 2.932 0.579 1.597 2.481 3.145 1.661 
97.0079 9.462 20.465 16.211 13.363 16.523 19.122 10.964 16.763 24.292 
99.0037 1.196 2.435 2.058 1.302 1.952 2.680 1.187 2.114 3.221 
102.0915 12.642 9.273 6.738 12.253 8.813 8.800 11.387 9.687 10.696 
102.9705 4.632 17.499 9.649 5.682 13.559 19.904 3.692 8.162 30.668 
104.0708 1.592 1.142 0.866 0.634 0.410 0.567 0.459 0.082 0.454 
104.1073 2.356 1.436 1.123 4.546 2.418 2.827 2.677 1.541 2.612 
105.0036 5.764 9.814 8.382 6.118 8.204 12.292 5.255 9.777 12.460 
106.0500 0.468 0.226 0.215 0.442 1.893 2.524 0.320 0.132 0.163 
111.0233 8.294 11.457 9.733 10.362 9.416 11.399 10.263 10.660 14.062 
113.0190 3.175 3.234 3.222 3.712 2.264 3.118 4.049 2.702 4.007 
120.9808 4.545 29.947 18.714 6.086 21.789 32.652 4.452 13.668 43.338 
121.0075 4.716 1.906 2.649 3.585 2.590 1.392 5.649 2.716 3.612 
122.0812 2.248 0.704 0.567 0.756 0.133 0.196 4.324 1.073 1.742 
125.0026 1.704 8.068 6.349 2.267 5.619 6.685 4.364 5.880 8.319 
126.9984 1.015 2.466 2.462 1.229 2.018 2.193 1.054 2.392 3.363 
132.1015 1.138 1.229 0.672 2.159 1.781 2.388 0.761 0.612 0.578 
133.0610 1.400 0.574 0.308 2.529 0.992 1.149 2.967 1.097 1.767 
134.9869 3.109 3.956 3.350 3.716 3.524 4.217 3.431 2.631 5.175 
136.0426 0.000 0.000 0.000 0.000 13.609 17.726 0.000 0.000 0.000 
139.0182 8.566 9.429 7.652 12.969 7.782 8.194 10.354 6.777 9.385 
140.1437 0.305 0.206 0.167 3.269 1.805 2.302 0.346 0.152 0.285 
141.0139 12.077 8.022 7.750 12.335 5.926 9.598 12.379 6.111 10.559 
142.1577 1.205 0.632 0.405 1.332 0.500 0.775 2.167 1.405 2.423 
144.0478 25.481 16.857 14.289 18.516 10.959 13.213 34.047 21.760 31.975 
144.1383 0.929 0.691 0.535 9.601 6.301 7.589 0.781 0.410 0.668 
148.9756 3.144 6.908 3.802 4.237 4.668 7.049 2.872 2.814 8.808 
218 
 
149.0026 43.735 21.255 18.548 53.391 18.030 21.279 24.006 19.510 26.110 
151.0541 0.000 0.259 0.627 0.000 1.354 1.861 0.000 2.216 3.579 
151.0971 0.965 0.783 0.594 0.545 0.538 0.627 0.732 0.544 0.867 
152.9974 7.705 15.315 12.723 11.253 11.632 13.879 9.616 12.353 16.311 
155.0299 7.231 4.112 3.000 8.916 3.176 4.331 8.659 2.820 4.622 
156.0766 0.311 0.098 0.118 0.181 1.705 1.842 0.417 0.132 0.204 
158.1175 0.404 0.241 0.087 0.229 0.106 0.156 1.455 0.874 1.186 
158.1539 5.131 3.599 3.473 42.927 27.603 35.305 5.768 3.476 5.557 
167.0130 29.913 21.806 19.312 42.521 17.182 21.018 18.762 16.264 22.823 
170.1539 0.468 0.316 0.297 0.692 0.331 0.643 1.439 0.496 1.883 
172.1692 1.213 1.025 1.047 40.483 28.069 36.687 19.447 13.831 22.302 
174.1605 1.969 1.674 1.543 0.808 0.464 0.640 0.013 0.090 0.059 
180.1272 0.934 0.985 1.381 2.615 0.788 2.609 4.147 3.283 3.218 
181.0289 10.658 5.063 3.944 4.246 4.329 5.028 13.483 3.309 4.540 
181.0453 0.141 0.384 0.901 0.138 1.376 2.473 0.217 1.934 2.786 
186.1276 4.075 7.167 3.787 36.859 17.513 8.811 18.041 31.881 37.636 
186.1277 8.532 3.952 5.938 9.315 21.347 26.559 50.975 11.999 38.745 
186.1855 0.100 0.057 0.053 7.632 1.928 6.090 0.558 1.122 1.624 
189.0335 0.109 0.869 2.563 0.071 7.093 10.390 0.035 8.807 14.455 
193.1356 1.788 1.387 0.265 13.241 6.099 8.246 14.637 11.186 14.036 
193.1360 2.220 0.457 0.260 7.844 3.287 1.469 5.621 0.379 2.955 
199.0942 4.391 1.553 4.444 3.434 1.263 4.570 8.334 1.342 2.830 
200.1253 0.105 0.591 0.506 10.802 8.283 12.192 2.029 2.064 3.297 
200.1254 0.526 0.591 0.506 12.012 5.464 11.487 1.936 2.064 3.386 
201.0442 0.091 0.094 0.171 1.415 1.393 1.849 1.558 1.453 2.193 
201.1500 1.593 1.128 0.353 5.549 2.594 1.639 3.289 2.086 2.448 
201.1508 1.643 0.077 0.242 2.504 0.947 1.852 3.361 0.365 1.040 
207.0443 0.072 0.408 0.798 0.101 2.305 3.944 0.136 1.785 4.770 
213.1099 32.693 41.099 54.816 20.652 18.685 25.870 17.252 41.486 12.591 
214.1134 0.608 4.151 3.695 8.954 4.373 2.548 1.839 4.104 2.031 
216.0431 0.000 0.000 0.000 0.365 0.142 0.198 3.125 1.704 2.444 
216.1569 0.073 1.192 0.879 2.957 2.052 2.299 0.011 1.955 2.712 
216.1959 9.662 7.719 6.427 3.031 3.910 2.184 0.450 0.797 1.388 
216.1962 0.269 8.105 6.633 6.259 1.801 5.441 0.239 0.797 1.388 
219.1357 0.179 0.173 0.375 10.339 4.501 8.786 0.492 0.293 0.820 
224.1539 0.256 1.021 1.030 3.122 5.307 7.462 4.938 3.532 5.976 
219 
 
229.1985 3.874 2.783 2.540 11.518 6.751 9.539 18.929 13.287 20.405 
230.2113 45.103 33.506 25.683 35.586 13.878 6.021 3.387 14.406 23.443 
230.2113 41.613 3.440 0.391 19.957 5.019 27.799 6.640 3.976 5.831 
230.2116 35.774 9.463 4.067 8.912 21.184 17.021 19.014 2.677 8.316 
232.1524 0.059 0.171 0.095 1.991 0.449 0.557 0.085 0.220 0.289 
235.0928 1.931 0.782 0.667 2.213 0.581 0.935 2.390 0.578 1.001 
240.1955 2.124 1.448 1.377 1.694 0.929 0.249 3.002 1.609 3.477 
242.2830 3.803 0.072 1.222 5.874 0.063 0.916 324.881 212.834 358.452 
244.1908 4.354 3.305 3.033 3.190 2.367 7.705 6.866 5.341 24.076 
244.1909 0.193 2.637 2.319 8.597 6.009 2.590 20.361 15.593 7.957 
244.2268 6.883 22.296 4.917 91.322 25.048 71.450 46.134 68.169 168.396 
244.2270 36.450 27.869 23.256 80.592 56.830 33.658 139.165 30.407 50.558 
244.2271 18.463 13.233 12.061 32.359 47.246 63.846 25.941 107.265 147.217 
245.1883 5.426 2.043 1.149 8.789 1.928 1.033 1.017 2.866 3.632 
247.0756 8.402 4.652 3.781 11.253 3.819 4.663 12.009 2.210 5.456 
254.2111 0.302 0.126 0.143 0.995 0.192 0.109 7.004 4.500 7.220 
256.2269 11.987 46.881 45.641 139.518 88.195 29.752 448.349 325.985 509.560 
256.2270 11.987 8.139 18.135 35.645 23.049 112.926 94.704 66.141 368.145 
258.2068 1.844 26.814 25.124 23.323 13.409 6.712 4.309 17.925 28.931 
259.2076 13.753 0.404 0.564 1.954 0.565 0.289 1.062 0.318 0.725 
259.2454 8.178 4.194 2.939 62.951 23.810 31.293 77.747 41.737 89.402 
259.6726 0.048 0.237 0.256 3.321 2.383 2.027 16.244 11.602 17.638 
260.2224 11.367 7.710 6.315 7.869 4.004 5.017 2.935 1.786 3.288 
260.2487 0.187 0.545 0.210 0.343 2.942 4.598 0.516 1.039 8.262 
261.0914 5.016 1.535 1.396 7.632 1.571 1.922 3.053 1.668 1.526 
270.2428 2.290 1.340 1.398 7.779 4.675 5.728 24.366 22.203 22.171 
270.3152 19.125 12.958 9.396 16.507 7.689 13.256 17.929 12.297 16.884 
272.2217 14.888 11.080 9.676 15.551 9.744 12.936 41.945 26.808 43.752 
273.1904 1.936 0.710 1.231 0.821 0.295 1.851 4.477 0.824 0.625 
273.2177 1.913 0.282 0.571 1.351 0.527 1.229 0.747 0.444 1.677 
273.2252 2.726 2.281 2.474 3.305 3.723 3.714 9.201 4.462 9.844 
273.2617 2.282 0.203 0.751 34.493 21.662 0.385 89.116 0.800 110.284 
274.2370 4.639 1.112 0.221 31.875 17.750 22.624 15.687 8.082 15.298 
281.1882 0.077 0.032 0.041 0.048 0.145 0.245 0.944 0.035 0.163 
282.2791 5.876 3.852 3.562 4.019 2.236 2.815 0.036 0.067 0.123 
286.2381 0.674 0.766 0.327 10.925 6.602 7.868 10.193 7.230 13.856 
220 
 
288.2179 6.298 4.589 3.592 0.206 1.347 1.996 0.591 3.651 4.030 
288.2529 9.034 6.543 0.122 61.936 37.181 0.648 37.792 26.301 40.748 
288.5204 0.613 0.413 0.301 3.639 3.029 3.205 3.934 3.220 4.900 
289.2040 0.013 0.349 0.948 0.135 0.487 0.639 4.272 1.780 0.498 
289.2561 1.327 0.929 0.973 13.767 7.072 9.935 6.955 4.540 6.417 
293.1343 0.012 0.116 0.095 4.578 0.837 2.240 3.889 1.703 2.645 
296.2948 0.192 1.050 0.651 2.899 0.415 1.753 0.318 0.052 0.102 
299.1612 6.945 5.493 8.938 6.901 3.370 3.356 5.495 1.861 1.350 
302.2324 1.471 0.258 0.277 1.261 0.276 0.139 2.265 0.110 0.724 
302.2694 0.194 0.034 0.101 3.142 0.276 0.308 0.150 0.196 0.232 
306.2129 1.764 0.283 0.025 2.736 1.295 1.679 2.961 0.473 1.360 
310.1655 1.184 3.631 0.609 0.408 0.244 0.126 5.171 1.333 1.983 
313.1913 0.054 0.011 0.010 0.206 0.308 0.514 6.620 0.260 5.197 
322.2371 0.080 0.125 0.145 2.227 0.927 1.352 2.684 1.251 4.133 
324.2076 0.000 0.031 0.104 0.000 0.010 0.171 0.013 0.019 2.055 
325.1336 7.176 3.407 0.108 1.576 0.122 0.000 0.000 0.000 0.000 
344.2389 0.124 0.112 0.111 0.152 2.004 0.313 6.004 6.370 3.525 
349.2278 0.354 0.173 0.546 2.744 0.054 2.382 0.142 0.251 0.075 
366.3362 0.000 0.000 0.000 0.623 0.220 0.152 4.202 0.190 0.694 
367.3323 3.057 0.411 2.091 6.011 3.467 4.374 0.116 0.084 0.184 
381.3479 0.131 0.387 0.356 6.180 1.239 0.187 0.070 0.116 0.184 
432.2771 0.684 0.637 0.568 6.401 4.587 6.950 5.447 4.606 8.354 
451.3899 0.067 0.101 0.040 0.000 0.149 0.110 10.884 4.438 6.723 
373.2638, 
187.1359 44.100 41.468 36.693 52.606 37.050 46.629 90.543 75.096 103.226 
387.2795, 
194.1415  942.501 872.394 815.170 1891.060 1524.384 1759.488 2670.708 2308.580 2858.175 
399.2822, 
200.1446  45.905 33.176 30.042 97.719 60.264 76.876 87.888 58.198 94.319 
401.2587, 
201.1284 5.141 5.290 3.694 26.461 17.515 25.144 33.295 24.223 40.417 
403.2740, 
202.1410  46.761 41.434 37.410 222.112 151.634 201.371 278.414 206.729 310.481 
415.2749, 
208.1415 8.236 7.163 5.850 41.007 25.798 37.216 15.961 11.667 18.680 
417.2537, 
209.1308 4.012 3.265 2.624 1.622 0.904 1.001 2.186 1.400 2.278 
419.2693, 
210.1383 0.441 0.362 0.322 3.804 3.460 5.039 5.237 4.932 8.298 
130.1595  90.164 69.670 54.757 89.153 55.952 81.086 91.112 63.845 102.822 
221 
 
200.2363  110.668 82.611 73.881 122.000 75.040 107.166 113.176 79.865 135.593 
228.1967  46.077 32.804 28.658 108.946 69.950 87.033 161.838 113.509 178.310 
242.2115 
isomer 55.703 39.533 32.039 107.643 65.919 79.901 213.728 149.076 250.758 
242.2115 
isomer 35.687 25.427 22.774 59.843 38.608 51.578 136.577 93.104 156.852 
242.2115 
isomer 196.865 155.823 133.270 317.947 206.694 258.134 748.534 546.598 843.107 
258.2437  67.182 47.603 38.916 505.039 313.575 413.151 674.147 474.522 773.172 





APPENDIX 2: CONFIDENCE INTERVAL CALCULATION FOR ERROR IN 
LOBINALINE CONCENTRATION FROM CALIBRATION CURVE. 
µ𝐶𝐶𝐴𝐴 = 𝐶𝐶𝐴𝐴 ± 𝑡𝑡(𝑠𝑠𝐶𝐶𝐴𝐴) 
 
CA = analyte concentration from the regression equation (y = b1x + b0) 
 
t =  t value based on the desired level of confidence and n–2 degrees of freedom (in this 


















where 𝑦𝑦𝑖𝑖 = average response for the ith standard and 𝑦𝑦𝚤𝚤�  = the calculated response for that 
standard using the regression equation 
 
m = number of internal standard replicates 
 
n = number of points in the curve 
 
𝑌𝑌� = response for analyte in sample 
 
𝑦𝑦� = average response for analyte in all standards 
 





APPENDIX 3: MS/MS OF PRIORITIZED PEAKS OF INTEREST. 
MS/MS spectra for: 1) m/z 387, 2) m/z 403, 3) m/z 419, 4) m/z228, 5) m/z 242-1, 6) m/z 
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